doc_id	relation_id	relation_name	gene_words	hpoterm_words	words	sentences_before	sentences_after	expectation	gene_expectation	hpoterm_expectation	features	weights
SCPDFS_40421.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_40421.pdf_520_520_2_2_10_10_UNSUP	HERG/HP:0011675|Arrhythmia	{2}	{10}	{Spectrum,of,HERG,K1,channel,dysfunction,in,an,inherited,cardiac,arrhythmia,.}	{"GENOMIC STRUCTURE OF KVLQT1 , HERG , AND KCNE1 97","Sanguinetti , M. C. , Curran , M. E. , Spector , P. S. , and Keating , M. T. ( 1996a ) ."}	{"Proc .","Natl. Acad ."}	0.84	0.614	0.99	{DEP_PATH_[nn@prep_in],POS_SEQ_[NN_NN_NN_IN_DT_VBN_JJ],DEP_PATH_POS_[nn@prep_in],VERB_DEP_PATH_[inherit]_[nn@amod-prep_in|arrhythmium]_[@amod],"WORD_SEQ_[k1 channel dysfunction in a inherit cardiac]",VERB_DEP_PATH_POS_[inherit]_[nn@amod-prep_in|NN]_[@amod]}	{0.374951,0.371328,0.356655,0.20515,0.20515,0.20515}
SCPDFS_38516.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_38516.pdf_217_217_23_23_31_31_UNSUP	FRDA/HP:0001251|Ataxia	{23}	{31}	{The,relative,frequency,of,Friedreich,ataxia,in,two,comparable,European,studies,was,shown,to,be,~,75,%,;,a,Spanish,study,found,FRDA,gene,mutations,in,175,of,241,recessive/sporadic,ataxia,patients,[,23,],and,a,French,study,found,the,same,in,140,of,187,patients,[,24,],.}	{"M. Gomez et al. / Genomics 84 ( 2004 ) 779-784 783","signiﬁcantly when assuming either bi-or triracial models for genetic admixture [ 17 ] ; ( C ) sub-Saharan Africans do not have E alleles [ 8 ] and therefore in bi-or triracial models European FRDA genes are their only plausible source ."}	{"In contrast , a similarly ascertained cohort of Mexican Mestizo patients revealed an eightfold lower frequency , indicating that the underlying cause for recessive/sporadic ataxia in the Mexican population remains largely unknown .","Indeed , most patients tested negative for other known mutations causing inherited ataxias ."}	0.802	0.966	0.948	{VERB_DEP_PATH_[find]_[nn-nsubj|mutation@]_[nn-prep_of|patient-prep_in|NUMBER-nsubj|mutation@],POS_SEQ_[NN_NNS_IN_CD_IN_CD_JJ],VERB_DEP_PATH_POS_[find]_[nn-nsubj|NNS@]_[nn-prep_of|NNS-prep_in|CD-nsubj|NNS@],DEP_PATH_[nn@nn-prep_of|patient-prep_in|NUMBER],"WORD_SEQ_[gene mutation in 175 of 241 recessive/sporadic]","WORD_SEQ_NER_[gene mutation in NUMBER of NUMBER recessive/sporadic]",DEP_PATH_POS_[nn@nn-prep_of|NNS-prep_in|CD]}	{0.199334,0.199334,0.199334,0.199334,0.199334,0.199334,0.199334}
SCPDFS_45489.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_45489.pdf_33_33_33_33_29_29_UNSUP	ASL/HP:0012072|Aciduria	{33}	{29}	{A,human,ASL,cDNA,was,cloned,",",sequenced,",",and,mapped,by,somatic,cell,hybrid,DNA,and,in,situ,chromosomal,analysis,to,begin,studying,the,affected,protein,in,argininosuccinate,aciduria,and,control,of,ASL,gene,expression,.}	{"This variable deﬁciency seems to contradict the evidence that the ASL protein expressed in every tissue is encoded by the same gene .","It is possible , however , that the gene is under the control of separate regulatory genes which are tissue speciﬁc ."}	{"Comparison of the human cDNA sequence with the yeast genomic sequence showed the gene to be highly conserved at both the nucleic acid and the putative amino acid sequence levels .","We were able to conﬁrm previous mapping reports while further delimiting the gene ’s location by in situ analysis of human metaphase chromosomes ."}	0.766	0.376	0.97	{INV_POS_SEQ_[CC_NN_IN],INV_VERB_DEP_PATH_[begin]_[nn-prep_of|expression-dobj|protein-xcomp|study@]_[prep_in-dobj|protein-xcomp|study@],INV_DEP_PATH_[nn-prep_of|expression@prep_in],INV_VERB_DEP_PATH_POS_[affect]_[nn-prep_of|NN@amod]_[prep_in@amod],INV_VERB_DEP_PATH_POS_[study]_[nn-prep_of|NN-dobj|NN@]_[prep_in-dobj|NN@],"INV_WORD_SEQ_[and control of]",INV_VERB_DEP_PATH_POS_[begin]_[nn-prep_of|NN-dobj|NN-xcomp|VBG@]_[prep_in-dobj|NN-xcomp|VBG@],INV_VERB_DEP_PATH_[affect]_[nn-prep_of|expression@amod]_[prep_in@amod],INV_VERB_DEP_PATH_[study]_[nn-prep_of|expression-dobj|protein@]_[prep_in-dobj|protein@],INV_DEP_PATH_POS_[nn-prep_of|NN@prep_in]}	{-0.901044,0.253071,0.253071,0.253071,0.253071,0.253071,0.253071,0.253071,0.253071,-0.0268641}
SCPDFS_26450.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_26450.pdf_394_394_0_1_7_10_UNSUP	Morquio_syndrome/HP:0000687|Widely spaced teeth	{0,1}	{7,9,10}	{Morquio,syndrome,involves,craniofacial,abnormalities,",",including,wide,—,spaced,teeth,",",thin,enamel,",",broad,mouth,",",and,dense,calvarium,",",but,has,been,attributed,to,a,deﬁciency,in,galactosamine,(,N,.}	{"Our chromosome localization analysis mapped C192 7 to the region 16q22 , in proximity to a zinc ﬁnger gene cluster on chromosome 16q22 ( Cannizzaro et al. , 1993 ) .","Amongst the diseases associated with this chromosome region are acute myeloid anemia , Fanconi anemia type A , and Mucopolysaccharidosis type IVA ( Morquio syndrome ) ."}	{"— .","acetyl ) ."}	0.702	0.076	0.996	{DEP_PATH_[nsubj@ccomp],DEP_PATH_POS_[nsubj@ccomp],VERB_DEP_PATH_POS_[attribute]_[nsubj@ccomp]_[ccomp@ccomp],"WORD_SEQ_[involve craniofacial abnormality , include]",VERB_DEP_PATH_[include]_[nsubj-_|involve@ROOT@_]_[ccomp-_|involve@ROOT@_],VERB_DEP_PATH_[attribute]_[nsubj@ccomp]_[ccomp@ccomp],VERB_DEP_PATH_[involve]_[nsubj@]_[ccomp@],VERB_DEP_PATH_POS_[be]_[nsubj@auxpass-ccomp|VBN]_[ccomp@auxpass-ccomp|VBN],VERB_DEP_PATH_[space]_[nsubj@ccomp]_[@],VERB_DEP_PATH_POS_[have]_[nsubj@aux-ccomp|VBN]_[ccomp@aux-ccomp|VBN],VERB_DEP_PATH_POS_[space]_[nsubj@ccomp]_[@],VERB_DEP_PATH_POS_[include]_[nsubj-_|VBZ@ROOT@_]_[ccomp-_|VBZ@ROOT@_],VERB_DEP_PATH_POS_[involve]_[nsubj@]_[ccomp@],VERB_DEP_PATH_[have]_[nsubj@aux-ccomp|attribute]_[ccomp@aux-ccomp|attribute],VERB_DEP_PATH_[be]_[nsubj@auxpass-ccomp|attribute]_[ccomp@auxpass-ccomp|attribute],"POS_SEQ_[VBZ_JJ_NNS_,_VBG]"}	{-0.728069,-0.728069,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,0.18929,-0.0310271}
SCPDFS_39202.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39202.pdf_77_77_0_0_14_16_UNSUP	BWS/HP:0000280|Coarse facial features	{0}	{14,15,16}	{BWS,traits,in,Patient,B,include,macroglossia,",",ear,creases,",",omphalocele,",",and,coarse,facial,features,.}	{"There were no other affected family members in this pedigree .","Patient B belongs to a pedigree where his mother is one of a pair of monozygotic twins ."}	{"Patient B ’s aunt suffered a placental abruption with fetal demise of a 30weekgestation fetus with features of BWS including macroglossia , adrenal cytomegaly , somatic growth retardation , and polyhydramnios .","Patient C was diagnosed on the basis of macroglossia , ear abnormalities , omphalocele , hypoglycemia , vascular abnormalities , and a positive family history ."}	0.762	0.022	0.994	{"WORD_SEQ_[trait in patient b include macroglossium , ear crease , omphalocele , and]",DEP_PATH_[nn-nsubj|trait@conj_and-dobj|macroglossium],"POS_SEQ_[NNS_IN_NN_NN_VBP_NN_,_NN_NNS_,_NN_,_CC]",VERB_DEP_PATH_[include]_[nn-nsubj|trait@]_[conj_and-dobj|macroglossium@],DEP_PATH_POS_[nn-nsubj|NNS@conj_and-dobj|NN],VERB_DEP_PATH_POS_[include]_[nn-nsubj|NNS@]_[conj_and-dobj|NN@]}	{0.234807,0.234807,0.234807,0.234807,0.225546,0.0189817}
journal.pbio.1000393.pdf	RELATION_GENEHPOTERM_journal.pbio.1000393.pdf_562_562_37_37_40_40	AKT/HP:0100753|Schizophrenia	{37}	{40}	{Ide,1,"\\\\",’,I,",",Ohnishi,T,",",1,"\\\\",’,Iurayama,IVI,",",Nlatsumoto,I,",",Yamada,K,",",et,al.,(,2006,),Failure,to,support,a,genetic,contribution,of,AKTI,polymorphisms,and,altered,AKT,signaling,in,schizophrenia,.}	{"( 2007 ) Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3 [ beta ] in ventral prefrontal cortex of depressed suicide victims .","Biological Psychiatry 61 : 240 — 245 ."}	{"J Neurochem 99 : 277 * 287 .","Keri S , Seres I , Kelemen O , Benedek G ( 2009 ) The relationship among neuregulin 1 ~ stimu1ated phosphorylation of AKT , psychosis proneness , and habituation of arousal in nonclinical individuals ."}	0.838	0.924	0.974	{"WORD_SEQ_[signaling in]",POS_SEQ_[NN_IN],DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],VERB_DEP_PATH_POS_[support]_[nn-conj_and|NN-dobj|NN@]_[prep_in-conj_and|NN-dobj|NN@],VERB_DEP_PATH_[support]_[nn-conj_and|signaling-dobj|contribution@]_[prep_in-conj_and|signaling-dobj|contribution@]}	{1.98883,-0.989443,0.374951,0.356655,0,0}
SCPDFS_4324.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_4324.pdf_342_342_9_9_2_3_UNSUP	CAR/HP:0001760|Abnormality of the foot	{9}	{2,3}	{Despite,the,abnormal,foot,process,morphology,",",podocytes,in,CAR,morphants,are,still,able,to,assemble,slit,diaphragms,in,agreement,with,their,following,a,normal,differentiation,pathway,.}	{"Subsequently , CAR expression becomes downregulated within differentiated podocytes to undetectable mRNA and protein levels yet persists within the parietal cells of the Bowman ’s capsule .","In CAR morphants , podocytes appear to follow a normal differentiation pathway as indicated by rzephrin mRNA expression but are unable to elaborate regularly patterned , interdigitated foot processes ."}	{"While more complex interpretations are possible , the most parsimonious explanation states that CAR is required within podocyte precursors for their proper morphological maturation .","A potential role for CAR in podocyte maturation was suggested by Nagai et al. who showed that CAR is found in newly formed podocyte tight junctions ( Nagai et al. , 2003 ) ."}	0.806	0.554	0.684	{"INV_POS_SEQ_[NN_NN_,_NNS_IN]",INV_VERB_DEP_PATH_[be]_[nn-prep_in|morphant-nsubj|podocyte@cop]_[amod-prep_despite|morphology@cop],INV_VERB_DEP_PATH_[assemble]_[nn-prep_in|morphant-nsubj|podocyte@xcomp]_[amod-prep_despite|morphology@xcomp],INV_VERB_DEP_PATH_POS_[be]_[nn-prep_in|NNS-nsubj|NNS@cop]_[amod-prep_despite|NN@cop],INV_DEP_PATH_POS_[nn-prep_in|NNS-nsubj|NNS@amod-prep_despite|NN],INV_VERB_DEP_PATH_POS_[assemble]_[nn-prep_in|NNS-nsubj|NNS@xcomp]_[amod-prep_despite|NN@xcomp],"INV_WORD_SEQ_[process morphology , podocyte in]",INV_DEP_PATH_[nn-prep_in|morphant-nsubj|podocyte@amod-prep_despite|morphology]}	{0.179898,0.179898,0.179898,0.179898,0.179898,0.179898,0.179898,0.179898}
journal.pone.0082879.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0082879.pdf_594_594_0_0_5_5_UNSUP	THAP1/HP:0001332|Dystonia	{0}	{5}	{THAP1,sequence,variants,in,primary,dystonia,.}	{"43 .","Xiao J , Zhao Y , Bastian RVV , Per1mutterJS , Racette BA , et al. ( 2010 ) Novel"}	{"Neurology 74 : 2294238 .","Brown DE , Thrall 1 \\\\ IA , VVa1k1ey SU , \\\\ / Vurzelmann S , \\\\ / Venger DA , et al. ( 1996 ) Nletabolic a1 ) normalities in feline Niemann-Pick type C heterozygotes ."}	0.702	0.136	0.994	{"WORD_SEQ_[sequence variant in primary]",DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NN_NNS_IN_JJ]}	{0.412053,0.374951,0.356655,-0.275686}
journal.pgen.1003675.pdf	RELATION_GENEHPOTERM_journal.pgen.1003675.pdf_550_550_32_32_36_36	IKBKAP/HP:0002459|Dysautonomia	{32}	{36}	{Slaugenhaupt,SA,",",Blumenfeld,A,",",Gill,SP,",",Leyne,1,"\\\\",’,I,",",lVIullJ,",",et,al.,(,2001,),Tissue,»,Speciﬁc,Expression,of,a,Splicing,lVIutation,in,the,IKBKAP,Gene,Causes,Familial,Dysautonomia,.}	{"1 \\\\ ’ Iolecular Cell 24 : 1394148 .","doi :10.1016 / j. molcel .2006.07.031 ."}	{"The American Journal of Human Genetics 68 : 5984 605 .","doi :10.1086 / 318810 ."}	0.854	0.282	0.992	{"WORD_SEQ_[gene cause familial]",POS_SEQ_[NN_VBZ_JJ],DEP_PATH_POS_[nn-prep_in|NN-prep_of|NN-dep|NN-nsubj|FW@dobj],DEP_PATH_[nn-prep_in|gene-prep_of|lviutation-dep|expression-nsubj|(@dobj]}	{1.55293,0.0276716,0,0}
journal.pone.0046742.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0046742.pdf_16_16_28_28_36_37_UNSUP	COL8A2/HP:0001131|Corneal dystrophy	{28}	{36,37}	{Citation,:,lgo,RP,Jr,",",Kopplin,LJ,",",Joseph,P,",",Truitt,B,",",Fondran,J,",",et,al.,(,2012,),Differing,Roles,for,TCF4,and,COL8A2,in,Central,Corneal,Thickness,and,Fuchs,Endothelial,Corneal,Dystrophy,.}	{"Thus , common variants in TCF4 appear to influence FECD directly , and CCT secondarily via FECD .","Additionally , changes in corneal thickness due to the effect of other loci may modify disease severity , age — at — onset , or other biomechanical characteristics ."}	{"PLOS ONE 7 ( 10 ) : e46742 .","doi :10.1371 / journa | ."}	0.774	0.494	0.97	{DEP_PATH_POS_[conj_and-prep_for|NN-dep|NNS-dep|FW-dep|NNP@dep],POS_SEQ_[IN_NNP_NNP_NNP_CC_NNP_JJ],"WORD_SEQ_[in Central Corneal Thickness and Fuchs endothelial]",DEP_PATH_[conj_and-prep_for|tcf4-dep|role-dep|(-dep|Jr@dep]}	{0.316332,0.316332,0.316332,0.316332}
journal.pone.0104154.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0104154.pdf_21_21_18_18_10_10_UNSUP	FGF23/HP:0002749|Osteomalacia	{18}	{10}	{nu,|,|,mice,had,significant,improvement,in,rickets,and,osteomalacia,in,association,with,a,decrease,in,serum,FGF23,(,3607,to,1099,pg/ml,),",",an,increase,in,serum,phosphate,(,6.0,mg/dl,to,9.3,mg/dl,),and,"1,25",(,OH,),2D,(,121,:23,to,192:34,pg/ml,),levels,",",but,only,a,30,%,reduction,in,bone,FGF23,mRNA,expression,.}	{"Compared to Hyp mice , compound Hyp ; Fgfr1D ' “ \\" l \\" K ° .","— ."}	{"FGF23 promoter activity in osteoblasts was stimulated by FGFR1 activation and inhibited by overexpression of a dominant negative FGFR1 ( TK — ) , PLCy and MAPK inhibitors .","FGF2 also stimulated the translation of an FGF23 cDNA transfected into osteoblasts via a FGFR1 and P | 3K/Akt — dependent mechanism ."}	0.812	0.988	1	{"INV_WORD_SEQ_[in association with a decrease in serum]",INV_VERB_DEP_PATH_POS_[have]_[prep_in-prep_with|NN-prep_in|NN@]_[prep_in-dobj|NN@],INV_DEP_PATH_[prep_in-prep_with|decrease-prep_in|association@prep_in-dobj|improvement],INV_DEP_PATH_POS_[prep_in-prep_with|NN-prep_in|NN@prep_in-dobj|NN],INV_POS_SEQ_[IN_NN_IN_DT_NN_IN_NN],INV_VERB_DEP_PATH_[have]_[prep_in-prep_with|decrease-prep_in|association@]_[prep_in-dobj|improvement@]}	{0.212624,0.212624,0.212624,0.212624,0.212624,0.212624}
journal.pone.0008247.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0008247.pdf_153_153_11_11_20_21_UNSUP	alpha-synuclein/HP:0100315|Lewy bodies	{11}	{20,21}	{However,",",recent,progresses,in,molecular,biology,and,histoimmunology,suggest,that,alpha-synuclein,deposits,",",which,constitute,the,main,part,of,Lewy,bodies,",",involve,other,cerebral}	{"The result we observe should therefore be considered with care , as an array of different microanatomical factors could be at the origin of this decrease .","Lewy bodies have been historically considered as the hallmark of the disease [ 25 ] , and more recently , their presence in the substantia nigra has been proposed to correlate with the motor scores of the UPDRS [ 26 ] ."}	{"December 2009 | Volume 4 | Issue 12 | e8247","structures than those latter , including the pons and the medulla oblongata , and that it should be considered as a more direct measure of PD pathology and clinical symptomatology [ 27 ] ."}	0.844	0.35	0.958	{"WORD_SEQ_[deposit , which constitute the main part of]",VERB_DEP_PATH_POS_[constitute]_[nn@rcmod]_[prep_of-dobj|NN@],DEP_PATH_[nn@prep_of-dobj|part-rcmod|constitute],VERB_DEP_PATH_[involve]_[nn-nsubj|deposit@]_[prep_of-dobj|part-rcmod|constitute-nsubj|deposit@],VERB_DEP_PATH_POS_[involve]_[nn-nsubj|NNS@]_[prep_of-dobj|NN-rcmod|VBP-nsubj|NNS@],"POS_SEQ_[NNS_,_WDT_VBP_DT_JJ_NN_IN]",VERB_DEP_PATH_[constitute]_[nn@rcmod]_[prep_of-dobj|part@],DEP_PATH_POS_[nn@prep_of-dobj|NN-rcmod|VBP]}	{0.211193,0.211193,0.211193,0.211193,0.211193,0.211193,0.211193,0.201071}
journal.pone.0092923.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0092923.pdf_42_42_41_41_51_51_UNSUP	KCNA5/HP:0011675|Arrhythmia	{41}	{51}	{Whereas,",",blockade,of,[,Km,may,facilitate,IC,",",",",",",L,activation,following,a,pronounced,spike-and-dome,conﬁguration,and,therefore,enhance,intracellular,Ca2,+,inﬂux,ocO,Moreover,",",human,Kv1,.5,(,hKv1,.5,),is,encoded,by,KCNA5,and,KCNA5,loss-of-function,mutations,have,been,reported,to,produce,kindred,atrial,arrhythmia,",",which,suggest,that,the,genetic,alteration,of,hKv1,.5,may,substantially,enhance,arrhythmia,susceptibility,[,"8,9",],.}	{"is expressed in the cardiac atrial , but scarcely in the ventricular cells in human [ 4,5 ] , thus IKH , has important roles in controlling action potential ( AP ) shape and contractility in the human atrium .","Physiologically , rapid activation of [ Km current following the AP upstroke may reduce Ca2 + inﬂux via L-type Ca2 + channels ( IC , , ) L ) and result in less positive plateau phase [ 6 ] ."}	{"Therefore , the normal expression or channel activity of Kvl .5 is important in the regulation of the proper electrical properties of cardiac atrial myocytes .","Recently , basic studies have"}	0.892	0.994	0.98	{DEP_PATH_POS_[nn-nsubjpass|NNS@dobj-xcomp|VB],VERB_DEP_PATH_[report]_[nn-nsubjpass|mutation@]_[dobj-xcomp|produce@],VERB_DEP_PATH_[produce]_[nn-nsubjpass|mutation@xcomp]_[dobj@],DEP_PATH_[nn-nsubjpass|mutation@dobj-xcomp|produce],VERB_DEP_PATH_[be]_[nn-nsubjpass|mutation@auxpass]_[dobj-xcomp|produce@auxpass],VERB_DEP_PATH_[encode]_[nn-nsubjpass|mutation-conj_and|report@]_[dobj-xcomp|produce-conj_and|report@],VERB_DEP_PATH_[facilitate]_[nn-nsubjpass|mutation-conj_and|report@advcl]_[dobj-xcomp|produce-conj_and|report@advcl],VERB_DEP_PATH_POS_[facilitate]_[nn-nsubjpass|NNS-conj_and|VBN@advcl]_[dobj-xcomp|VB-conj_and|VBN@advcl],VERB_DEP_PATH_POS_[produce]_[nn-nsubjpass|NNS@xcomp]_[dobj@],POS_SEQ_[NN_NNS_VBP_VBN_VBN_TO_VB_NN_JJ],VERB_DEP_PATH_[enhance]_[nn-nsubjpass|mutation-conj_and|report@dep]_[dobj-xcomp|produce-conj_and|report@dep],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NNS-conj_and|VBN@auxpass]_[dobj-xcomp|VB-conj_and|VBN@auxpass],VERB_DEP_PATH_[be]_[nn-nsubjpass|mutation-conj_and|report@auxpass]_[dobj-xcomp|produce-conj_and|report@auxpass],VERB_DEP_PATH_[have]_[nn-nsubjpass|mutation@aux]_[dobj-xcomp|produce@aux],VERB_DEP_PATH_POS_[report]_[nn-nsubjpass|NNS@]_[dobj-xcomp|VB@],"WORD_SEQ_[loss-of-function mutation have be report to produce kindred atrial]",VERB_DEP_PATH_POS_[encode]_[nn-nsubjpass|NNS-conj_and|VBN@]_[dobj-xcomp|VB-conj_and|VBN@],VERB_DEP_PATH_POS_[enhance]_[nn-nsubjpass|NNS-conj_and|VBN@dep]_[dobj-xcomp|VB-conj_and|VBN@dep],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NNS@auxpass]_[dobj-xcomp|VB@auxpass],VERB_DEP_PATH_POS_[have]_[nn-nsubjpass|NNS@aux]_[dobj-xcomp|VB@aux]}	{-0.223717,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,0.147386,-0.112887,-0.0167037}
SCPDFS_46034.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46034.pdf_9_9_23_23_10_10_UNSUP	TUBA1A/HP:0002126|Polymicrogyria	{23}	{10}	{The,recent,discovery,of,patients,with,lissencephaly,and,bilateral,asymmetrical,polymicrogyria,(,PMG,),carrying,mutations,in,the,a,-,and,B-tubulin-encoding,genes,TUBA1A,and,TUBB2B,further,supports,this,view,",",and,also,raises,interesting,questions,about,the,specific,roles,played,by,certain,tubulin,isotypes,during,the,development,of,the,cortex,.}	{"Over the past few years , the importance of cytoskeleton components in cellular processes crucial for cortical development has emerged from a body of functional data .","This was reinforced by the association of mutations in the LIS1 and DCX genes , which both encode proteins involved in microtubule ( MT ) homeostasis , with cerebral cortex developmental disorders ."}	{"Genetic basis of cortical dysgeneses Genetic studies in humans and mice have identiﬁed a spectrum of mutations in genes involved in a large array of crucial processes ( e.g. cell proliferation , cell adhesion , cell migration , chemoattraction and repulsion , posttranslational modiﬁcations and dynamics of the cytoskeleton ) that often disrupts the development of the cerebral cortex ( Box 1 and Figure I ) and can lead to severe cortical malformations .","The heterogeneity of developmental disorders affecting the cortex recapitulates its development , because impairments in the different steps are associated With speciﬁc features [ 1 — 3 ] ."}	0.844	0.824	0.988	{INV_DEP_PATH_POS_[nsubj-conj_and|VBZ@nn-conj_and|NN-prep_of|NNS-nsubj|NN],INV_VERB_DEP_PATH_POS_[carry]_[nsubj-conj_and|VBZ@]_[nn-conj_and|NN-prep_of|NNS-nsubj|NN@],INV_VERB_DEP_PATH_[carry]_[nsubj-conj_and|support@]_[nn-conj_and|(-prep_of|patient-nsubj|discovery@],INV_DEP_PATH_[nsubj-conj_and|support@nn-conj_and|(-prep_of|patient-nsubj|discovery],"INV_WORD_SEQ_NER_[( ORGANIZATION NUMBER carry mutation in the a - and b-tubulin-encoding gene]","INV_WORD_SEQ_[( pmg ) carry mutation in the a - and b-tubulin-encoding gene]",INV_POS_SEQ_[NN_NN_CD_VBG_NNS_IN_DT_SYM_:_CC_JJ_NNS]}	{0.339924,0.339924,0.339924,0.339924,0.136748,0.136748,0.136748}
SCPDFS_40649.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_40649.pdf_436_436_6_6_14_15_UNSUP	FGFR3/HP:0000956|Acanthosis nigricans	{6}	{14,15}	{Fibroblast,growth,factor,receptor,3,(,FGFR3,),transmembrane,mutation,in,Crouzon,syndrome,with,acanthosis,nigricans,.}	{"USA 92 : 3249-3253 .","Meyers , G. A. , Orlow , S. J. , Munro , I. R. , Przylepa , K. A. , and Jabs , E. W. ( 1995 ) ."}	{"Nat .","Genet ."}	0.886	1	0.998	{"WORD_SEQ_[) transmembrane mutation in crouzon syndrome with]","WORD_SEQ_NER_[NUMBER transmembrane mutation in crouzon syndrome with]",DEP_PATH_[@prep_with-prep_in|syndrome-dep|mutation],DEP_PATH_POS_[@prep_with-prep_in|NN-dep|NN],POS_SEQ_[CD_NN_NN_IN_NN_NN_IN]}	{0.546881,0.546881,0.44184,0.325209,0.311179}
journal.pgen.1000649.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1000649.pdf_2_2_3_3_12_13_UNSUP	SCN9A/HP:0002373|Febrile seizures	{3}	{12,13}	{A,Role,of,SCN9A,in,Human,Epilepsies,",",As,a,Cause,of,Febrile,Seizures,and,As,a,Potential,Modifier,of,Dravet}	{"OPEN 8 ACCESS Freely available online PLUS GENETICS"}	{Syndrome,"Nanda A. Singh ‘ * , Chris Pappas ‘ , E. Jill Dahle ‘ , Lieve R. F. Claesz , Timothy H. Pruess3 , Peter De Jonghez , Joel Thompson “ , Missy Dixon ‘ , Christina Gurnetts , Andy Peiffers , H. Steve White3 , Francis Fi | | oux4 , Mark F. Leppert ‘"}	0.796	0.602	0.988	{"POS_SEQ_[IN_JJ_NNS_,_IN_DT_NN_IN]","WORD_SEQ_[in human epilepsy , as a cause of]",DEP_PATH_[prep_of@prep_of-prep_as|cause],DEP_PATH_POS_[prep_of@prep_of-prep_as|NN]}	{0.702491,0.702491,0.169672,0.0632314}
journal.pone.0101898.pdf	RELATION_GENEHPOTERM_journal.pone.0101898.pdf_345_345_31_31_35_37	CA9/HP:0005584|Renal cell carcinoma	{31}	{35,36,37}	{Cho,NI,",",Uemura,H,",",Kim,SC,",",Kawada,Y,",",Yoshida,K,",",et,al.,(,2001,),Hypomethylation,of,the,MN,/,CA9,promoter,and,upregulated,MN,/,CA9,expression,in,human,renal,cell,carcinoma,.}	{"Genomics 33 : 480 — 487 .","12 ."}	{"Br ] Cancer 85 : 5634567 .","13 ."}	0.792	0.868	1	{"WORD_SEQ_[expression in human]",DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NN_IN_JJ],VERB_DEP_PATH_[upregulate]_[nn-dep|expression@dep]_[prep_in-dep|expression@dep],VERB_DEP_PATH_POS_[upregulate]_[nn-dep|NN@dep]_[prep_in-dep|NN@dep]}	{0.384103,0.374951,0.356655,0.199886,0,0}
journal.pone.0003652.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0003652.pdf_102_102_33_33_29_29_UNSUP	SCA3/HP:0001251|Ataxia	{33}	{29}	{MiRNAs,have,already,been,shown,to,play,a,role,",",possibly,positively,inﬂuencing,neuronal,survival,",",in,the,modulation,of,Ataxin-3,(,ATXN3,),in,the,polyglutamine,disease,spinocerebellar,ataxia,type,3,(,SCA3,),where,the,miRNA,ban,was,determined,to,act,down-stream,of,ATXN-3,toxicity,[,l8,],.}	{"+ PLoS ONE | www .","p | osone.org neurodegenerative disorders , especially those linked with the accumulation of aggregated proteins ."}	{"Bioinformatic analysis identiﬁed Ataxin-l ( ATXNl ) itself as a potential target of miRNAs up-regulated in this study .","The disruption in the clearance of protein aggregates by the ubiquitin-proteasome ( UPS ) pathway has also been found to play a role in pathogenesis of several neurodegenerative conditions including late-onset Parkinson ’s and Huntington ’s disease [ 29 ] ."}	0.86	0.014	1	{"INV_WORD_SEQ_NER_[type NUMBER (]",INV_POS_SEQ_[NN_CD_NN],"INV_WORD_SEQ_[type 3 (]",INV_DEP_PATH_[@nn],INV_DEP_PATH_POS_[@nn],INV_VERB_DEP_PATH_[determine]_[prep_in-prep_of|)@rcmod]_[nn-prep_in|sca3-prep_of|)@rcmod],INV_VERB_DEP_PATH_POS_[show]_[prep_in-prep_of|NN-prep_in|NN@]_[nn-prep_in|NN-prep_of|NN-prep_in|NN@],INV_VERB_DEP_PATH_POS_[determine]_[prep_in-prep_of|NN@rcmod]_[nn-prep_in|NN-prep_of|NN@rcmod],INV_VERB_DEP_PATH_[show]_[prep_in-prep_of|)-prep_in|modulation@]_[nn-prep_in|sca3-prep_of|)-prep_in|modulation@]}	{2.45298,-1.05044,0.306515,-0.261945,-0.245954,0.156024,0.156024,0.156024,0.156024}
journal.pone.0002247.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0002247.pdf_95_95_1_1_10_10_UNSUP	ALL/HP:0001909|Leukemia	{1}	{10}	{The,ALL,set,is,further,divided,into,T-cell,and,B-cell,leukemia,and,the,AML,set,is,divided,into,patients,who,underwent,treatment,and,those,who,did,not,.}	{"dataset has served as a benchmark for several clustering methods [ 17 — 19 ] .","The experiment sampled 72 patients with two types of leukemia , ALL and AML ."}	{"For each patient , the expression levels of 7129 genes is reported .","The clustering task is to ﬁnd the four cancer groups within the 72 patients in a [ 72 patients > < 7129 genes ] gene expression matrix ( Table S4 , supplementary material ) ."}	0.886	0.01	0.998	{VERB_DEP_PATH_POS_[divide]_[nn-nsubj|NN@partmod]_[prep_into@],VERB_DEP_PATH_[be]_[nn-nsubj|set@auxpass-conj_and|divide]_[prep_into-partmod|divide@auxpass-conj_and|divide],VERB_DEP_PATH_[be]_[nn-nsubj|set@cop]_[prep_into-partmod|divide@cop],VERB_DEP_PATH_[divide]_[nn-nsubj|set@conj_and]_[prep_into-partmod|divide@conj_and],"WORD_SEQ_[set be further divide into t-cell and b-cell]",DEP_PATH_[nn-nsubj|set@prep_into-partmod|divide],"WORD_SEQ_NER_[set be further divide into MISC and MISC]",VERB_DEP_PATH_POS_[be]_[nn-nsubj|NN@auxpass-conj_and|VBN]_[prep_into-partmod|VBN@auxpass-conj_and|VBN],VERB_DEP_PATH_POS_[be]_[nn-nsubj|NN@cop]_[prep_into-partmod|VBN@cop],DEP_PATH_POS_[nn-nsubj|NN@prep_into-partmod|VBN],VERB_DEP_PATH_[divide]_[nn-nsubj|set@partmod]_[prep_into@],POS_SEQ_[NN_VBZ_JJ_VBN_IN_NN_CC_NN],VERB_DEP_PATH_POS_[divide]_[nn-nsubj|NN@conj_and]_[prep_into-partmod|VBN@conj_and]}	{0.14405,0.14405,0.14405,0.14405,0.14405,0.14405,0.14405,0.14405,0.14405,0.14405,0.14405,0.14405,0.14405}
SCPDFS_43229.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_43229.pdf_140_140_57_57_64_65_UNSUP	RYR1/HP:0002047|Malignant hyperthermia	{57}	{64,65}	{A,single-nucleotide,deletion,at,nucleotide,4010,in,the,murine,skeletal,muscle,DHP,receptor,oz,",",~,subunit,mRNA,has,recently,been,shown,to,underlie,the,fatal,recessive,disorder,of,mice,",",muscular,dysgenesis,(,mdg,;,3,),",",and,mutations,in,or,near,the,gene,encoding,the,calcium,efﬁux,channel,of,skeletal,muscle,sarcoplasmic,reticulum,(,RYR1,),have,been,associated,with,porcine,malignant,hyperthermia,(,10,),.}	{"CACNL1A3 , to band q32 in the region q32 .1 ~ q32 .2 of chromosome 1 .","Recently , much interest has arisen in the potential role played by defects in calcium channels in hereditary diseases of skeletal muscle ."}	{"The reﬁned localization of human skeletal muscle DHP receptor oz,-subunit gene to chromosome 1q32 and the identiﬁcation of a new , highly polymorphic dinucleotide repeat marker at the CACNL 1A3 locus should facilitate further investigation of the potential role played by this protein in other hereditary disorders of skeletal muscle .",ACKNOWLEDGMENTS}	0.74	0.012	0.644	{POS_SEQ_[CD_VBP_VBN_VBN_IN_NN],DEP_PATH_[nsubjpass-rcmod|associate-dobj|channel-partmod|encode@amod-tmod|(-partmod|encode],DEP_PATH_POS_[nsubjpass-rcmod|VBN-dobj|NN-partmod|VBG@amod-tmod|NN-partmod|VBG],"WORD_SEQ_[) have be associate with porcine]","WORD_SEQ_NER_[NUMBER have be associate with porcine]"}	{0.222673,0.222673,0.222673,0.222673,0.222673}
SCPDFS_46656.pdf	RELATION_GENEHPOTERM_SCPDFS_46656.pdf_125_125_0_0_7_8	MC1R/HP:0002297|Red hair	{0}	{7,8}	{MC1R,antagonist,MC1R,16q24,.3,MSH,receptor,Red,hair,(,skin,type,),G,—,protein,coupled,receptor,POMC,2p23,.3,POMC,",",MSH,",",ACTH,Red,hair,MC1R,agonist,OA1,Xp22,.3,OA1,protein,OA1,G,—,protein,coupled,receptor,MITF,3p12,.3,—,3p14,.1,MITF,Waardenburg,syndrome,type,2,Transcription,factor,Proteins,involved,in,melanosome,transport,or,uptake,by,keratinocytes,MYO5A,15q21,MyosinVa,Griscelli,syndrome,Motor,protein,RAB27A,15q15,—,15q21,.1,Rab27a,Griscelli,syndrome,RAS,family,protein,HPS1,10q23,.1,—,10q23,.3,HPS1,Hermansky,.}	{"Dopachrome tautomerase SILV 12q13 — 12q14 gp100 , pMe | 17 , Silver ?","DH | CA — po | ymerisation and melanosome striations OCA2 15q11 .2 — 15q12 P — protein OCA2 ( eye colour ) pH of melanosome and melanosome maturation MATP 5p14 .3 — 5q12 .3 MATP , A | M — 1 OCA4 ( skin colour ) Melanosome maturation Signal proteins ASIP 20q11 .2 — 20q12 Agouti signal protein ?"}	{"— .","Pud | ak syndrome 1 Organelle biogenesis and size HPS6 10q24 .32 HPS6 Hermansky ."}	0.768	0.942	0.692	{POS_SEQ_[NN_NN_NN_NN_NN_NN],VERB_DEP_PATH_[couple]_[nn@partmod-dep|protein]_[@partmod-dep|protein],VERB_DEP_PATH_POS_[couple]_[nn@partmod-dep|NN]_[@partmod-dep|NN],VERB_DEP_PATH_[couple]_[nn@rcmod]_[@rcmod],VERB_DEP_PATH_POS_[couple]_[nn@rcmod]_[@rcmod],DEP_PATH_POS_[nn@],DEP_PATH_[nn@],"WORD_SEQ_NER_[antagonist mc1r 16q24 NUMBER msh receptor]","WORD_SEQ_[antagonist mc1r 16q24 .3 msh receptor]"}	{-0.57273,0.54199,0.54199,0.54199,0.54199,-0.256246,-0.25619,0,0}
SCPDFS_20290.pdf	RELATION_GENEHPOTERM_SCPDFS_20290.pdf_286_286_3_3_9_10	EXT1/HP:0002762|Multiple exostoses	{3}	{9,10}	{Mutations,in,the,EXT1,and,EXT2,genes,in,hereditary,multiple,exostoses,",",Am,.}	{"5 , 1547-1557 .","Wuyts , W. , et al. , 1998 ."}	{"J. Hum .","Genet ."}	0.804	0.384	1	{POS_SEQ_[CC_NN_NNS_IN_JJ],DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],"WORD_SEQ_[and ext2 gene in hereditary]",VERB_DEP_PATH_[be]_[nn-prep_in|gene-nsubj|mutation@]_[prep_in-prep_in|gene-nsubj|mutation@],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NNS-nsubj|NNS@]_[prep_in-prep_in|NNS-nsubj|NNS@]}	{0.635656,0.374951,0.356655,0,0,0}
gb-2012-13-2-r12.pdf	RELATION_GENEHPOTERM_SUP_MAP_gb-2012-13-2-r12.pdf_290_290_28_28_13_14_UNSUP	C12orf62/HP:0003128|Lactic acidosis	{28}	{13,14}	{Additionally,",",while,this,work,was,under,review,",",a,report,on,neonatal,lactic,acidosis,was,published,[,52,],that,supports,our,prediction,and,experimental,confirmation,of,C12orf62,as,a,COX,assembly,factor,.}	{"PTCD1 has been recently implicated in negative regulation of leucine tRNA levels , as well as negative regulation of mitochondria-encoded proteins and COX activity [ 51 ] .","Recently , the identification of human orthologs of yeast COX assembly factors allowed us to prioritize C20rjf64 / COAS ( Table 2 ) as a candidate gene for a neonatal cardiomyopathy [ 32 ] ."}	{"Of note , the authors argue that C12orf62 is a vertebratespecific protein , while we show that it is orthologous to COX14 .","These discoveries signify the relevance of orthology prediction using profile-based approaches , such as Ortho-Profile , for biomedical research ."}	0.85	0.1	0.328	{INV_VERB_DEP_PATH_POS_[publish]_[prep_of-dobj|NN-rcmod|VBZ-dobj|NN@]_[prep_on-nsubjpass|NN@],INV_POS_SEQ_[VBD_VBN_NN_CD_NN_WDT_VBZ_PRP$_NN_CC_JJ_NN_IN],"INV_WORD_SEQ_[be publish [ 52 ] that support we prediction and experimental confirmation of]",INV_DEP_PATH_POS_[prep_of-dobj|NN-rcmod|VBZ-dobj|NN@prep_on-nsubjpass|NN],INV_VERB_DEP_PATH_POS_[support]_[prep_of-dobj|NN@]_[prep_on-nsubjpass|NN@rcmod-dobj|NN],INV_VERB_DEP_PATH_[publish]_[prep_of-dobj|prediction-rcmod|support-dobj|]@]_[prep_on-nsubjpass|report@],INV_DEP_PATH_[prep_of-dobj|prediction-rcmod|support-dobj|]@prep_on-nsubjpass|report],INV_VERB_DEP_PATH_[support]_[prep_of-dobj|prediction@]_[prep_on-nsubjpass|report@rcmod-dobj|]],"INV_WORD_SEQ_NER_[be publish [ NUMBER ] that support we prediction and experimental confirmation of]"}	{0.182269,0.182269,0.182269,0.182269,0.182269,0.182269,0.182269,0.182269,0.182269}
journal.pone.0039469.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0039469.pdf_870_870_27_27_35_36_UNSUP	FGFR3/HP:0002862|Bladder carcinoma	{27}	{35,36}	{Kimura,T,",",Suzuki,H,",",Ohashi,T,",",Asano,K,",",Kiyota,H,",",et,al.,(,2001,),The,incidence,of,thanatophoric,dysplasia,mutations,in,FGFR3,gene,is,higher,in,low-grade,or,superﬁcial,bladder,carcinomas,.}	{"J Clin Oncol .","21 ( 10 ) : 1912421 ."}	{"Cancer 92 ( 10 ) : 2555461 .",.}	0.866	0.494	1	{DEP_PATH_[prep_in-dep|(@prep_in],VERB_DEP_PATH_[be]_[prep_in-dep|(@cop]_[prep_in@cop],DEP_PATH_POS_[prep_in-dep|FW@prep_in],VERB_DEP_PATH_POS_[be]_[prep_in-dep|FW@cop]_[prep_in@cop],"WORD_SEQ_[gene be higher in low-grade or superﬁcial]",POS_SEQ_[NN_VBZ_JJR_IN_JJ_CC_JJ]}	{0.352721,0.352721,0.352721,0.352721,0.2434,0.2434}
journal.pone.0039465.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0039465.pdf_422_422_30_30_34_35_UNSUP	alpha-synuclein/HP:0100315|Lewy bodies	{30}	{34,35}	{Zarranz,J,],",",Alegre,J,",",Gomez-Estel,),an,JC,",",Lezcano,E,",",Ros,R,",",et,al.,(,2004,),The,new,mutation,",",E46K,",",of,alpha-synuclein,causes,Parkinson,and,Lewy,body,dementia,.}	{"Singleton AB , Farrer 1 \\\\ ’ I , Johnson J , Singleton A , Hague S , et al. ( 2003 ) alphaSynuclein locus triplication causes Parkinson ’s disease .","Science 302 : 841 ."}	{"Ann Neurol 55 : 164-173 .","Edwards TL , Scott VVK , Almonte C , Burt A , Powell EH , et al. ( 2010 ) Genomewide association study conﬁrms SNPs in SNCA and the lVlAPT region as common risk factors for Parkinson disease ."}	0.888	0.246	0.998	{"WORD_SEQ_[cause Parkinson and]",POS_SEQ_[VBZ_NNP_CC],DEP_PATH_POS_[prep_of-appos|NNP-nsubj|NNP@nn-dobj|NN],VERB_DEP_PATH_POS_[cause]_[prep_of-appos|NNP-nsubj|NNP@]_[nn-dobj|NN@],VERB_DEP_PATH_[cause]_[prep_of-appos|PERSON-nsubj|JC@]_[nn-dobj|dementia@],DEP_PATH_[prep_of-appos|PERSON-nsubj|JC@nn-dobj|dementia]}	{1.52373,1.03611,-0.142096,-0.129191,-0.0582128,-0.0582128}
journal.pbio.0050325.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pbio.0050325.pdf_552_552_5_5_2_2_UNSUP	PTEN/HP:0001337|Tremor	{5}	{2}	{Tumours,and,tremors,:,how,PTEN,regulation,underlies,both,.}	{.,"Kim RH , Mak TW ( 2006 ) ."}	{"Br _ ] Cancer 94 : 620 — 624 .","Fallon L , Belanger CM , Corera AT , Kontogiannea M , Regan-Klapisz E , et al. ( 2006 ) ."}	0.836	0.766	0.984	{INV_DEP_PATH_[nn-nsubj|regulation-dep|underlie@conj_and],INV_DEP_PATH_POS_[nn-nsubj|NN-dep|VBZ@conj_and],INV_VERB_DEP_PATH_POS_[underlie]_[nn-nsubj|NN@]_[conj_and@dep],INV_VERB_DEP_PATH_[underlie]_[nn-nsubj|regulation@]_[conj_and@dep],"INV_WORD_SEQ_[: how]",INV_POS_SEQ_[:_WRB]}	{0.348765,0.348765,0.348765,0.348765,0.0912287,0.0912287}
journal.pone.0048042.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0048042.pdf_8_8_18_18_10_11_UNSUP	alpha-synuclein/HP:0100315|Lewy bodies	{18}	{10,11}	{The,main,component,of,the,underlying,pathologic,substrate,",",i.e.,Lewy,bodies,and,Lewy,neurites,",",is,misfolded,alpha-synuclein,(,Asyn,),",",and,—,in,particular,in,demented,LBD,patients,—,co,—,occurring,misfolded,amy,|,oid,—,beta,(,Abeta,),.}	{Abstract,"Parkinson 's disease ( PD ) without ( non — demented , PDND ) and with dementia ( PDD ) , and dementia with Lewy bodies ( DLB ) are subsumed under the umbrella term Lewy body disorders ( LBD ) ."}	{"Lowered blood and cerebrospinal fluid ( CSF ) levels of transthyretin ( ' | ' | ' R ) — a clearance protein mainly produced in the liver and , autonomously , in the choroid plexus — are associated with Abeta accumulation in Alzheimer 's disease .","In addition , a recent study suggests that ' | ' | ' R is involved in Asyn clearance ."}	0.874	0.434	0.912	{"INV_WORD_SEQ_[and Lewy neurite , be misfold]",INV_VERB_DEP_PATH_POS_[misfold]_[amod-dobj|NN@]_[ccomp@],INV_DEP_PATH_[amod-dobj|)@ccomp],"INV_WORD_SEQ_NER_[and PERSON neurite , be misfold]",INV_DEP_PATH_POS_[amod-dobj|NN@ccomp],INV_VERB_DEP_PATH_POS_[occur]_[amod-dobj|NN@conj_and]_[ccomp@conj_and],INV_VERB_DEP_PATH_[occur]_[amod-dobj|)@conj_and]_[ccomp@conj_and],INV_VERB_DEP_PATH_[misfold]_[amod-dobj|)@]_[ccomp@],INV_VERB_DEP_PATH_POS_[be]_[amod-dobj|NN@auxpass]_[ccomp@auxpass],"INV_POS_SEQ_[CC_NNP_NNS_,_VBZ_VBN]",INV_VERB_DEP_PATH_[be]_[amod-dobj|)@auxpass]_[ccomp@auxpass]}	{0.178477,0.178477,0.178477,0.178477,0.178477,0.178477,0.178477,0.178477,0.178477,0.178477,0.178477}
journal.pone.0007878.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0007878.pdf_346_346_12_12_17_19_UNSUP	SYS/HP:0004325|Decreased body weight	{12}	{17,18,19}	{Two,rats,did,not,develop,the,behavioral,features,after,the,fourweek,rotenone,SYS,infusion,",",but,their,body,weight,decreased,gradually,(,by,2,—,5,g/d,),.}	{"In SYS models , a progressive loss of body weight ( by 2 — 5 g / d , data not shown ) and yellow discoloration of the skin were also observed .","These changes might have been caused by difficulty in eating and skin-cleaning associated with behavioral changes ."}	{"After treatment with SYS-infused rotenone for another four weeks , they developed behavioral changes .","\\\\ Ve found that rotenone could accumulate in the subcutaneous adipose tissue because of its lipophilic nature , which might , in part , explain the variation in susceptibility among the animals ."}	0.75	0.876	0.636	{DEP_PATH_[nn-prep_after|infusion@conj_but],"POS_SEQ_[NN_,_CC_PRP$]",VERB_DEP_PATH_[develop]_[nn-prep_after|infusion@]_[conj_but@],"WORD_SEQ_[infusion , but they]",VERB_DEP_PATH_POS_[develop]_[nn-prep_after|NN@]_[conj_but@],VERB_DEP_PATH_[do]_[nn-prep_after|infusion@aux]_[conj_but@aux],VERB_DEP_PATH_[decrease]_[nn-prep_after|infusion@conj_but]_[@],DEP_PATH_POS_[nn-prep_after|NN@conj_but],VERB_DEP_PATH_POS_[decrease]_[nn-prep_after|NN@conj_but]_[@],VERB_DEP_PATH_POS_[do]_[nn-prep_after|NN@aux]_[conj_but@aux]}	{0.140306,0.140306,0.140306,0.140306,0.140306,0.140306,0.140306,0.140306,0.140306,0.140306}
journal.pone.0055324.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0055324.pdf_159_159_16_16_3_3_UNSUP	CD19/HP:0002665|Lymphoma	{16}	{3}	{In,the,GW-584,lymphoma,",",all,were,detected,in,the,primary,tumor,and,",",except,for,CD19,and,VIA/I,",",also,in,all,transplant,passages,examined,(,generations,l,",",26,",",28,",",and,57,),.}	{"However , as listed in Table 1 , other genes on some of these same chromosomes were consistently absent .","In GW-532 , all were present in the primary tumor as well as in most of the 4 transplant generations examined ( generations 2 , 25 , 39 , and 115 ) ."}	{"Thus , these human genes were retained for over 33 months in","Human Hamster"}	0.78	0.056	0.166	{INV_VERB_DEP_PATH_[examine]_[pobj@conj_and]_[prep_in@conj_and],"INV_WORD_SEQ_[, all be detect in the primary tumor and , except for]",INV_VERB_DEP_PATH_POS_[detect]_[pobj@]_[prep_in@],INV_VERB_DEP_PATH_[detect]_[pobj@]_[prep_in@],INV_VERB_DEP_PATH_POS_[examine]_[pobj@conj_and]_[prep_in@conj_and],"INV_POS_SEQ_[,_DT_VBD_VBN_IN_DT_JJ_NN_CC_,_IN_IN]",INV_DEP_PATH_POS_[pobj@prep_in],INV_DEP_PATH_[pobj@prep_in],INV_VERB_DEP_PATH_[be]_[pobj@auxpass]_[prep_in@auxpass],INV_VERB_DEP_PATH_POS_[be]_[pobj@auxpass]_[prep_in@auxpass]}	{0.27449,0.27449,0.27449,0.27449,0.27449,0.27449,-0.252748,-0.252748,0.0885576,0.0885576}
journal.pone.0060177.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0060177.pdf_107_107_2_2_13_13_UNSUP	WT1/HP:0000093|Proteinuria	{2}	{13}	{Detection,of,WT1,protein,in,urinary,exosomes,of,diabetic,patients,with,or,without,proteinuria,.}	{"f f ' Proteinuria + - Protemuna + - Figure","1 ."}	{"A ) Representative immunoblots for WT1 and TSG101 proteins in urinary exosome samples from , type 1 diabetic patients with or without proteinuria and healthy controls .","Exosomal protein obtained from same urine volume was loaded for all the samples ."}	0.75	0.064	0.988	{DEP_PATH_[TOO_FAR_AWAY],POS_SEQ_[NN_IN_JJ_NNS_IN_JJ_NNS_IN_CC_IN],"WORD_SEQ_[protein in urinary exosome of diabetic patient with or without]"}	{0.354873,0.311235,0.311235}
journal.pone.0006020.pdf	RELATION_GENEHPOTERM_journal.pone.0006020.pdf_248_248_7_7_11_11	BAL/HP:0002090|Pneumonia	{7}	{11}	{Alveolar,macrophages,(,AM,),isolated,from,BAL,fluids,of,C.,pneumoniae,—,DNA,negative,patients,were,either,directly,infected,with,C.,pneumoniae,(,open,bars,),or,co,incubated,with,C.,pneumoniae,infected,PMN,at,a,ratio,of,1:1,(,closed,bars,",",66,h,p.i.,),.}	{"Figure 5 .","Alveolar macrophages harbor intracellular chlamydiae in vivo ."}	{"The percentage of AM harvesting large and small inclusions were calculated 90 h p.i. by counting a minimum of 200 cells/slide using a F | TC — labeled anti — C. pneumoniae LPS — staining protocol ( A ) .","Significantly more large chlamydial inclusions were detected in AM co incubated with C. pneumoniae — infected apoptotic PMN than in directly infected AM ( A ."}	0.712	0	0.918	{POS_SEQ_[NNS_IN_NNP],VERB_DEP_PATH_POS_[infect]_[nn@rcmod-prep_of|NNP]_[nn-nsubjpass|NN@],DEP_PATH_[nn@nn-nsubjpass|dna-rcmod|infect-prep_of|C.],VERB_DEP_PATH_[be]_[nn@auxpass-rcmod|infect-prep_of|C.]_[nn-nsubjpass|dna@auxpass],VERB_DEP_PATH_[infect]_[nn@rcmod-prep_of|C.]_[nn-nsubjpass|dna@],DEP_PATH_POS_[nn@nn-nsubjpass|NN-rcmod|VBN-prep_of|NNP],"WORD_SEQ_[fluid of C.]",VERB_DEP_PATH_POS_[be]_[nn@auxpass-rcmod|VBN-prep_of|NNP]_[nn-nsubjpass|NN@auxpass]}	{0.875134,0,0,0,0,0,0,0}
SCPDFS_51992.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_51992.pdf_237_237_15_15_18_18_UNSUP	p53/HP:0002861|Melanoma	{15}	{18}	{17,Satyamoorthy,",",K.,et,al.,(,2000,),Aberrant,regulation,and,function,of,wild-type,p53,in,radioresistant,melanoma,cells,.}	{"100 , 342S-345S","194 Research U pdate"}	{"Cell Growth Differ .","11 , 467-474 18 Soengas , M.S. et al. ( 2001 ) Inactivation of the apoptosis effectorApa.f-1 in malignant melanoma ."}	0.79	0.902	0.994	{DEP_PATH_POS_[prep_of-dobj|NN@nn-prep_in|NNS],"WORD_SEQ_[in radioresistant]",POS_SEQ_[IN_JJ],DEP_PATH_[prep_of-dobj|function@nn-prep_in|cell]}	{0.920263,0.698463,-0.548537,0.418343}
journal.pone.0058031.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0058031.pdf_514_514_26_26_34_34_UNSUP	endoglin/HP:0001009|Telangiectasia	{26}	{34}	{A1,),da11a,SA,",",Pece-Barbara,N,",",Vera,S,",",Tapia,E,",",Paez,E,",",et,al.,(,2000,),Analysis,of,ALK-1,and,endoglin,in,newborns,from,families,with,hereditary,hemorrhagic,telangiectasia,type,2,.}	{"J Med Genet 43 : 7934 797 .","17 ."}	{"Hum 1 \\\\ ’ Iol Genet 9 : 122741237 .","18 ."}	0.884	0.542	1	{POS_SEQ_[IN_NNS_IN_NNS_IN_JJ_JJ],DEP_PATH_[prep_of-dobj|analysis@prep_with-prep_from|family-prep_in|newborn],DEP_PATH_POS_[prep_of-dobj|NN@prep_with-prep_from|NNS-prep_in|NNS],"WORD_SEQ_[in newborn from family with hereditary hemorrhagic]"}	{0.611134,0.380063,0.380063,0.380063}
journal.pbio.0040334.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pbio.0040334.pdf_641_641_0_0_6_7_UNSUP	TTD/HP:0002299|Brittle hair	{0}	{6,7}	{TTD,also,causes,scaly,skin,and,brittle,hair,.}	{"XP results in dramatically elevated cancer risk from extreme sun sensitivity — though , surprisingly , sun sensitivity does not necessarily cause skin cancer — and , in severe cases , primary neurodegeneration .","Neither CS nor TTD increase cancer risk but lead to accelerated aging , reduced stature , and degeneration of the nerves ’ protective myelin sheath ."}	{"As its name implies , the even rarer XP combined with CS ( XPCS ) combines cancer predisposition with neurodevelopmental problems .","In the current model , which Andressoo et al. refer to as the “ monoallelic ” paradigm of XPD-related disease , “ causative ” mutations are linked to a speciﬁc XPD syndrome ."}	0.852	0.076	0.996	{"WORD_SEQ_[also cause scaly skin and]",DEP_PATH_[nsubj@dobj],DEP_PATH_POS_[nsubj@dobj],POS_SEQ_[RB_VBZ_JJ_NN_CC],VERB_DEP_PATH_[cause]_[nsubj@]_[dobj@],VERB_DEP_PATH_POS_[cause]_[nsubj@]_[dobj@]}	{1.89869,-1.23771,-1.23744,1.17642,0.623721,0.623721}
journal.pone.0058403.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0058403.pdf_10_10_1_1_4_5_UNSUP	PSP/HP:0100543|Cognitive impairment	{1}	{4,5}	{Since,PSP,is,more,cognitively,impaired,relative,to,PD,and,MSAp,",",we,expected,that,combining,motor,and,cognitive,measures,would,further,distinguish,PSP,from,PD,and,MSAp,.}	{"The first goal was to determine which features of grip force are abnormal in MSAp and PSP .","The second goal was to determine whether a single variable or a combination of motor and cognitive measures would distinguish patient groups ."}	{"Methods : We studied 44 participants : 12 PD , 12 MSAp , 8 PSP , and 12 controls .","Patients were diagnosed by a movement disorders neurologist and were tested off anti ."}	0.764	0.074	0.332	{DEP_PATH_[nsubj@dep],DEP_PATH_POS_[nsubj@dep],VERB_DEP_PATH_POS_[distinguish]_[nsubj-advcl|JJ@ccomp]_[dep-advcl|JJ@ccomp],VERB_DEP_PATH_[combine]_[nsubj-advcl|relative@csubj-ccomp|distinguish]_[dep-advcl|relative@csubj-ccomp|distinguish],VERB_DEP_PATH_POS_[combine]_[nsubj-advcl|JJ@csubj-ccomp|VB]_[dep-advcl|JJ@csubj-ccomp|VB],VERB_DEP_PATH_[distinguish]_[nsubj-advcl|relative@ccomp]_[dep-advcl|relative@ccomp],VERB_DEP_PATH_[expect]_[nsubj-advcl|relative@]_[dep-advcl|relative@],VERB_DEP_PATH_POS_[expect]_[nsubj-advcl|JJ@]_[dep-advcl|JJ@],POS_SEQ_[VBZ_RBR],"WORD_SEQ_[be more]",VERB_DEP_PATH_[be]_[nsubj@cop]_[dep@cop],VERB_DEP_PATH_POS_[be]_[nsubj@cop]_[dep@cop]}	{-0.926203,-0.926203,0.328507,0.328507,0.328507,0.328507,0.328507,0.328507,0.328507,0.190167,0.1896,0.1896}
SCPDFS_24304.pdf	RELATION_GENEHPOTERM_SCPDFS_24304.pdf_52_52_25_25_11_11	SMRT/HP:0002665|Lymphoma	{25}	{11}	{For,example,",",the,BTB/POZ,—,proteins,BCL6,(,B,cell,lymphoma,),and,PLZF,(,promyelocytic,leukemia,zinc,ﬁnger,),repress,transcription,by,recruiting,SMRT,(,silencing,mediator,for,retinoid,and,thyroid,hormone,receptors,),/,N-CoR,(,nuclear,receptor,corepressor,),-,mSin3A-histone,deacetylase,complexes,(,David,et,al.,",",1998,;,Dhordain,et,al.,",",1998,;,Huynh,and,Bardwell,",",1998,;,Wong,and,Privalsky,",",1998,),",",whereas,HIC-1,(,hypermethylated,in,cancer,),mediates,transcriptional,repression,by,both,histone,deacetylase-dependent,and,-,independent,mechanisms,that,involve,binding,to,the,corepressor,",",CtBP,(,C-terminal,binding,protein,),(,Deltour,et,al.,",",1999,",",2002,),.}	{"The BTB/POZ is an evolutionarily conserved domain found in most organisms , including human , mouse , ﬂy , and yeast ( Lander et al. , 2001 ; Venter et al. , 2001 ) .","This domain is capable of mediating homo - and heterodimerization and several BTB/POZ-containing proteins silence gene expression by distinct recruitment mechanisms ."}	{"In contrast to the BTB/POZ domain , the KRAB domain-containing CZHZ zinc ﬁnger proteins are unique to the vertebrate lineage ( Lander et al. , 2001 ; Venter et al. , 2001 ) .","Similar to the BTB/POZ domain , the KRAB domain functions as a potent repressor of gene expression , by a mechanism involving recruitment of the corepressor protein , KAP-1 ( KRAB-associated protein ) ( Friedman et al. , 1996 ; Kim et al. , 1996 ; Moosmann et al. , 1996 ) , followed by recruitment of the NURD histone deacetylase complex , histone methylases , and heterochromatin proteins ( Ryan et al. , 1999 ; Lechner et al. , 2000 ; Schultz et al. , 2001 , 2002 ) ."}	0.838	0.984	1	{INV_VERB_DEP_PATH_[mediate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[mediate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[bind]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[bind]_[dep@dep]_[dep@dep],INV_DEP_PATH_[dep@dep],INV_DEP_PATH_POS_[dep@dep],INV_VERB_DEP_PATH_[recruit]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[recruit]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[involve]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[involve]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_[repress]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[repress]_[dep@dep]_[dep@dep],INV_POS_SEQ_[NN_CC_NN_CD_JJ_NN_NN_NN_CD_VBP_NN_IN_VBG],INV_VERB_DEP_PATH_[hypermethylate]_[dep@dep]_[dep@dep],INV_VERB_DEP_PATH_POS_[hypermethylate]_[dep@dep]_[dep@dep],"INV_WORD_SEQ_[) and plzf ( promyelocytic leukemia zinc ﬁnger ) repress transcription by recruit]","INV_WORD_SEQ_NER_[) and plzf NUMBER promyelocytic leukemia zinc ﬁnger NUMBER repress transcription by recruit]"}	{0.605089,0.605089,0.458359,0.458359,-0.298014,-0.280071,-0.137707,-0.137707,0.12065,0.12065,0.0994181,0.0994181,0,0,0,0,0}
journal.pone.0007771.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0007771.pdf_49_49_7_7_19_19_UNSUP	TRPC6/HP:0000093|Proteinuria	{7}	{19}	{A,recent,study,showed,that,induction,of,TRPC6,expression,in,cultured,podocytes,causes,loss,of,actin,stress,ﬁbers,and,proteinuria,in,mice,",",thereby,suggesting,that,TRPC6,",",in,podocytes,",",is,functionally,connected,to,the,actin,cytoskeleton,[,16,],.}	{"In the kidney , TRPC6 is expressed in both renal tubules and glomeruli , with predominance in podocytes .","TRPC6 is an essential component of the podocyte slit diaphragm , where it is integrated into a signaling complex that interacts with nephrin and podocin [ 10 ] ."}	{"The exact pathophysiology through which dysregulated Ca2 + inﬂux in patients with TRPC6 mutations leads to FSGS remains unclear .","So far , seven different mutations in TRPC6 were identiﬁed in seven different families from different ethnic backgrounds [ 9 , 10,12 ] ."}	0.898	0.484	0.97	{DEP_PATH_POS_[nn-prep_of|NN-nsubj|NN@conj_and-dobj|NN],DEP_PATH_[nn-prep_of|expression-nsubj|induction@conj_and-dobj|loss],VERB_DEP_PATH_[suggest]_[nn-prep_of|expression-nsubj|induction@xcomp]_[conj_and-dobj|loss@xcomp],VERB_DEP_PATH_POS_[cause]_[nn-prep_of|NN-nsubj|NN@]_[conj_and-dobj|NN@],POS_SEQ_[NN_IN_VBN_NNS_VBZ_NN_IN_NN_NN_NNS_CC],VERB_DEP_PATH_[show]_[nn-prep_of|expression-nsubj|induction-ccomp|cause@]_[conj_and-dobj|loss-ccomp|cause@],VERB_DEP_PATH_POS_[suggest]_[nn-prep_of|NN-nsubj|NN@xcomp]_[conj_and-dobj|NN@xcomp],VERB_DEP_PATH_[cause]_[nn-prep_of|expression-nsubj|induction@]_[conj_and-dobj|loss@],"WORD_SEQ_[expression in culture podocyte cause loss of actin stress ﬁbers and]",VERB_DEP_PATH_POS_[show]_[nn-prep_of|NN-nsubj|NN-ccomp|VBZ@]_[conj_and-dobj|NN-ccomp|VBZ@]}	{1.00992,0.123717,0.123717,0.123717,0.123717,0.123717,0.123717,0.123717,0.123717,0.123717}
SCPDFS_21702.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_21702.pdf_958_958_6_6_17_17_UNSUP	DYT1/HP:0001332|Dystonia	{6}	{17}	{Novel,mutation,in,the,TOR1A,(,DYT1,),gene,in,atypical,early,onset,dystonia,and,polymorphisms,in,dystonia,and,early,onset,parkinsonism,.}	{"275 , 27933-27939 .","Leung , J.C. , et al. , 2001 ."}	{"Neuroge — netics 3 , 133-143 .","Liu , 2. , Zolkiewska , A. , Zolkiewski , M. , 2003 ."}	0.83	0.712	0.992	{"WORD_SEQ_[) gene in atypical early onset dystonium and polymorphism in]",POS_SEQ_[NN_NN_IN_JJ_JJ_NN_NN_CC_NNS_IN],DEP_PATH_[nn-prep_in|gene@nn-prep_in|parkinsonism],DEP_PATH_POS_[nn-prep_in|NN@nn-prep_in|NN]}	{0.600687,0.600687,0.385896,0.0378935}
SCPDFS_38837.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_38837.pdf_573_573_13_13_22_22_UNSUP	PITX3/HP:0000518|Cataract	{13}	{22}	{[,6,],E.V.,Semina,",",et,al.,",",A,novel,homeobox,gene,PITX3,is,mutated,in,families,with,autosomal,—,dominant,cataracts,and,ASMD,",",Nat,.}	{"Genet .","36 ( 1999 ) 152-155 ."}	{"Genet .","19 ( 1998 ) 167-170 ."}	0.898	0.148	1	{POS_SEQ_[VBZ_VBN_IN_NNS_IN_JJ_JJ_JJ],"WORD_SEQ_[be mutate in family with autosomal — dominant]",DEP_PATH_POS_[appos-appos|FW-nsubjpass|NNP@prep_with-prep_in|NNS],VERB_DEP_PATH_[be]_[appos-appos|al.-nsubjpass|PERSON@auxpass]_[prep_with-prep_in|family@auxpass],VERB_DEP_PATH_POS_[mutate]_[appos-appos|FW-nsubjpass|NNP@]_[prep_with-prep_in|NNS@],DEP_PATH_[appos-appos|al.-nsubjpass|PERSON@prep_with-prep_in|family],VERB_DEP_PATH_POS_[be]_[appos-appos|FW-nsubjpass|NNP@auxpass]_[prep_with-prep_in|NNS@auxpass],VERB_DEP_PATH_[mutate]_[appos-appos|al.-nsubjpass|PERSON@]_[prep_with-prep_in|family@]}	{0.509654,0.509654,0.183039,0.183039,0.183039,0.183039,0.183039,0.183039}
journal.pone.0071969.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0071969.pdf_28_28_49_49_57_57_UNSUP	RB/HP:0002665|Lymphoma	{49}	{57}	{Introduction,Subsequent,studies,using,mouse,models,with,tissue-speciﬁc,Dicer,],ablation,reported,that,a,single,allele,of,Dicer,],in,mice,leads,to,oncogenesis,in,a,lung,cancer,model,caused,by,a,K-ras,protooncogene,mutation,[,18,],",",a,retinoblastoma,model,caused,by,mutations,in,the,tumor,suppressor,RB,gene,[,19,],",",and,a,lymphoma,model,caused,by,Eu-myc,[,20,],.}	{"Competing Interests : Motoyuki Otsuka is a PLOS ONE Editorial Board member and this does not alter the authors ’ adherence to all the PLOS ONE policies on sharing data and materials .","* E — mai | : otsukamo-tky@umin.ac.jp"}	{"In these models , monoallelic , but not complete , loss of Dicer alleles enhanced tumor formation .","In addition , although frequent deletion of a Dicer allele has been reported , inactivation of the second wild-type allele has not [ 18 ] ."}	0.802	1	1	{DEP_PATH_[TOO_FAR_AWAY],"WORD_SEQ_[gene [ 19 ] , and a]","POS_SEQ_[NN_CD_CD_NN_,_CC_DT]","WORD_SEQ_NER_[gene NUMBER NUMBER ] , and a]"}	{0.354873,0.288496,0.288496,0.288496}
journal.pone.0032192.pdf	RELATION_GENEHPOTERM_journal.pone.0032192.pdf_353_353_25_25_30_31	CAPN10/HP:0000147|Polycystic ovaries	{25}	{30,31}	{Gonzalez,A,",",Abril,E,",",Roca,A,",",Aragon,1,"\\\\",’,I,],",",Figueroa,NI,],",",et,al.,(,2002,),CAPN10,alleles,are,associated,with,polycystic,ovary,syndrome,.}	{"J Clin Endocrinol 1VIetab 87 : l669 — l673 .","8 ."}	{"J Clin Endocrinol Metal ) 87 : 397l — 3976 .","Gonzalez A , Abril E , Roca A , Aragon NI ] , Figueroa 1 \\\\ ’ I ] , et al. ( 2003 ) Speciﬁc CAPN10 gene haplotypes inﬂuence the clinica .1 proﬁle of polycystic ovary patients . ]"}	0.808	0.984	1	{DEP_PATH_[nn-nsubjpass|allele@amod-prep_with|syndrome],VERB_DEP_PATH_[be]_[nn-nsubjpass|allele@auxpass]_[amod-prep_with|syndrome@auxpass],"WORD_SEQ_[allele be associate with]",VERB_DEP_PATH_[associate]_[nn-nsubjpass|allele@]_[amod-prep_with|syndrome@],POS_SEQ_[NNS_VBP_VBN_IN],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NNS@]_[amod-prep_with|NN@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NNS@auxpass]_[amod-prep_with|NN@auxpass],DEP_PATH_POS_[nn-nsubjpass|NNS@amod-prep_with|NN]}	{0.336525,0.336525,0.336525,0.336525,0.276808,-0.21674,-0.0108329,-0.0108329}
SCPDFS_41681.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41681.pdf_397_397_8_8_4_4_UNSUP	INK4/HP:0002861|Melanoma	{8}	{4}	{Mutations,associated,with,familial,melanoma,impair,p16,(,INK4,),function,.}	{"2 : 1749 .","Ranade , K. , Hussussian , C. J. , Sikorski , R. S. , Varmus , H. E. , Goldstein , A. M. , Tucker , M. A. , Serrano , M. , Hannon , G. J. , Beach , D. , and Dracopoli , N. C. ( 1995 ) ."}	{"Nature Genet .","10 : 114-116 ."}	0.772	0.016	1	{INV_DEP_PATH_POS_[nn-nsubj|NN@prep_with-dep|VBN],INV_POS_SEQ_[VBP_NN_CD],"INV_WORD_SEQ_NER_[impair p16 NUMBER]",INV_DEP_PATH_[nn-nsubj|function@prep_with-dep|associate],"INV_WORD_SEQ_[impair p16 (]",INV_VERB_DEP_PATH_POS_[impair]_[nn-nsubj|NN@]_[prep_with-dep|VBN@],INV_VERB_DEP_PATH_[impair]_[nn-nsubj|function@]_[prep_with-dep|associate@],INV_VERB_DEP_PATH_[associate]_[nn-nsubj|function@dep]_[prep_with@],INV_VERB_DEP_PATH_POS_[associate]_[nn-nsubj|NN@dep]_[prep_with@]}	{0.356979,-0.323479,0.181504,0.181504,0.181504,0.181504,0.181504,0.181504,0.0188133}
journal.pone.0031557.pdf	RELATION_GENEHPOTERM_journal.pone.0031557.pdf_10_10_4_4_16_18	EMT/HP:0005584|Renal cell carcinoma	{4}	{16,17,18}	{mesenchyma,|,transition,(,EMT,),has,recently,been,implicated,in,the,initiation,and,progression,of,renal,cell,carcinoma,(,RCC,),.}	{"to .","— ."}	{"Some mRNA gene expression studies have suggested a link between the EMT phenotype and poorer clinical outcome from RCC .","This study evaluated expression of EMT — associated proteins in RCC using in situ automated quantitative analysis immunofluorescence ( AQUA ) and compared expression levels with clinical outcome ."}	0.812	0.038	1	{VERB_DEP_PATH_POS_[be]_[nn-dep|NN-nsubjpass|NN@auxpass]_[prep_of-prep_in|NN@auxpass],DEP_PATH_POS_[nn-dep|NN-nsubjpass|NN@prep_of-prep_in|NN],VERB_DEP_PATH_POS_[implicate]_[nn-dep|NN-nsubjpass|NN@]_[prep_of-prep_in|NN@],VERB_DEP_PATH_[be]_[nn-dep|)-nsubjpass|transition@auxpass]_[prep_of-prep_in|initiation@auxpass],"WORD_SEQ_[) have recently be implicate in the initiation and progression of]",VERB_DEP_PATH_[implicate]_[nn-dep|)-nsubjpass|transition@]_[prep_of-prep_in|initiation@],VERB_DEP_PATH_POS_[have]_[nn-dep|NN-nsubjpass|NN@aux]_[prep_of-prep_in|NN@aux],POS_SEQ_[NN_VBZ_RB_VBN_VBN_IN_DT_NN_CC_NN_IN],VERB_DEP_PATH_[have]_[nn-dep|)-nsubjpass|transition@aux]_[prep_of-prep_in|initiation@aux],DEP_PATH_[nn-dep|)-nsubjpass|transition@prep_of-prep_in|initiation],"WORD_SEQ_NER_[) have DATE be implicate in the initiation and progression of]"}	{0.770173,0.770173,0,0,0,0,0,0,0,0,0}
journal.pone.0039247.pdf	RELATION_GENEHPOTERM_journal.pone.0039247.pdf_395_395_28_28_33_33	AOAH/HP:0002099|Asthma	{28}	{33}	{Barnes,KC,",",Grant,A,",",Gao,P,",",Baltadjieva,D,",",Berg,T,",",et,al.,(,2006,),Polymorphisms,in,the,novel,gene,acyloxyacyl,hydroxylase,(,AOAH,),are,associated,with,asthma,and,associated,phenotypes,.}	{"Bejarano F , Gonzalez 1 , Vidal 1 \\\\ ’ I , Busturia A ( 2005 ) The Drosophila RYBP gene functions as a Polycomh-dependent transcriptional repressor .","Nlech Dev 122 : 1 1 18 — 1 129 ."}	{"J Allergy Clin Immunol 118 : 70 * 77 .","Savenije OE , Kerkhof IVI , Reijmerink NE , Brunekreef B , de Jongste JC , et al. ( 2011 ) Inter1eukin ~ 1 receptor-like 1 polymorphisms are associated with serum IL1RLl-a , eosinophils , and asthma in childhood ."}	0.86	0.032	1	{VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NN@]_[prep_with@],VERB_DEP_PATH_[associate]_[nn-nsubjpass|)@]_[prep_with@],"WORD_SEQ_[) be associate with]",VERB_DEP_PATH_[be]_[nn-nsubjpass|)@auxpass]_[prep_with@auxpass],DEP_PATH_[nn-nsubjpass|)@prep_with],DEP_PATH_POS_[nn-nsubjpass|NN@prep_with],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_with@auxpass],POS_SEQ_[NN_VBP_VBN_IN],VERB_DEP_PATH_[associate]_[nn-nsubjpass|)@conj_and]_[prep_with@conj_and],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NN@conj_and]_[prep_with@conj_and]}	{0.707044,0.560782,0.524271,0.334899,0.334899,-0.219543,-0.219543,-0.126104,0,0}
SCPDFS_19416.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19416.pdf_443_443_5_5_10_10_UNSUP	BRIP1/HP:0001903|Anemia	{5}	{10}	{The,BRCA1,—,interacting,helicase,BRIP1,is,deﬁcient,in,Fanconi,anemia,.}	{"37 , 934-935 .","Levran , o. , et al. , 2005 ."}	{"Nat .","Genet ."}	0.766	0.936	1	{POS_SEQ_[VBZ_JJ_IN_JJ],VERB_DEP_PATH_POS_[interact]_[dobj@]_[prep_in@partmod-nsubj|NN],VERB_DEP_PATH_[be]_[dobj-partmod|interact-nsubj|—@cop]_[prep_in@cop],VERB_DEP_PATH_[interact]_[dobj@]_[prep_in@partmod-nsubj|—],VERB_DEP_PATH_POS_[be]_[dobj-partmod|VBG-nsubj|NN@cop]_[prep_in@cop],"WORD_SEQ_[be deﬁcient in fanconi]",DEP_PATH_[dobj-partmod|interact-nsubj|—@prep_in],DEP_PATH_POS_[dobj-partmod|VBG-nsubj|NN@prep_in]}	{0.224298,0.162503,0.162503,0.162503,0.162503,0.162503,0.162503,-0.0463219}
SCPDFS_20836.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20836.pdf_115_115_14_14_23_24_UNSUP	ISCU/HP:0003128|Lactic acidosis	{14}	{23,24}	{Genetic,testing,revealed,she,was,homozygous,for,the,IVS5,+,382,G,>,C,ISCU,mutation,conﬁrming,the,diagnosis,of,hereditary,myopathy,with,lactic,acidosis,.}	{"The clinical features of this 27 year old female have been described previously ( Sanaker et al. , 2010 ) .","In addition to exercise intolerance from childhood , she has had two episodes of severe rhabdomyolysis following which she experienced transient symptom improvement ."}	{"The study was approved by the Regional ethical committee for research , and was carried out in accordance with the Code of Ethics of the World Medical Association ( Declaration of Helsinki ) for experiments involving humans .","2.2 ."}	0.852	0.61	1	{DEP_PATH_[nn@prep_with-partmod|conﬁrming],VERB_DEP_PATH_[conﬁrming]_[nn@partmod]_[prep_with@],VERB_DEP_PATH_POS_[be]_[nn-tmod|NN@cop]_[prep_with-partmod|VBG-tmod|NN@cop],VERB_DEP_PATH_[be]_[nn-tmod|mutation@cop]_[prep_with-partmod|conﬁrming-tmod|mutation@cop],VERB_DEP_PATH_POS_[reveal]_[nn-tmod|NN-ccomp|JJ@]_[prep_with-partmod|VBG-tmod|NN-ccomp|JJ@],VERB_DEP_PATH_[reveal]_[nn-tmod|mutation-ccomp|homozygous@]_[prep_with-partmod|conﬁrming-tmod|mutation-ccomp|homozygous@],POS_SEQ_[NN_VBG_DT_NN_IN_JJ_NN_IN],VERB_DEP_PATH_POS_[conﬁrming]_[nn@partmod]_[prep_with@],"WORD_SEQ_[mutation conﬁrming the diagnosis of hereditary myopathy with]",DEP_PATH_POS_[nn@prep_with-partmod|VBG]}	{0.165453,0.165453,0.165453,0.165453,0.165453,0.165453,0.165453,0.165453,0.165453,0.0403212}
SCPDFS_18990.pdf	RELATION_GENEHPOTERM_SCPDFS_18990.pdf_287_287_4_4_8_9	FBN1/HP:0002803|Congenital contracture	{4}	{8,9}	{Mutations,of,FBN2,and,FBN1,are,associated,with,congenital,contractural,arachnodactyly,(,OMIM,121050,),and,Marfan,syndrome,(,OMIM,154700,),",",respectively,.}	{"Mb deletion at 5q23 .1 — q23 .3 encompassing FBN2 , and the phenotypic features of interrupted aortic arch and atrial septal defect .","FBN2 ( OMIM 612570 ) and FBN1 ( OMIM 134797 ) encode ﬁbrillin — 2 and ﬁbrillin — 1 , respectively , which are highly similar and are the main structural components of extracellular microﬁbrils responsible for elastogenesis ."}	{"Congenital contractural arachnodactyly is caused by mutations in FBN2 and is an autosomal dominant Marfan — like connective tissue disorder characterized by long , slender ﬁngers and toes ( arachnodactyly ) , crumpled ears , contractures of major joints , camptodactyly , kyphoscoliosis .","muscular hypoplasia and aortic root dilation ( Godfrey , 1993 ; Gupta et al. , 2002 ; Putnam et al. , 1995 ) ."}	0.804	0.204	0.956	{"WORD_SEQ_[be associate with]",POS_SEQ_[VBP_VBN_IN],VERB_DEP_PATH_[associate]_[conj_and-prep_of|fbn2-nsubjpass|mutation@]_[amod-prep_with|)@],VERB_DEP_PATH_[be]_[conj_and-prep_of|fbn2-nsubjpass|mutation@auxpass]_[amod-prep_with|)@auxpass],DEP_PATH_POS_[conj_and-prep_of|NN-nsubjpass|NNS@amod-prep_with|NN],VERB_DEP_PATH_POS_[associate]_[conj_and-prep_of|NN-nsubjpass|NNS@]_[amod-prep_with|NN@],DEP_PATH_[conj_and-prep_of|fbn2-nsubjpass|mutation@amod-prep_with|)],VERB_DEP_PATH_POS_[be]_[conj_and-prep_of|NN-nsubjpass|NNS@auxpass]_[amod-prep_with|NN@auxpass]}	{1.63926,0.0467467,0,0,0,0,0,0}
SCPDFS_3576.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_3576.pdf_430_430_10_10_18_19_UNSUP	HCN4/HP:0001688|Sinus bradycardia	{10}	{18,19}	{A,mutation,in,the,cAMP,binding,site,of,the,human,HCN4,gene,was,identiﬁed,as,the,cause,of,sinus,bradycardia,and,sick,sinus,syndrome,in,a,familial,case,(,Milanesi,et,al.,",",2006,),.}	{"Lewis et al. / Developmental Biology 327 ( 2009 ) 376-385 383","the strongest and has been demonstrated to simulate pacemaker characteristics when overexpressed in cell cultures ( Santoro and Tibbs , 1999 ; Santoro et al. , 2000 ; Moosmang et al. , 2001 ; Stieber et al. , 2003 ; Liu et al. , 2007 ) ."}	{"Moreover , mice deﬁcient in Hcn4 die between E9 .5 and E11 .5 presenting a similar electrophysiological phenotype with lower heart beat rate and slower pacemaker kinetics as compared to the wild type controls ( Stieber et al. , 2003 ) .","In this study we demonstrate that the expression of Hcn4 is down-regulated in the Shox2 ' / ' heart beginning at E10 .5 ."}	0.82	0.894	1	{POS_SEQ_[NN_VBD_VBN_IN_DT_NN_IN],DEP_PATH_POS_[nn-prep_of|NN-prep_in|NN-nsubjpass|NN@prep_of-prep_as|NN],DEP_PATH_[nn-prep_of|gene-prep_in|site-nsubjpass|mutation@prep_of-prep_as|cause],"WORD_SEQ_[gene be identiﬁed as the cause of]",VERB_DEP_PATH_[identiﬁed]_[nn-prep_of|gene-prep_in|site-nsubjpass|mutation@]_[prep_of-prep_as|cause@],VERB_DEP_PATH_POS_[identiﬁed]_[nn-prep_of|NN-prep_in|NN-nsubjpass|NN@]_[prep_of-prep_as|NN@]}	{0.39036,0.229966,0.229966,0.229966,0.229966,0.229966}
SCPDFS_39779.pdf	RELATION_GENEHPOTERM_SCPDFS_39779.pdf_325_325_3_3_10_11	ZNF218/HP:0003002|Breast carcinoma	{3}	{10,11}	{This,gene,is,ZNF218,",",which,is,not,expressed,in,breast,carcinoma,(,Collins,et,al.,",",1998,),.}	{"scribed in multiple tissues and is ampliﬁed and overexpressed in tumors including breast carcinoma .","These investigators mention still another zinc ﬁnger gene in this region ."}	{"Additional genes that have been mapped to this region encode for tumor necrosis factor receptor superfamily , member 5 ( CD40 antigen ; TNFRSF5 , CD40 ) ; guanine nucleotide-binding protein ( G protein ) , astimulating activity polypeptide-1 ( GNAS1 , GNAS , GPSA ) associated with mutations in patients with pseudohypoparathyroidism type Ia , McCune .","— ."}	0.792	0.716	0.996	{VERB_DEP_PATH_POS_[express]_[@rcmod]_[prep_in@],DEP_PATH_[@prep_in-rcmod|express],VERB_DEP_PATH_[express]_[@rcmod]_[prep_in@],VERB_DEP_PATH_POS_[be]_[@cop]_[prep_in-rcmod|VBN@cop],VERB_DEP_PATH_POS_[be]_[@auxpass-rcmod|VBN]_[prep_in@auxpass],VERB_DEP_PATH_[be]_[@auxpass-rcmod|express]_[prep_in@auxpass],VERB_DEP_PATH_[be]_[@cop]_[prep_in-rcmod|express@cop],"POS_SEQ_[,_WDT_VBZ_RB_VBN_IN]",DEP_PATH_POS_[@prep_in-rcmod|VBN],"WORD_SEQ_[, which be not express in]"}	{0.513812,0.513812,0.513812,-0.23236,0.21757,-0.118277,-0.118277,-0.0828736,-0.0693873,0}
journal.pone.0050123.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0050123.pdf_1182_1182_10_10_16_17_UNSUP	alpha-synuclein/HP:0100315|Lewy bodies	{10}	{16,17}	{Kramer,lVIL,",",Schulz-Schaelfer,W1,],(,2007,),Presynaptic,alpha-synuclein,aggre,~,gates,",",not,Lewy,bodies,",",cause,neurodegeneration,in,dementia,with,Lewy,bodies,.}	{"lVIolecular modification of glycolytic enzymes and heat shock proteins .","FEBSJ 273 : 527345287 ."}	{"J Neurosci 27 : 140541410 .","Kramer ML , Behrens B , Schulz-Schaelfer V \\\\ [ ] ( 2008 ) Selective detection , quantification , and subcellular location of ( X-synuclein aggregates with a protein aggregate filtration assay ."}	0.766	0.428	0.636	{VERB_DEP_PATH_POS_[cause]_[nn-dep|NNS-appos|NN-nsubj|NNP@]_[appos-nsubj|NNP@],"POS_SEQ_[NN_NN_NNS_,_RB]","WORD_SEQ_[aggre ~ gate , not]",VERB_DEP_PATH_[cause]_[nn-dep|gate-appos|w1-nsubj|lVIL@]_[appos-nsubj|lVIL@],DEP_PATH_POS_[nn-dep|NNS-appos|NN@appos],DEP_PATH_[nn-dep|gate-appos|w1@appos]}	{0.205447,0.205447,0.205447,0.205447,0.205447,0.205447}
journal.pbio.1000408.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pbio.1000408.pdf_907_907_23_23_36_37_UNSUP	SPG15/HP:0001258|Spastic paraplegia	{23}	{36,37}	{Hanein,S,",","1\\\\/Iartin",E,",",Boukhris,A,",",Byrne,P,",",Goizet,C,",",et,al.,(,2008,),Identification,of,the,SPG15,gene,",",encoding,spastizin,",",as,a,frequent,cause,of,complicated,autosomal-recessive,spastic,paraplegia,",",including,Kjellin,syndrome,.}	{"Stevanin G , Santorelli FIVI , Azzedine H , Coutinho P , ChomilierJ , et al. ( 2007 ) Nlutations in SPG1 1 , encoding spatacsin , are a major cause of spastic paraplegia with thin corpus callosum .","Nat Genet 39 : 3664372 ."}	{"AmJ Hum Genet 82 : 99241002 .","Stevanin G , Ruherg M , Brice A ( 2008 ) Recent advances in the genetics of spastic paraplegias ."}	0.788	0.27	1	{"POS_SEQ_[NN_,_VBG_NN_,_IN_DT_JJ_NN_IN_JJ_JJ]",DEP_PATH_[nn-prep_of|gene-dep|identification-appos|et@prep_of-prep_as|cause-partmod|encode],"WORD_SEQ_[gene , encode spastizin , as a frequent cause of complicated autosomal-recessive]",DEP_PATH_POS_[nn-prep_of|NN-dep|NN-appos|FW@prep_of-prep_as|NN-partmod|VBG]}	{0.376662,0.376662,0.376662,0.376662}
SCPDFS_42721.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_42721.pdf_18_18_50_50_55_55_UNSUP	SLC3A1/HP:0003131|Cystinuria	{50}	{55}	{Since,all,three,homologous,cDNAs,(,D2,",",D2H,",",and,rBAT,),induce,high-aiﬁnity,transport,of,cystine,",",dibasic,",",and,neutral,amino,acids,and,are,highly,expressed,in,small,intestine,and,kidney,(,4,),",",it,has,been,proposed,that,a,defect,in,the,transporter,encoded,by,SLC3A1,might,be,involved,in,cystinuria,or,Hartnup,disease,.}	{"All rights of reproduction in any form reserved .","Similar expression cloning strategies were used to isolate the rabbit kidney cDNA ( rBAT ) by Bertran et al. ( 2 ) and its human homologue , also called rBAT ( 1 ) , encoded by the gene SLC3A1 ."}	{"Recently , Calonge et al. ( 3 ) identiﬁed six mutations in the rBAT gene in their study of ﬁve patients affected with cystin — uria .","One of the mutations nearly abolished the amino acid transport activity induced by this gene in Xenopus oocytes ."}	0.726	0.414	0.994	{DEP_PATH_POS_[agent-partmod|VBN-prep_in|NN-nsubjpass|NN@nn-prep_in|NN],VERB_DEP_PATH_POS_[involve]_[agent-partmod|VBN-prep_in|NN-nsubjpass|NN@]_[nn-prep_in|NN@],VERB_DEP_PATH_[involve]_[agent-partmod|encode-prep_in|transporter-nsubjpass|defect@]_[nn-prep_in|disease@],DEP_PATH_[agent-partmod|encode-prep_in|transporter-nsubjpass|defect@nn-prep_in|disease],POS_SEQ_[MD_VB_VBN_IN],"WORD_SEQ_[might be involve in]"}	{0.277458,0.277458,0.277458,0.277458,0.0171224,0.00383513}
SCPDFS_44036.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_44036.pdf_156_156_9_9_21_24_UNSUP	MASA/HP:0002410|Aqueductal stenosis	{9}	{21,24}	{X-linked,complicated,spastic,paraplegia,(,McKusick,31290,),",",MASA,syndrome,(,McKusick,30925,),and,X-linked,hydrocephalus,due,to,congenital,stenosis,of,the,aqueduct,of,Sylvius,(,McKusick,30700,),:,A,variable,expression,of,the,same,mutation,at,Xq28,.}	{"J .","( 1990 ) ."}	{"In “ Proceedings , 1st European Meeting of Dysmorphology ” ( J. P. Fryns , Ed . )",", Zaragoza ."}	0.774	0.136	0.996	{POS_SEQ_[NN_CD_NNP_CD_NN_CC_JJ_NN_JJ_TO_JJ],"WORD_SEQ_NER_[syndrome NUMBER PERSON NUMBER ) and x-linked hydrocephalus due to congenital]",DEP_PATH_[nn-appos|syndrome-dep|NUMBER@prep_due_to-dep|)],"WORD_SEQ_[syndrome ( McKusick 30925 ) and x-linked hydrocephalus due to congenital]",DEP_PATH_POS_[nn-appos|NN-dep|CD@prep_due_to-dep|NN]}	{0.237163,0.237163,0.237163,0.237163,0.237163}
journal.pone.0071963.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0071963.pdf_7_7_5_5_1_1_UNSUP	PH1/HP:0003159|Hyperoxaluria	{5}	{1}	{Primary,hyperoxaluria,type,I,(,PH1,),is,a,conformational,disease,which,result,in,the,loss,ofalaninezglyoxylate,aminotransferase,(,AGT,),function,.}	{"Torres ” , Israel Fabelo-Rosa ” , Debora Riverolz , Cristina Yunta3 , Armando A | bert3 , Eduardo Sa | ido2 * , Angel L. Pey ‘ * 1 Department of Physical Chemistry , Faculty of Sciences , University of Granada , Granada , Spain , 2Centre for Biomedical Research on Rare Diseases , Instituto Tecnologias Biomédicas , University of La Laguna , Tenerife , Spain , 3 Department of Cwstallography and Structural Biology , Instituto de Quimica Fisica “ Rocasolano ” , Consejo Superior de Investigaciones Cientificas , Madrid , Spain",Abstract}	{"The study of AGT has important implications for protein folding and trafficking because PH1 mutants may cause protein aggregation and mitochondrial mistargeting .","We herein describe a multidisciplinary study aimed to understand the molecular basis of protein aggregation and mistargeting in PH1 by studying twelve AGT variants ."}	0.898	0.006	0.994	{"INV_WORD_SEQ_NER_[type NUMBER (]",INV_DEP_PATH_POS_[nn-dobj|NN@nn-nsubj|NN],INV_POS_SEQ_[NN_CD_VBP],"INV_WORD_SEQ_[type i (]",INV_VERB_DEP_PATH_[result]_[nn-dobj|)-dep|(@rcmod]_[nn-nsubj|type-dep|(@rcmod],INV_VERB_DEP_PATH_[be]_[nn-dobj|)-dep|(@cop]_[nn-nsubj|type-dep|(@cop],INV_VERB_DEP_PATH_POS_[result]_[nn-dobj|NN-dep|VBP@rcmod]_[nn-nsubj|NN-dep|VBP@rcmod],INV_VERB_DEP_PATH_POS_[be]_[nn-dobj|NN-dep|VBP@cop]_[nn-nsubj|NN-dep|VBP@cop],INV_DEP_PATH_[nn-dobj|)@nn-nsubj|type]}	{2.45298,-1.12458,0.21072,0.138215,0.105711,0.105711,0.105711,0.105711,0.105711}
journal.pone.0000856.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0000856.pdf_12_12_9_9_20_21_UNSUP	CGD/HP:0002719|Recurrent infections	{9}	{20,21}	{Lack,of,this,protein,causes,chronic,granulomatous,disease,(,CGD,),",",a,rare,genetic,disorder,characterized,by,severe,and,recurrent,infections,due,to,the,incapacity,of,phagocytes,to,kill,microorganisms,.}	{"Background .","Gp91p \\" ° \\" is a transmembrane protein and the catalytic core of the NADPH oxidase complex of neutrophils ."}	{"Methodology .","Here we optimize a prokaryotic cell-free expression system to produce integral mammalian membrane proteins ."}	0.896	0.03	0.56	{VERB_DEP_PATH_[characterize]_[nn@partmod-appos|disorder]_[agent@],DEP_PATH_[nn@agent-partmod|characterize-appos|disorder],"WORD_SEQ_[) , a rare genetic disorder characterize by severe and]","POS_SEQ_[NN_,_DT_JJ_JJ_NN_VBN_IN_JJ_CC]",VERB_DEP_PATH_POS_[characterize]_[nn@partmod-appos|NN]_[agent@],DEP_PATH_POS_[nn@agent-partmod|VBN-appos|NN],VERB_DEP_PATH_POS_[kill]_[nn@xcomp-partmod|VBN-appos|NN]_[agent@xcomp],VERB_DEP_PATH_[cause]_[nn-tmod|)@]_[agent-partmod|characterize-appos|disorder-tmod|)@],VERB_DEP_PATH_[kill]_[nn@xcomp-partmod|characterize-appos|disorder]_[agent@xcomp],VERB_DEP_PATH_POS_[cause]_[nn-tmod|NN@]_[agent-partmod|VBN-appos|NN-tmod|NN@]}	{0.620643,0.620643,0.273963,0.273963,0.234106,-0.153692,0.120204,0.120204,0.120204,0.120204}
journal.pone.0023350.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0023350.pdf_655_655_28_28_32_33_UNSUP	SEDL/HP:0002655|Spondyloepiphyseal dysplasia	{28}	{32,33}	{Gedeon,AK,",",Colley,A,",",Jamieson,R,",",Thompson,E1,"\\\\",’,I,",",Rogers,J,",",et,al.,(,1999,),Identification,of,the,gene,(,SEDL,),causing,X-linked,spondyloepiphyseal,dysplasia,tarda,.}	{"The American Journal of Human Genetics 85 : 9094315 .","27 ."}	{"Nat Genet 22 : 400 — 404 .","28 ."}	0.852	0.006	0.924	{"WORD_SEQ_NER_[NUMBER cause MISC]","WORD_SEQ_[) cause x-linked]",DEP_PATH_POS_[dep-prep_of|NN-dobj|NN@amod-dobj|NN-xcomp|VBG],DEP_PATH_[dep-prep_of|gene-dobj|identification@amod-dobj|tarda-xcomp|cause],VERB_DEP_PATH_POS_[cause]_[dep-prep_of|NN-dobj|NN@xcomp]_[amod-dobj|NN@],VERB_DEP_PATH_[cause]_[dep-prep_of|gene-dobj|identification@xcomp]_[amod-dobj|tarda@],POS_SEQ_[CD_VBG_JJ]}	{0.57005,0.57005,0.150351,0.150351,0.150351,0.150351,-0.000337445}
journal.pone.0066877.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0066877.pdf_59_59_13_13_23_23_UNSUP	APOE/HP:0000726|Dementia	{13}	{23}	{We,sought,to,determine,whether,episodic,memory,impairment,",",age,and,apolipoprotein-E,(,APOE,),genotype,have,an,effect,on,progression,to,AD,dementia,.}	{"greater decrease correlates with greater cognitive impairment along the continuum from prodromal to AD dementia .","The present study was conducted to deﬁne the MCI due to AD using PET amyloid imaging of AB deposition and FGD-PET imaging of neuronal dysfunction as a biomarker ."}	{"Materials and Methods","Subjects Sixty-eight Japanese participants were recruited from our memory clinic ."}	0.766	0.306	0.97	{DEP_PATH_POS_[nn-nsubj|NN@prep_to],"WORD_SEQ_NER_[NUMBER genotype have a effect on progression to ad]",VERB_DEP_PATH_POS_[determine]_[nn-nsubj|NN-rcmod|VBP-dobj|NN@]_[prep_to-rcmod|VBP-dobj|NN@],POS_SEQ_[CD_NN_VBP_DT_NN_IN_NN_TO_NN],"WORD_SEQ_[) genotype have a effect on progression to ad]",VERB_DEP_PATH_[have]_[nn-nsubj|genotype@]_[prep_to@],DEP_PATH_[nn-nsubj|genotype@prep_to],VERB_DEP_PATH_[determine]_[nn-nsubj|genotype-rcmod|have-dobj|memory@]_[prep_to-rcmod|have-dobj|memory@],VERB_DEP_PATH_POS_[have]_[nn-nsubj|NN@]_[prep_to@]}	{-0.192859,0.18514,0.18514,0.18514,0.18514,0.18514,0.18514,0.18514,0.133369}
SCPDFS_41011.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41011.pdf_16_16_16_16_29_29_UNSUP	CAN/HP:0001909|Leukemia	{16}	{29}	{A,rearrangement,involving,chromosomal,band,9q34,juxtaposes,CAN,to,SET,and,gives,rise,to,SET,—,CAN,",",a,fusion,gene,originally,detected,in,a,patient,with,acute,undifferentiated,leukemia,(,15,),.}	{"— .","CAN gene ( 13 , 14 ) ."}	{"The CAN/Nup214 protein is a nuclear pore complex component , whose depletion results in defective nucleocytoplasmic transport and cell cycle arrest ( 12 ) .","However , its contribution to leukemogenesis is not yet understood ."}	0.826	0.128	1	{VERB_DEP_PATH_POS_[give]_[dobj@]_[prep_with-prep_in|NN@conj_and-ccomp|VBZ],"WORD_SEQ_[, a fusion gene originally detect in a patient with acute undifferentiated]",VERB_DEP_PATH_[juxtapose]_[dobj-conj_and|give@]_[prep_with-prep_in|patient@ccomp],VERB_DEP_PATH_[give]_[dobj@]_[prep_with-prep_in|patient@conj_and-ccomp|juxtapose],VERB_DEP_PATH_POS_[detect]_[dobj-conj_and|VBZ-ccomp|VBZ@]_[prep_with-prep_in|NN@],DEP_PATH_[dobj-conj_and|give-ccomp|juxtapose@prep_with-prep_in|patient],DEP_PATH_POS_[dobj-conj_and|VBZ-ccomp|VBZ@prep_with-prep_in|NN],VERB_DEP_PATH_[detect]_[dobj-conj_and|give-ccomp|juxtapose@]_[prep_with-prep_in|patient@],"POS_SEQ_[,_DT_NN_NN_RB_VBN_IN_DT_NN_IN_JJ_JJ]",VERB_DEP_PATH_POS_[juxtapose]_[dobj-conj_and|VBZ@]_[prep_with-prep_in|NN@ccomp]}	{0.16797,0.16797,0.16797,0.16797,0.16797,0.16797,0.16797,0.16797,0.16797,0.16797}
journal.pone.0074071.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0074071.pdf_605_605_24_24_30_30_UNSUP	MSH6/HP:0009733|Glioma	{24}	{30}	{Hunter,C,",",Smith,R,",",Cahill,DP,",",Stephens,P,",",Stevens,C,et,al.,(,2006,),A,Hypermutation,Phenotype,and,Somatic,MSH6,Mutations,in,Recurrent,Human,Malignant,Gliomas,after,Alkylator,Chemotherapy,.}	{"CCR-06-2149 .","PubMed : 17404084 ."}	{"Cancer Res 66 : 3987-3991 .","doi :10.1158 / 0008-5472 ."}	0.808	0.74	1	{DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NNS_IN_NNP_NNP_JJ],"WORD_SEQ_NER_[MISC in Recurrent Human malignant]","WORD_SEQ_[mutation in Recurrent Human malignant]"}	{0.374951,0.356655,0.220118,0.220118,0.220118}
journal.pone.0037680.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0037680.pdf_38_38_21_21_35_36_UNSUP	PPARG/HP:0000855|Insulin resistance	{21}	{35,36}	{Finally,",",human,Familial,partial,lipodystrophy,subtype,3,(,FPLD3,",",MIM,604367,),patients,",",harbouring,heterozygous,mutations,in,the,PPARG,gene,",",are,characterized,by,aberrant,fat,distribution,and,metabolic,disturbances,",",including,insulin,resistance,and,dyslipidemia,[,15,],.}	{"Furthermore , PPARY _ / _ mice are severely lipodystrophic , while PPARY + / _ mice have reduced amounts of adipose tissue [ 10,1 l , l2 ,13 ] .","PPARY is also essential for the maintenance of adipose tissue , since conditional knock-out of the Ppalg gene resulted in reduced in viva survival of mature adipocytes [ 14 ] ."}	{"Besides PPARV , other proteins are also essential for adipogenesis , including transcription factors ( eg .","KLF5 [ 16 ] ) , transcriptional co-regulators ( e.g. TRAP220/Medl [ 17 ] , Tip60 [ 18 ] , TLE3 [ 19 ] and TRIP3 [ 20 ] ) and lipid droplet proteins ( e.g. CIDEC/Fsp27 [ 21 ] ) ."}	0.886	0.73	1	{VERB_DEP_PATH_[characterize]_[nn-prep_in|gene-partmod|harbour-nsubjpass|fpld3@]_[prep_including@],VERB_DEP_PATH_POS_[harbour]_[nn-prep_in|NN@]_[prep_including@partmod-nsubjpass|NN],VERB_DEP_PATH_POS_[characterize]_[nn-prep_in|NN-partmod|VBG-nsubjpass|NN@]_[prep_including@],"POS_SEQ_[NN_,_VBP_VBN_IN_JJ_JJ_NN_CC_JJ_NNS_,_VBG]","WORD_SEQ_[gene , be characterize by aberrant fat distribution and metabolic disturbance , include]",VERB_DEP_PATH_[harbour]_[nn-prep_in|gene@]_[prep_including@partmod-nsubjpass|fpld3],DEP_PATH_[nn-prep_in|gene-partmod|harbour-nsubjpass|fpld3@prep_including],DEP_PATH_POS_[nn-prep_in|NN-partmod|VBG-nsubjpass|NN@prep_including]}	{0.254804,0.254804,0.254804,0.254804,0.254804,0.254804,0.254804,0.254804}
journal.pone.0041802.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0041802.pdf_597_597_44_44_29_30_UNSUP	SCN1A/HP:0002373|Febrile seizures	{44}	{29,30}	{NIancardi,1,"\\\\",’,I1,"\\\\",’,I,",",Striano,P,",",Gennaro,E,",","1\\\\/Iadia",F,",",Paravidino,R,",",et,al.,(,2006,),Familial,occurrence,of,febrile,seizures,and,epilepsy,in,severe,myoclonic,epilepsy,of,infancy,(,SNIEI,),patients,with,SCN1A,mutations,.}	{"( 2010 ) Novel SCN 1A mutations in Indonesian patients with severe myoclonic epilepsy in infancy .","Pediatr Int 52 : 2344239 ."}	{"Epilepsia 47 : 162941635 .","NIeisler 1 \\\\ ’ IH , Kearney ] A ( 2005 ) Sodium channel mutations in epilepsy and other neurological disorders . ]"}	0.714	0.698	1	{INV_DEP_PATH_[nn-prep_with|mutation-dep|patient@prep_of-dep|occurrence-dep|(-dep|I],INV_DEP_PATH_POS_[nn-prep_with|NNS-dep|NNS@prep_of-dep|NN-dep|FW-dep|PRP],INV_POS_SEQ_[CC_NN_IN_JJ_JJ_NN_IN_NN_CD_NNP_CD_NNS_IN],"INV_WORD_SEQ_[and epilepsy in severe myoclonic epilepsy of infancy ( SNIEI ) patient with]","INV_WORD_SEQ_NER_[and epilepsy in severe myoclonic epilepsy of infancy NUMBER SNIEI NUMBER patient with]"}	{0.210646,0.210646,0.210646,0.210646,0.210646}
journal.pone.0019120.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0019120.pdf_249_249_10_10_17_17_UNSUP	CF/HP:0000027|Azoospermia	{10}	{17}	{This,notion,is,further,supported,by,the,observed,down-regulation,of,CF,TR,and,CREB,expression,in,human,azoospermia,testes,",",suggesting,that,abnormal,CFTR-CREB,pathway,may,be,a,possible,cause,of,azoospermia,.}	{"It should be noted that both CREB and CREM are known to be the master-switch transcription factors coupled to the FSH-regulated CAMP pathway [ 32,39 ] , mutations of which are known to be related to male infertility or shown to affect spermatogenesis [ 40,41 ] .","The aberrance of both CREB and CREM observed in CF mice testes provides a link between CF TR mutations and defective spermatogenesis ."}	{"The current ﬁndings not only reveal a previously undeﬁned role of CFTR in regulation of spermatogenesis but also provide a possible mechanism underlying the pathogenesis of azoospermia in nonCF patients .","Of note , there are more than 1800 mutations of CFTR and most of them may not cause typical CF phenotypes , but may lead to compromised spermatogenesis ."}	0.804	0.014	0.99	{DEP_PATH_[nn@nn-prep_in|testis],DEP_PATH_POS_[nn@nn-prep_in|NNS],VERB_DEP_PATH_POS_[observe]_[nn-prep_of|NN@amod]_[nn-prep_in|NNS-prep_of|NN@amod],"WORD_SEQ_[tr and creb expression in human]",VERB_DEP_PATH_POS_[support]_[nn-prep_of|NN-prep_by|NN@]_[nn-prep_in|NNS-prep_of|NN-prep_by|NN@],VERB_DEP_PATH_[support]_[nn-prep_of|tr-prep_by|down-regulation@]_[nn-prep_in|testis-prep_of|tr-prep_by|down-regulation@],VERB_DEP_PATH_[observe]_[nn-prep_of|tr@amod]_[nn-prep_in|testis-prep_of|tr@amod],POS_SEQ_[NN_CC_NN_NN_IN_JJ]}	{0.479328,-0.405433,0.255042,0.255042,0.255042,0.255042,0.255042,0.091233}
SCPDFS_46834.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46834.pdf_398_398_16_17_23_24_UNSUP	keratin_5/HP:0001070|Mottled pigmentation	{16,17}	{23,24}	{23,Irvine,",",A.D.,et,al.,(,1997,),A,mutation,in,the,V1,domain,of,keratin,5,causes,epidermolysis,bullosa,simplex,with,mottled,pigmentation,.}	{"116 , 511-519","TRENDS in Genetics Vol .19 No. 5 May 2003 235"}	{"J. Invest .","Dermatol ."}	0.794	0.788	0.984	{VERB_DEP_PATH_[cause]_[prep_of-prep_in|domain-dep|(-nsubj|A.D.@]_[prep_with-dobj|simplex@],VERB_DEP_PATH_POS_[cause]_[prep_of-prep_in|NN-dep|FW-nsubj|NNP@]_[prep_with-dobj|NN@],"WORD_SEQ_[cause epidermolysis bullosa simplex with]",DEP_PATH_[prep_of-prep_in|domain-dep|(-nsubj|A.D.@prep_with-dobj|simplex],DEP_PATH_POS_[prep_of-prep_in|NN-dep|FW-nsubj|NNP@prep_with-dobj|NN],POS_SEQ_[VBZ_NN_NN_NN_IN]}	{0.304722,0.304722,0.304722,0.304722,0.304722,-0.251058}
journal.pone.0082810.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0082810.pdf_169_169_21_21_35_35_UNSUP	ANKRD11/HP:0001572|Macrodontia	{21}	{35}	{Sirmaci,A,",",Spiliopoulos,M,",",Brancati,F,",",Powell,E,",",Duman,D,et,al.,(,2011,),Mutations,in,ANKRD11,cause,KBG,syndrome,",",characterized,by,intellectual,disability,",",skeletal,malformations,",",and,macrodontia,.}	{"Nat Genet 12 : 1109-1112 .","4 ."}	{"Am J Hum Genet 2 : 289-294 .","PubMed : 21782149 ."}	0.714	0.122	0.992	{"WORD_SEQ_[cause kbg syndrome , characterize by intellectual disability , skeletal malformation , and]","POS_SEQ_[NN_NN_NN_,_VBN_IN_JJ_NN_,_JJ_NNS_,_CC]",DEP_PATH_[nn-prep_in|syndrome-dep|(-appos|D-nsubj|MISC@conj_and-prep_by|disability],DEP_PATH_POS_[nn-prep_in|NN-dep|FW-appos|NNP-nsubj|NNP@conj_and-prep_by|NN]}	{0.40425,0.40425,-0.0442168,-0.0442168}
journal.pone.0014299.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0014299.pdf_7_7_37_37_31_31	CCL11/HP:0002099|Asthma	{37}	{31}	{Methodology/Principal,Findings,:,In,this,study,we,investigated,serum,samples,from,944,individuals,of,218,asthma,—,affected,families,by,a,multiplex,",",microsphere,based,system,detecting,at,high,sensitivity,eleven,asthma,associated,mediators,:,eotaxin,(,CCL11,),",",granulocyte,macrophage,stimulating,factor,(,GM-CSF,),",",interferon,gamma,(,IFNy,),",",interleukin-4,(,IL-4,),",",IL-5,",",IL-8,",",IL-10,",",IL-12,(,p40,),",",IL-13,",",IL-17,and,tumor,necrosis,factor,alpha,(,I,',NFol,),.}	{Abstract,"Background : Circulating cytokine patterns may be relevant for the diagnosis of asthma , for the discrimination of certain phenotypes , and prognostic factors for exacerbation of disease ."}	{"Single cytokine levels were largely similar between asthmatic and healthy individuals when analysing asthma as single disease entity .","Regulatory differences between parental and pediatric asthma were reflected by six of the eleven mediators analyzed ( eotaxin , IL-4 , IL-5 , IL-10 , IL-12 , TNFor ) ."}	0.722	0.96	0.964	{INV_VERB_DEP_PATH_POS_[associate]_[nn-dep|NN-dobj|NNS@]_[@partmod],INV_DEP_PATH_[nn-dep|)-dobj|mediator-partmod|associate@],INV_VERB_DEP_PATH_[associate]_[nn-dep|)-dobj|mediator@]_[@partmod],INV_DEP_PATH_POS_[nn-dep|NN-dobj|NNS-partmod|VBN@],"INV_WORD_SEQ_NER_[associate mediator : eotaxin NUMBER]",INV_POS_SEQ_[VBN_NNS_:_NN_CD],"INV_WORD_SEQ_[associate mediator : eotaxin (]"}	{0.276874,0.276874,0.276874,0.276874,0,0,0}
SCPDFS_46034.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_46034.pdf_9_9_25_25_10_10_UNSUP	TUBB2B/HP:0002126|Polymicrogyria	{25}	{10}	{The,recent,discovery,of,patients,with,lissencephaly,and,bilateral,asymmetrical,polymicrogyria,(,PMG,),carrying,mutations,in,the,a,-,and,B-tubulin-encoding,genes,TUBA1A,and,TUBB2B,further,supports,this,view,",",and,also,raises,interesting,questions,about,the,specific,roles,played,by,certain,tubulin,isotypes,during,the,development,of,the,cortex,.}	{"Over the past few years , the importance of cytoskeleton components in cellular processes crucial for cortical development has emerged from a body of functional data .","This was reinforced by the association of mutations in the LIS1 and DCX genes , which both encode proteins involved in microtubule ( MT ) homeostasis , with cerebral cortex developmental disorders ."}	{"Genetic basis of cortical dysgeneses Genetic studies in humans and mice have identiﬁed a spectrum of mutations in genes involved in a large array of crucial processes ( e.g. cell proliferation , cell adhesion , cell migration , chemoattraction and repulsion , posttranslational modiﬁcations and dynamics of the cytoskeleton ) that often disrupts the development of the cerebral cortex ( Box 1 and Figure I ) and can lead to severe cortical malformations .","The heterogeneity of developmental disorders affecting the cortex recapitulates its development , because impairments in the different steps are associated With speciﬁc features [ 1 — 3 ] ."}	0.882	0.168	0.988	{INV_DEP_PATH_POS_[nsubj-conj_and|VBZ@nn-conj_and|NN-prep_of|NNS-nsubj|NN],INV_VERB_DEP_PATH_[carry]_[nsubj-conj_and|support@]_[nn-conj_and|(-prep_of|patient-nsubj|discovery@],INV_DEP_PATH_[nsubj-conj_and|support@nn-conj_and|(-prep_of|patient-nsubj|discovery],INV_VERB_DEP_PATH_POS_[carry]_[nsubj-conj_and|VBZ@]_[nn-conj_and|NN-prep_of|NNS-nsubj|NN@],INV_POS_SEQ_[NN_NN_CD_VBG_NNS_IN_DT_SYM_:_CC_JJ_NNS_NN_CC],"INV_WORD_SEQ_[( pmg ) carry mutation in the a - and b-tubulin-encoding gene tuba1a and]","INV_WORD_SEQ_NER_[( ORGANIZATION NUMBER carry mutation in the a - and b-tubulin-encoding gene tuba1a and]"}	{0.339924,0.339924,0.339924,0.339924,0.203176,0.203176,0.203176}
journal.pone.0060177.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0060177.pdf_70_70_19_19_8_8_UNSUP	WT1/HP:0000093|Proteinuria	{19}	{8}	{Interestingly,",",50,%,of,diabetic,patients,without,proteinuria,(,15,out,of,30,),were,detected,positive,for,WT1,(,Figure,1B,),.}	{"Therefore , we divided diabetic population based on urine albumin-to-creatinine ratio ( ACR ) into Proteinuria ( ACR > 30 mg / g creatinine ) and Non-Proteinuria ( ACR < 30 mg / g creatinine ) groups .","WT1 was detected in all the patients in Proteinuria group ( 100 % ) ."}	{"Furthermore , Proteinuria group had signiﬁcantly higher levels of WT1 compared to Non-Proteinuria and control groups ( p < 0.001 , Figure 1D ) .","Expression of \\\\ / \\\\ / T1 protein in Urinary exosomes of Diabetic patient ’s associates with increase in urine protein excretion Higher levels of \\\\ / VTl observed in Proteinuria group led us to determine its relation with urine protein excretion in diabetic patients ."}	0.796	0.088	0.996	{INV_VERB_DEP_PATH_POS_[detect]_[nn-prep_for|NN-amod|JJ-dobj|NN@]_[prep_without-prep_of|NNS-nsubjpass|NN@],"INV_WORD_SEQ_NER_[NUMBER NUMBER out of NUMBER NUMBER be detect positive for]","INV_WORD_SEQ_[( 15 out of 30 ) be detect positive for]",INV_VERB_DEP_PATH_[detect]_[nn-prep_for|1b-amod|positive-dobj|)@]_[prep_without-prep_of|patient-nsubjpass|PERCENT@],INV_POS_SEQ_[CD_CD_IN_IN_CD_CD_VBD_VBN_JJ_IN],INV_DEP_PATH_POS_[nn-prep_for|NN-amod|JJ-dobj|NN@prep_without-prep_of|NNS-nsubjpass|NN],INV_DEP_PATH_[nn-prep_for|1b-amod|positive-dobj|)@prep_without-prep_of|patient-nsubjpass|PERCENT]}	{0.191513,0.191513,0.191513,0.191513,0.191513,0.191513,0.191513}
SCPDFS_31.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_31.pdf_426_426_12_12_18_18_UNSUP	BRAF/HP:0002861|Melanoma	{12}	{18}	{In,vivo,identification,of,tumor,—,suppressive,PTEN,ceRNAs,in,an,oncogenic,BRAF,—,induced,mouse,model,of,melanoma,.}	{"— .","Mancera , P.A. , et al. ( 2011 ) ."}	{"Cell 147 , 382-395 .","Keeling , K.M. , Wang , D. , Dai , Y. , Murugesan , S. , Chenna , B. , Clark , J. , Belakhov , V. , Kandasamy , J. , Velu , S.E. , Baasov , T. , and Bedwell , D.M. ( 2013 ) ."}	0.83	0.812	0.996	{DEP_PATH_POS_[nn-prep_in|NN-nsubj|NN@prep_of-dobj|NN],"WORD_SEQ_[— induce mouse model of]",VERB_DEP_PATH_POS_[induce]_[nn-prep_in|NN-nsubj|NN@]_[prep_of-dobj|NN@],POS_SEQ_[NN_VBD_NN_NN_IN],VERB_DEP_PATH_[induce]_[nn-prep_in|—-nsubj|identification@]_[prep_of-dobj|model@],DEP_PATH_[nn-prep_in|—-nsubj|identification@prep_of-dobj|model]}	{1.02729,0.347197,0.347197,-0.250665,0.179274,0.179274}
journal.pone.0087079.pdf	RELATION_GENEHPOTERM_journal.pone.0087079.pdf_591_591_26_26_29_30	E2/HP:0003003|Colon cancer	{26}	{29,30}	{Sheng,H,",",ShaoJ,",",NIorrowJD,",",Beauchamp,RD,",",DuBois,RN,(,1998,),l,"\\\\",’,Iodulation,of,apoptosis,and,Bcl-2,expression,by,prostaglandin,E2,in,human,colon,cancer,cells,.}	{"BrJ Pharmacol 149:61 14623 .","29 ."}	{"Cancer Res 583624366 .","30 ."}	0.86	0.208	1	{"WORD_SEQ_[in human]",DEP_PATH_[@nn-prep_in|cell],POS_SEQ_[IN_JJ],DEP_PATH_POS_[@nn-prep_in|NNS]}	{1.36163,1.13524,-0.548537,-0.364379}
journal.pone.0055328.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0055328.pdf_468_468_21_21_34_34_UNSUP	CST3/HP:0000726|Dementia	{21}	{34}	{Nlaetzler,VV,",",Schmid,B,",",Synofzik,NI,",",Schulte,C,",",Riester,K,",",et,al.,(,2010,),The,CST3,BB,genotype,and,low,cystatin,C,cerebrospinal,ﬂuid,levels,are,associated,with,dementia,in,Lewy,body,disease,.}	{"Ghanem KG ( 2010 ) REVIEW ’ : Neurosyphilis : A historical perspective and review .","CNS Neurosci Ther 16 : el574l68 ."}	{"J Alzheimers Dis 19 : 9374942 .","Blennow K , Zetterberg H , Fagan Al \\\\ ’ I ( 2012 ) Fluid biomarkers in Alzheimer disease ."}	0.782	0.544	1	{DEP_PATH_[nn-dep|genotype-dep|(-appos|PERSON-nsubjpass|VV@prep_with],"WORD_SEQ_[bb genotype and low cystatin c cerebrospinal ﬂuid level be associate with]",POS_SEQ_[NN_NN_CC_JJ_NN_NN_JJ_NN_NNS_VBP_VBN_IN],DEP_PATH_POS_[nn-dep|NN-dep|FW-appos|NNP-nsubjpass|NNP@prep_with]}	{0.254674,0.254674,0.254674,0.212015}
journal.pone.0036690.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0036690.pdf_413_413_9_9_22_26_UNSUP	HERG/HP:0012232|Shortened QT interval	{9}	{22,25,26}	{Then,",",the,net,effect,caused,by,inhibition,of,HERG,channels,has,been,proposed,as,a,primary,test,Verapamil,leads,to,a,shortening,of,the,QT,interval,.}	{"with our data indicating that Verapamil does not cause an AV for screening purposes , several ion currents are involved in the block in zebraﬁsh embryos .","An explanation could be that although generation of the cardiac potential ."}	{A,"Sorafenib 1 1.1 M AG1478 20 1.1 M"}	0.728	0.246	0.268	{"WORD_SEQ_NER_[channel have be propose as a primary test MISC lead to a]","WORD_SEQ_[channel have be propose as a primary test verapamil lead to a]",DEP_PATH_[nn-prep_of|channel-agent|inhibition-partmod|cause-nsubjpass|effect-_|propose@ROOT@_],DEP_PATH_POS_[nn-prep_of|NNS-agent|NN-partmod|VBN-nsubjpass|NN-_|VBN@ROOT@_],POS_SEQ_[NNS_VBZ_VBN_VBN_IN_DT_JJ_NN_NN_VBZ_TO_DT]}	{0.200956,0.200956,0.200956,0.200956,0.200956}
journal.pgen.0040026.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.0040026.pdf_681_681_28_28_20_20_UNSUP	SYCP3/HP:0000027|Azoospermia	{28}	{20}	{Miyamoto,T,",",Hasuike,S,",",Yogev,L,",",Maduro,MR,",",Ishikawa,M,",",et,al.,(,2003,),Azoospermia,in,patients,heterozygous,for,a,mutation,in,SYCP3,.}	{"Morley M , Molony CM , Weber TM , Devlin JL , Ewens KG , et al. ( 2004 ) Genetic analysis of genome-wide variation in human gene expression .","Nature 430 : 743 — 747 ."}	{"Lancet 362:1714 — 1719 .","Kuo PL , Wang ST , Lin YM , Lin YH , Teng YN , et al. ( 2004 ) Expression proﬁles of the DAZ gene family in human testis with and without spermatogenic failure ."}	0.838	0.12	1	{INV_POS_SEQ_[IN_NNS_JJ_IN_DT_NN_IN],"INV_WORD_SEQ_[in patient heterozygous for a mutation in]",INV_DEP_PATH_[prep_in-prep_for|mutation-amod|heterozygous-prep_in|patient@dep-dobj|NUMBER],INV_DEP_PATH_POS_[prep_in-prep_for|NN-amod|JJ-prep_in|NNS@dep-dobj|CD]}	{0.518855,0.518855,0.281169,0.281169}
journal.pone.0092800.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0092800.pdf_297_297_11_11_5_6_UNSUP	TGFB/HP:0000118|Phenotypic abnormality	{11}	{5,6}	{Despite,the,lack,of,an,abnormal,phenotype,seen,with,loss,of,TGFB,signaling,in,prostate}	{"While stabilized Bcatenin was able to accelerate the Pten null phenotype , deletion of B-catenin did not slow the progression of Pten null tumors to HGPIN , suggesting that it is not required for the early stages of tumorigenesis in this model [ 40 ] .","We found that inactivation of TGFB signaling results in a dramatic acceleration of tumor progression initiated by Apc deletion ."}	{"WT Apc ” Pten ”","| % ."}	0.866	0.768	0.094	{INV_DEP_PATH_POS_[nn-prep_of|NN-prep_with|NN-partmod|VBN@],INV_POS_SEQ_[VBN_IN_NN_IN],INV_VERB_DEP_PATH_POS_[see]_[nn-prep_of|NN-prep_with|NN@]_[@partmod],INV_VERB_DEP_PATH_[see]_[nn-prep_of|signaling-prep_with|loss@]_[@partmod],"INV_WORD_SEQ_[see with loss of]",INV_DEP_PATH_[nn-prep_of|signaling-prep_with|loss-partmod|see@]}	{0.673237,0.622353,0.144383,0.144383,0.144383,0.144383}
journal.pone.0074793.pdf	RELATION_GENEHPOTERM_journal.pone.0074793.pdf_59_59_0_0_4_5	MMP9/HP:0012189|Hodgkin lymphoma	{0}	{4,5}	{MMP9,expression,in,classical,Hodgkin,lymphoma,(,200x,),.}	{"Clinical data","Figure 1 ."}	{"( A ) Cytoplasmic expression of MMP9 by Hodgkin .","— ."}	0.714	0.78	0.992	{DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NN_IN_JJ],"WORD_SEQ_[expression in classical]"}	{0.374951,0.356655,0.199886,0}
journal.pone.0090275.pdf	RELATION_GENEHPOTERM_journal.pone.0090275.pdf_853_853_22_22_27_28	BCR/HP:0012324|Myeloid leukemia	{22}	{27,28}	{VVarsch,VV,",",VValz,C,",",Sexl,V,(,2013,),JAK,of,all,trades,:,JAK2-STAT5,as,novel,therapeutic,targets,in,BCR,~,ABL1,+,chronic,myeloid,leukemia,.}	{"Q_uintas ~ Cardama A , V erstovsek S ( 2013 ) Nlolecular pathways : Jak / STAT pathway : mutations , inhibitors , and resistance .","Clin Cancer Res OffJ Am Assoc Cancer Res 19 : 193341940 ."}	{"Blood 122 : 21674 2175 .","Hayakawa F , Sugimoto K , Harada Y , Hashimoto N , Ohi N , et al. ( 2013 ) A novel STAT inhibitor , OPB ~ 3l 121 , has a significant antitumor effect on leukemia with STAT-addictive oncokinases ."}	0.782	0.886	1	{POS_SEQ_[NN_NN_CC_JJ],DEP_PATH_POS_[nn-prep_in|NN@prep_in],"WORD_SEQ_[~ abl1 + chronic]",DEP_PATH_[nn-prep_in|abl1@prep_in]}	{1.07617,0.240741,0,0}
SCPDFS_49556.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_49556.pdf_31_31_15_15_24_24_UNSUP	p53/HP:0100242|Sarcoma	{15}	{24}	{The,paper,by,Oliner,et,al.,reports,that,the,human,MDM2,gene,",",encoding,another,p53,inhibitor,protein,",",is,amplified,in,many,human,sarcomas,.}	{"Second , the ability of p53 to activate is strongly inhibited by addition of the SV/10 large T antigen .","The surmise that oncogenesis may be promoted by inhibition of p53 by :1 second protein may not be restricted to tumor viruses ."}	{"Thus p53 may interact with a variety of cellular proteins that are crucial for progression through the cell cycle and control of cell growth .","The in vitro assay described by Farmer et al. should permit other possible inhibitors of p53 Io be identified ."}	0.8	0.716	0.998	{"POS_SEQ_[NN_NN_,_VBZ_VBN_IN_JJ_JJ]","WORD_SEQ_[inhibitor protein , be amplify in many human]",VERB_DEP_PATH_[amplify]_[nn-dobj|protein-partmod|encode@]_[prep_in@],DEP_PATH_POS_[nn-dobj|NN-partmod|VBG@prep_in],DEP_PATH_[nn-dobj|protein-partmod|encode@prep_in],VERB_DEP_PATH_POS_[be]_[nn-dobj|NN-partmod|VBG@auxpass]_[prep_in@auxpass],VERB_DEP_PATH_POS_[amplify]_[nn-dobj|NN-partmod|VBG@]_[prep_in@],VERB_DEP_PATH_[be]_[nn-dobj|protein-partmod|encode@auxpass]_[prep_in@auxpass],VERB_DEP_PATH_[encode]_[nn-dobj|protein@]_[prep_in@partmod],VERB_DEP_PATH_POS_[encode]_[nn-dobj|NN@]_[prep_in@partmod]}	{0.464672,0.464672,0.0376436,0.0376436,0.0376436,0.0376436,0.0376436,0.0376436,0.0376436,0.0376436}
journal.pone.0003905.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0003905.pdf_31_31_2_2_11_11_UNSUP	STOX1/HP:0100602|Preeclampsia	{2}	{11}	{Mutations,in,STOX1,were,proposed,to,be,causal,for,predisposing,to,preeclampsia,[,1,],",",a,hypertensive,disorder,originating,from,placental,defects,affecting,up,to,10,%,of,human,pregnancies,[,2,],.}	{"* E — mai | : vaiman@cochin.inserm.fr",Introduction}	{"However , three recent studies have shown that the polymorphism described in the ﬁrst paper as a causal mutation is widely shared by non-preeclamptic women from various populations [ 3 — 5 ] .","One of the speciﬁc features of STOX1 , as depicted in the primary study , was its allele-speciﬁc expression from maternal alleles , since the authors showed that STOX1 mRNA was absent in hydatiform moles , which are exclusively of paternal origin [ 1 ] ."}	0.832	0.404	0.99	{"WORD_SEQ_[be propose to be causal for predispose to]",POS_SEQ_[VBD_VBN_TO_VB_JJ_IN_VBG_TO],VERB_DEP_PATH_POS_[be]_[prep_in-nsubjpass|NNS@cop-xcomp|JJ]_[nn-prep_to|NN-prepc_for|VBG@cop],DEP_PATH_POS_[prep_in-nsubjpass|NNS@nn-prep_to|NN-prepc_for|VBG-xcomp|JJ],VERB_DEP_PATH_[propose]_[prep_in-nsubjpass|mutation@]_[nn-prep_to|[-prepc_for|predispose-xcomp|causal@],VERB_DEP_PATH_POS_[predispose]_[prep_in-nsubjpass|NNS@prepc_for-xcomp|JJ]_[nn-prep_to|NN@],VERB_DEP_PATH_POS_[propose]_[prep_in-nsubjpass|NNS@]_[nn-prep_to|NN-prepc_for|VBG-xcomp|JJ@],VERB_DEP_PATH_[be]_[prep_in-nsubjpass|mutation@cop-xcomp|causal]_[nn-prep_to|[-prepc_for|predispose@cop],VERB_DEP_PATH_[predispose]_[prep_in-nsubjpass|mutation@prepc_for-xcomp|causal]_[nn-prep_to|[@],DEP_PATH_[prep_in-nsubjpass|mutation@nn-prep_to|[-prepc_for|predispose-xcomp|causal]}	{0.258714,0.258714,0.125927,0.125927,0.125927,0.125927,0.125927,0.125927,0.125927,0.125927}
journal.pone.0039942.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0039942.pdf_661_661_31_31_22_22_UNSUP	ATP13A2/HP:0001332|Dystonia	{31}	{22}	{Crosiers,D,",",Ceulemans,B,",",Nleeus,B,",",Nuytemans,K,",",Pals,P,",",et,al.,(,201,l,),Juvenile,dystonia,~,parkinsonism,and,dementia,caused,by,a,novel,ATP13A2,frameshift,mutation,.}	{"Behrens IVII , Bruggemann N , Chana P , Venegas P , Kagi NI , et al. ( 2010 ) Clinical spectrum of Kufor ~ Rakeb syndrome in the Chilean kindred with ATP13A2 mutations .","l \\\\ ’ Iov Disord 25 : 192941937 ."}	{"Parkinsonism Relat Disord 17 : 1354138 .","Santoro L , Breedveld GJ , l \\\\ ’ Ianganelli F , Iodice R , Pisciotta C , et al. ( 201 1 ) Novel ATP13A2 ( PARK9 ) homozygous mutation in a family with marked phenotype variability ."}	0.728	0.882	0.998	{INV_POS_SEQ_[NN_NN_CC_NN_VBN_IN_DT_JJ],INV_DEP_PATH_[nn-agent|mutation-partmod|cause@nn-dep|parkinsonism-dep|juvenile-dep|(],"INV_WORD_SEQ_[~ parkinsonism and dementia cause by a novel]",INV_DEP_PATH_POS_[nn-agent|NN-partmod|VBN@nn-dep|NN-dep|NN-dep|FW]}	{0.26085,0.26085,0.26085,0.26085}
journal.pone.0044973.pdf	RELATION_GENEHPOTERM_journal.pone.0044973.pdf_1194_1194_23_23_26_29	OPTC/HP:0012108|Primary open angle glaucoma	{23}	{26,27,28,29}	{Acharya,IVI,",",Nlookherjee,S,",",Bhattacharjee,A,",",Thakur,SK,",",Bandyopadhyay,AK,",",et,al.,(,2007,),Evaluation,of,the,OPTC,gene,in,primary,open,angle,glaucoma,:,functional,significance,of,a,silent,change,.}	{"\\\\ / Vang X , Sam » \\\\ / Vah TS , Ng YK ( 2000 ) Nitric oxide , microglial activities and neuronal cell death in the lateral geniculate nucleus of glaucomatous rats .","Brain Res 878 : 1364147 ."}	{"BIVIC Nlol Biol 8 : 21 .","Kumar A , Basavaraj IVIG , Gupta SK , Q_amar 1 , Ali AIVI , et al. ( 2007 ) Role of CYP1B1 , IVIYOC , OPTN , and OPTC genes in adult » onset primary open » angle glaucoma : predominance of CYP1B1 mutations in Indian patients ."}	0.834	0.242	0.98	{"WORD_SEQ_[gene in]",POS_SEQ_[NN_IN],DEP_PATH_POS_[nn-prep_of|NN-dobj|NN@prep_in],DEP_PATH_[nn-prep_of|gene-dobj|evaluation@prep_in]}	{1.4523,-0.989443,0.967369,0}
SCPDFS_2967.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_2967.pdf_563_563_20_20_5_5_UNSUP	FGF3/HP:0008551|Microtia	{20}	{5}	{Syndromic,congenital,sensorineural,deafness,",",microtia,and,microdontia,resulting,from,a,novel,homoallelic,mutation,in,ﬁbroblast,growth,factor,3,(,FGF3,),.}	{"— .","Saud , H. , Ramzan , K. , AlSayed , M. , 2009 ."}	{"Eur .","J. Hum ."}	0.838	0.952	0.982	{INV_DEP_PATH_[nn-dep|)-prep_in|factor-prep_from|mutation-partmod|result@conj_and],INV_VERB_DEP_PATH_POS_[result]_[nn-dep|NN-prep_in|NN-prep_from|NN@]_[conj_and@partmod],INV_DEP_PATH_POS_[nn-dep|NN-prep_in|NN-prep_from|NN-partmod|VBG@conj_and],INV_VERB_DEP_PATH_[result]_[nn-dep|)-prep_in|factor-prep_from|mutation@]_[conj_and@partmod],INV_POS_SEQ_[CC_NN_VBG_IN_DT_JJ_JJ_NN_IN_NN_NN_NN_CD_NN],"INV_WORD_SEQ_NER_[and microdontium result from a novel homoallelic mutation in ﬁbroblast growth factor NUMBER (]","INV_WORD_SEQ_[and microdontium result from a novel homoallelic mutation in ﬁbroblast growth factor 3 (]"}	{0.316985,0.316985,0.316985,0.316985,0.170614,0.170614,0.170614}
journal.pone.0065546.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0065546.pdf_320_320_20_20_29_30_UNSUP	ABCA4/HP:0000548|Cone-rod dystrophy	{20}	{29,30}	{Fishman,GA,",",Stone,EIVI,",",Eliason,DA,",",Taylor,CNI,",",Lindeman,IVI,",",et,al.,(,2003,),ABCA4,gene,sequence,variations,in,patients,with,autosomal,recessive,cone-rod,dystrophy,.}	{"Ducroq D , RozetJNI , Gerber S , Perrault I , Barbet D , et al. ( 2002 ) The ABCA4 gene in autosomal recessive cone-rod dystrophies .","AmJ Hum Genet 71 : 14804 1482 ."}	{"Arch Ophthalmol 121 : 8514855 .","Thiadens AA , Phan T1 \\\\ I , Zekveld-Vroon RC , Leroy BP , van den Born LI , et al. ( 2012 ) Clinical course , genetic etiology , and visual outcome in cone and conerod dystrophy ."}	0.872	0.788	0.994	{DEP_PATH_POS_[nn-dobj|NNS@prep_with],POS_SEQ_[NN_NN_NNS_IN_NNS_IN_JJ_JJ],"WORD_SEQ_[gene sequence variation in patient with autosomal recessive]",DEP_PATH_[nn-dobj|variation@prep_with]}	{0.689784,0.473776,0.383812,0.0137797}
journal.pone.0071215.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0071215.pdf_414_414_18_18_16_16_UNSUP	DAZ/HP:0000027|Azoospermia	{18}	{16}	{moto,l,"\\\\",’,I,(,2000,),Caenorhal,),ditis,elegans,homologue,of,the,human,azoospermia,factor,DAZ,is,required,for,oogenesis,but,not,for,spermatogenesis,.}	{"14 .","Karashima T , Sugimoto A , Yama ."}	{"Development 127 : 106941079 .","15 ."}	0.766	0.416	0.77	{INV_POS_SEQ_[NN],INV_WORD_SEQ_[factor],INV_VERB_DEP_PATH_[require]_[prep_of-nsubjpass|homologue@]_[nn-prep_of|DAZ-nsubjpass|homologue@],INV_VERB_DEP_PATH_[be]_[prep_of-nsubjpass|homologue@auxpass]_[nn-prep_of|DAZ-nsubjpass|homologue@auxpass],INV_VERB_DEP_PATH_POS_[require]_[prep_of-nsubjpass|NN@]_[nn-prep_of|NNP-nsubjpass|NN@],INV_VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[nn-prep_of|NNP-nsubjpass|NN@auxpass],INV_DEP_PATH_[@nn],INV_DEP_PATH_POS_[@nn]}	{-2.77211,0.970196,0.867685,0.867685,0.867685,0.813801,-0.261945,-0.245954}
journal.pone.0074908.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0074908.pdf_286_286_9_9_15_17_UNSUP	AF10/HP:0004808|Acute myeloid leukemia	{9}	{15,16,17}	{The,human,homolog,of,zfp,—,1,is,called,AF10,and,is,involved,in,pediatric,acute,myeloid,leukemia,(,AML,),[,61,],making,zfp,—,1,an,interesting,gene,to,explore,.}	{"While single mutants of any SynMuv gene show no aberrant vulva development , double mutants of two genes belonging to different SynMuv classes will result in the typical multivulval phenotype .","ZFP-1 has also been suggested to act in the RNAi pathway , again counteracting SynMuv genes [ 59,60 ] ."}	{"The op481 mutation introduces a premature stop codon in the ZFP-1 open reading frame ( Table 1 ) .","A second zfp — 1 allele , ok554 , deletes part of the gene and shows an identical axon guidance phenotype as op481 ( Figure 3A ) ."}	0.896	0.348	1	{POS_SEQ_[CC_VBZ_VBN_IN_JJ],VERB_DEP_PATH_POS_[be]_[dobj@auxpass-conj_and|VBN]_[amod-prep_in|NN@auxpass],VERB_DEP_PATH_POS_[make]_[dobj@xcomp-conj_and|VBN]_[amod-prep_in|NN@xcomp],VERB_DEP_PATH_[be]_[dobj@auxpass-conj_and|involve]_[amod-prep_in|ORGANIZATION@auxpass],VERB_DEP_PATH_[make]_[dobj@xcomp-conj_and|involve]_[amod-prep_in|ORGANIZATION@xcomp],VERB_DEP_PATH_POS_[be]_[dobj@auxpass]_[amod-prep_in|NN-conj_and|VBN@auxpass],VERB_DEP_PATH_POS_[involve]_[dobj@conj_and]_[amod-prep_in|NN@],VERB_DEP_PATH_POS_[call]_[dobj@]_[amod-prep_in|NN-conj_and|VBN@],DEP_PATH_[dobj@amod-prep_in|ORGANIZATION-conj_and|involve],VERB_DEP_PATH_[call]_[dobj@]_[amod-prep_in|ORGANIZATION-conj_and|involve@],DEP_PATH_POS_[dobj@amod-prep_in|NN-conj_and|VBN],VERB_DEP_PATH_[be]_[dobj@auxpass]_[amod-prep_in|ORGANIZATION-conj_and|involve@auxpass],VERB_DEP_PATH_[involve]_[dobj@conj_and]_[amod-prep_in|ORGANIZATION@],"WORD_SEQ_[and be involve in pediatric]"}	{0.82141,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905,0.0943905}
journal.pone.0016479.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0016479.pdf_265_265_13_13_21_21_UNSUP	VDR/HP:0002901|Hypocalcemia	{13}	{21}	{Importantly,",",the,altered,mammary,gland,development,observed,in,both,young,and,aged,VDR,KO,mice,occurred,in,the,absence,of,hypocalcemia,",",indicating,that,these,effects,of,VDR,ablation,are,not,secondary,to,the,role,of,VDR,in,maintenance,of,extracellular,calcium,homeostasis,.}	{"Through comparative analysis of mammary gland development and gene expression in relation to age , we report that mice lacking the VDR exhibit ductal ectasia , reduced branching and progressive atrophy of the mammary fat pad with age .","These changes do not become evident until the onset of the second year of life and are in sharp contrast to the effects of VDR ablation observed during puberty and pregnancy , when lack of the VDR is associated with accelerated branching and precocious alveolar development [ 10,15 ] ."}	{"Due to the chronic and systemic nature of VDR ablation in these studies , the extent to which VDR signaling within the mammary gland is responsible for maintaining glandular homeostasis is unclear .","In support of direct effects of VDR signaling , VDR expression remained high in the aging mammary gland , and positive VDR staining was observed in glandular epithelial and stromal cells as well as adipocytes ."}	0.804	0.414	0.912	{"WORD_SEQ_[ko mouse occur in the absence of]",VERB_DEP_PATH_POS_[observe]_[nn-conj_and|NNS-prep_in|JJ@]_[prep_of-prep_in|NN@partmod-nsubj|NN],POS_SEQ_[NN_NNS_VBD_IN_DT_NN_IN],VERB_DEP_PATH_[observe]_[nn-conj_and|mouse-prep_in|young@]_[prep_of-prep_in|absence@partmod-nsubj|development],DEP_PATH_[nn-conj_and|mouse-prep_in|young-partmod|observe-nsubj|development@prep_of-prep_in|absence],DEP_PATH_POS_[nn-conj_and|NNS-prep_in|JJ-partmod|VBN-nsubj|NN@prep_of-prep_in|NN]}	{0.237873,0.237873,0.237873,0.237873,0.237873,0.237873}
SCPDFS_18980.pdf	RELATION_GENEHPOTERM_SCPDFS_18980.pdf_464_464_2_2_7_8	CAPN10/HP:0000147|Polycystic ovaries	{2}	{7,8}	{Comment,:,CAPN10,alleles,are,associated,with,polycystic,ovary,syndrome,.}	{"Online 7 , 602-605 .","Gonzalez , A. , et al. , 2002 ."}	{"J. Clin .","Endocrinol ."}	0.84	0.808	1	{VERB_DEP_PATH_[associate]_[nn-nsubjpass|allele@]_[amod-prep_with|syndrome@],"WORD_SEQ_[allele be associate with]",DEP_PATH_[nn-nsubjpass|allele@amod-prep_with|syndrome],VERB_DEP_PATH_[be]_[nn-nsubjpass|allele@auxpass]_[amod-prep_with|syndrome@auxpass],POS_SEQ_[NNS_VBP_VBN_IN],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NNS@]_[amod-prep_with|NN@],DEP_PATH_POS_[nn-nsubjpass|NNS@amod-prep_with|NN],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NNS@auxpass]_[amod-prep_with|NN@auxpass]}	{0.336525,0.336525,0.336525,0.336525,0.276808,-0.21674,-0.0108329,-0.0108329}
journal.pone.0049570.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0049570.pdf_420_420_20_20_11_11_UNSUP	NF1/HP:0009733|Glioma	{20}	{11}	{Because,both,CREB,and,miR,—,9,are,highly,expressed,in,glioma,cells,compared,with,normal,glial,cells,",",the,NF1,protein,level,is,determined,by,the,balance,between,them,.}	{"A similar manner of regulation of E2Fl has been discussed by O’Donnell et al. , who found that MYC simultaneously activates E2Fl transcription and limits its translation through up-regulating E2Fl-targeting miRNAs [ 33 ] .","This type of two-tier regulation allows tight control of the expression levels of target genes and relevant cell signals ."}	{"Moreover , in addition to directly targeting the NF1 3 ’ UTR , miR — 9 can indirectly repress the expression of NF 1 by targeting its activator , CREB .","In this study , our cell models are glioblastoma cell lines ( U87MG , T98G and U251 ) with high expression levels of miR — 9 , partly due to copy number ampliﬁcations of the miR-9-2 gene ."}	0.816	0.478	0.996	{INV_DEP_PATH_POS_[nn-nsubjpass|NN@nn-prep_in|NNS-advcl|VBN],INV_VERB_DEP_PATH_POS_[determine]_[nn-nsubjpass|NN@]_[nn-prep_in|NNS-advcl|VBN@],INV_VERB_DEP_PATH_POS_[express]_[nn-nsubjpass|NN@advcl]_[nn-prep_in|NNS@],"INV_WORD_SEQ_[cell compare with normal glial cell , the]",INV_VERB_DEP_PATH_[determine]_[nn-nsubjpass|level@]_[nn-prep_in|cell-advcl|express@],INV_VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[nn-prep_in|NNS-advcl|VBN@auxpass],INV_VERB_DEP_PATH_[be]_[nn-nsubjpass|level@auxpass]_[nn-prep_in|cell-advcl|express@auxpass],"INV_POS_SEQ_[NNS_VBN_IN_JJ_JJ_NNS_,_DT]",INV_DEP_PATH_[nn-nsubjpass|level@nn-prep_in|cell-advcl|express],INV_VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass-advcl|VBN]_[nn-prep_in|NNS@auxpass],INV_VERB_DEP_PATH_[express]_[nn-nsubjpass|level@advcl]_[nn-prep_in|cell@],INV_VERB_DEP_PATH_[be]_[nn-nsubjpass|level@auxpass-advcl|express]_[nn-prep_in|cell@auxpass]}	{0.12294,0.12294,0.12294,0.12294,0.12294,0.12294,0.12294,0.12294,0.12294,0.12294,0.12294,0.12294}
journal.pgen.1003702.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1003702.pdf_49_49_18_18_14_14_UNSUP	ATR/HP:0001009|Telangiectasia	{18}	{14}	{In,all,eukaryotes,",",two,evolutionarily,conserved,P13-kinase-like,protein,kinases,",",ATM,(,Ataxia,telangiectasia,mutated,),and,ATR,(,ATM,-,and,Rad3related,),respond,directly,to,DNA,damage,to,control,cell-cycle,progression,and,regulate,other,DNA,damage,responses,such,as,DNA,repair,and,apoptosis,.}	{Introduction,"In response to endogenous and exogenous stress , cells have evolved a range DNA damage response ( DDR ) pathways to maintain genomic stability [ 1,2,3,4 ] ."}	{"ATM activation is triggered by doublestrand breaks ( DSBs ) , whereas ATR activation is induced by single stranded DNA ( ssDNA ) occurring due to replication stress , I ‘ 6SCCt6Cl-DSBS or other single strand lesions [ 5,6,7,8 ] .","In all eukaryotic organisms , ATR is found associated with ATRIP ( ATR-interacting protein ) which is necessary to recruit ATR to RPA-coated ssDNA [ 9,10,11,12 ] ."}	0.84	0.32	0.746	{"INV_WORD_SEQ_[mutate ) and]",INV_VERB_DEP_PATH_POS_[conserve]_[nn-dobj|NNP-partmod|VBN-dobj|NN@]_[dobj@],INV_VERB_DEP_PATH_[mutate]_[nn-dobj|ATM@]_[@partmod],INV_VERB_DEP_PATH_POS_[mutate]_[nn-dobj|NNP@]_[@partmod],INV_DEP_PATH_[nn-dobj|ATM-partmod|mutate@],INV_DEP_PATH_POS_[nn-dobj|NNP-partmod|VBN@],INV_VERB_DEP_PATH_[conserve]_[nn-dobj|ATM-partmod|mutate-dobj|telangiectasium@]_[dobj@],INV_POS_SEQ_[VBN_NN_CC]}	{0.460549,0.196331,0.196331,0.196331,0.196331,0.196331,0.196331,0.102261}
SCPDFS_182.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_182.pdf_44_44_21_21_8_9_UNSUP	hemochromatosis/HP:0001402|Hepatocellular carcinoma	{21}	{8,9}	{A,20,-,to,200-fold,higher,risk,for,hepatocellular,carcinoma,or,many,other,types,of,cancer,was,reported,for,patients,with,hemochromatosis,with,iron,overload,",",highlighting,a,strong,association,between,increased,iron,metabolism,and,human,malignancy,(,Torti,and,Torti,",",2013,),.}	{"— .","10 % among female carriers ( Fleming and Ponka , 2012 ) ."}	{"However , the underlying mechanism remains unclear .","Mice with homozygous deletion of the human hemochromatosis ( Hfe ) gene ( Hfe ”’ ) faithfully recapitulate most human HH symptoms , including significant liver iron overload as assessed by Perls ’ Prussian Blue staining ( Zhou et al. , 1998 ) ( Figure 1A ) ."}	0.802	0.294	1	{INV_DEP_PATH_POS_[prep_with-prep_for|NNS@prep_for-pobj|NN-dep|TO-dep|CD],"INV_WORD_SEQ_[or many other type of cancer be report for patient with]",INV_DEP_PATH_[prep_with-prep_for|patient@prep_for-pobj|risk-dep|to-dep|NUMBER],INV_VERB_DEP_PATH_[report]_[prep_with-prep_for|patient@]_[prep_for-pobj|risk-dep|to-dep|NUMBER@],INV_VERB_DEP_PATH_POS_[report]_[prep_with-prep_for|NNS@]_[prep_for-pobj|NN-dep|TO-dep|CD@],INV_POS_SEQ_[CC_JJ_JJ_NNS_IN_NN_VBD_VBN_IN_NNS_IN]}	{0.21746,0.21746,0.21746,0.21746,0.21746,0.21746}
journal.pone.0097720.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0097720.pdf_75_75_14_14_24_26_UNSUP	SCN5A/HP:0001657|Prolonged QT interval	{14}	{24,25,26}	{Therefore,",",we,next,tested,the,role,of,channel,availability,by,simulating,the,LQT3,SCN5A,mutation,Fl473C,",",a,mutation,characterized,clinically,by,severe,QT,interval,prolongation,and,heavy,arrhythmia,burden,[,l7,],",",and,characterized,biophysically,by,a,rightward,shift,in,the,availability,curve,of,10,mV,and,large,amplitude,late,current,.}	{"The ﬁnding that VM are more affected by AKPQ than PFC was surprising , since in PFC there is a larger driving force for sodium entry during the plateau .","\\\\ / V e hypothesized that the more depolarized diastolic potential in PFC may force a larger fraction of SCNSA channels into unavailable states , preventing entry into the pathologic bursting states ."}	{"Fl473C channels were simulated with the","Figure 1 ."}	0.87	0.982	0.998	{DEP_PATH_[nn@prep_by-dep|clinically-dep|characterize-appos|mutation],DEP_PATH_POS_[nn@prep_by-dep|RB-dep|VBN-appos|NN],VERB_DEP_PATH_POS_[characterize]_[nn@dep-appos|NN]_[prep_by-dep|RB-dep|VBN@dep],VERB_DEP_PATH_POS_[characterize]_[nn@dep-appos|NN]_[prep_by-dep|RB@],VERB_DEP_PATH_[characterize]_[nn@dep-appos|mutation]_[prep_by-dep|clinically-dep|characterize@dep],VERB_DEP_PATH_[characterize]_[nn@dep-appos|mutation]_[prep_by-dep|clinically@],"POS_SEQ_[NN_NN_,_DT_NN_VBN_RB_IN_JJ]","WORD_SEQ_[mutation fl473c , a mutation characterize clinically by severe]"}	{0.269158,0.269158,0.269158,0.269158,0.269158,0.269158,0.151306,0.151306}
SCPDFS_20580.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20580.pdf_373_373_6_6_14_16_UNSUP	TBX20/HP:0001655|Patent foramen ovale	{6}	{14,15,16}	{A,gain,—,of,—,function,TBX20,mutation,causes,congenital,atrial,septal,defects,",",patent,foramen,ovale,and,cardiac,valve,defects,.}	{"279 , 19026-19034 .","Posch , M.G. , et al. , 2010 ."}	{"J. Med .","Genet ."}	0.814	0.904	1	{DEP_PATH_POS_[nn-prep_of|NN-nsubj|NN@dobj],VERB_DEP_PATH_POS_[cause]_[nn-prep_of|NN-nsubj|NN@]_[dobj@],"POS_SEQ_[NN_VBZ_JJ_JJ_JJ_NNS_,]","WORD_SEQ_[mutation cause congenital atrial septal defect ,]",DEP_PATH_[nn-prep_of|mutation-nsubj|—@dobj],VERB_DEP_PATH_[cause]_[nn-prep_of|mutation-nsubj|—@]_[dobj@]}	{-1.02604,1.00787,0.607019,0.607019,0.0224393,0.0224393}
journal.pgen.1000642.pdf	RELATION_GENEHPOTERM_journal.pgen.1000642.pdf_22_22_21_21_32_33	USF1/HP:0008356|Combined hyperlipidemia	{21}	{32,33}	{Vazquez,A,",",Cruz,»,Bautista,I,",",Herrera,MF,",",et,al.,(,2009,),A,Systems,Genetics,Approach,lmplicates,USF1,",",FADS3,",",and,Other,Causal,Candidate,Genes,for,Familial,Combined,Hyperlipidemia,.}	{"Citation : Plaisier CL , Horvath S , Huertas .","— ."}	{"PLoS Genet 5 ( 9 ) : e1000642 .","doi :10.1371 / journa | ."}	0.806	0.216	0.874	{DEP_PATH_POS_[nn-dobj|NN@prep_for],VERB_DEP_PATH_POS_[lmplicate]_[nn-dobj|NN@]_[prep_for@],DEP_PATH_[nn-dobj|fads3@prep_for],VERB_DEP_PATH_[lmplicate]_[nn-dobj|fads3@]_[prep_for@],"POS_SEQ_[,_NN_,_CC_JJ_NNP_NNP_NNS_IN_NNP]","WORD_SEQ_[, fads3 , and other Causal Candidate gene for Familial]"}	{0.272425,0.222919,0.222919,0.222919,0.222919,0.222919}
journal.pone.0022128.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0022128.pdf_449_449_44_44_36_38_UNSUP	C4B/HP:0002725|Systemic lupus erythematosus	{44}	{36,37,38}	{Rupert,KL,",",Nloulds,Jl,"\\\\",’,I,",",Yang,Y,",",Arnett,FC,",","\\\\",Varren,RVV,",",et,al.,(,2002,),The,molecular,basis,of,complete,complement,C4A,and,C413,deﬁciencies,in,a,systemic,lupus,erythematosus,patient,with,homozygous,C4A,and,C4B,mutant,genes,.}	{"J Autoimmun 25 : 77484 .","13 ."}	{"JImmuno1 169 : 157041578 .","14 ."}	0.784	0.402	0.994	{INV_POS_SEQ_[NN_IN_JJ_NN_CC],INV_DEP_PATH_[nn-prep_with|gene@amod],"INV_WORD_SEQ_[patient with homozygous c4a and]",INV_DEP_PATH_POS_[nn-prep_with|NNS@amod]}	{0.499796,0.335513,0.335513,0.214591}
journal.pone.0096622.pdf	RELATION_GENEHPOTERM_journal.pone.0096622.pdf_583_583_11_11_19_20	FE/HP:0002133|Status epilepticus	{11}	{19,20}	{Ekstrand,J,],",",Pouliot,VV,",",Scheerlinck,P,",",Dudek,FE,(,2011,),Lithium,pilocarpine,»,induced,status,epilepticus,in,postnatal,day,20,rats,results,in,greater,neuronal,injury,in,ventral,versus,dorsal,hippocampus,.}	{"Rao lVIS , Hattiangady B , Reddy DS , Shetty AK ( 2006 ) Hippocampal neurodegeneration , spontaneous seizures , and mossy ﬁber sprouting in the F344 rat model of temporal lobe epilepsy .","J Neurosci Res 83 : 108841105 ."}	{"Neuroscience 192 : 6994707 .","Dalby N O , Nlody 1 ( 2001 ) The process of epileptogenesis : a pathophysiological approach ."}	0.894	0	1	{VERB_DEP_PATH_[induce]_[nsubj@dep]_[dobj@],DEP_PATH_[nsubj@dobj-dep|induce],VERB_DEP_PATH_POS_[induce]_[nsubj@dep]_[dobj@],DEP_PATH_POS_[nsubj@dobj-dep|VBD],VERB_DEP_PATH_[result]_[nsubj-parataxis|(@]_[dobj-dep|induce-parataxis|(@],POS_SEQ_[VBD_CD_CD_NN_NN_NN_VBD],"WORD_SEQ_[( 2011 ) lithium pilocarpine » induce]","WORD_SEQ_NER_[( DATE NUMBER lithium pilocarpine » induce]",VERB_DEP_PATH_POS_[result]_[nsubj-parataxis|VBD@]_[dobj-dep|VBD-parataxis|VBD@]}	{0.598261,0.598261,0.598261,0.343065,0,0,0,0,0}
SCPDFS_31098.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_31098.pdf_56_56_8_8_3_3_UNSUP	p53/HP:0009919|Retinoblastoma	{8}	{3}	{(,d,),Retinoblastoma,(,RB,),and,p53,Among,the,human,tumor,associated,suppressor,gene,losses,",",p53,mutations,and,deletions,play,a,predominant,role,",",with,RB,losses,as,a,good,second,.}	{"Tumor suppressor genes are often spotted by LOH ( loss of heterozygosis ) , a fairly easy screening test for tumor associated gene losses .","There is no corresponding test to detect activated oncogenes ."}	{"The central role of these two genes has also been brought out in a totally different and unexpected way .","It turned out that three unrelated groups of DNA tumor viruses ."}	0.82	0.248	1	{INV_DEP_PATH_POS_[dep@dep-dep|NN],"INV_WORD_SEQ_[( rb ) and]","INV_WORD_SEQ_NER_[NUMBER MISC ) and]",INV_POS_SEQ_[CD_NN_NN_CC],INV_VERB_DEP_PATH_POS_[associate]_[dep@prepc_among]_[dep-dep|NN@prepc_among],INV_VERB_DEP_PATH_[associate]_[dep@prepc_among]_[dep-dep|)@prepc_among],INV_VERB_DEP_PATH_[play]_[dep@]_[dep-dep|)@],INV_VERB_DEP_PATH_POS_[play]_[dep@]_[dep-dep|NN@],INV_DEP_PATH_[dep@dep-dep|)]}	{-1.00715,0.856995,0.856995,-0.639366,0.292668,0.292668,0.292668,0.292668,0.203922}
journal.pone.0057699.pdf	RELATION_GENEHPOTERM_journal.pone.0057699.pdf_249_249_20_20_26_27	KRAS/HP:0003003|Colon cancer	{20}	{26,27}	{Richman,SD,",",Seymour,NIT,",",Chambers,F,",",Elliott,F,",",Daly,CL,",",et,al.,(,2009,),KRAS,and,BRAF,mutations,in,advanced,colon,cancer,are,associated,with,poor,prognosis,but,do,not,preclude,beneﬁt,from,oxaliplatin,or,irinotecan,:,results,from,MRC,FOCUS,tria1,.,]}	{"Dig Dis Sci 50 : 1741 — 1746 .","17 ."}	{"Clin Oncol 27 : 5931 — 5937 .","18 ."}	0.718	0.656	1	{POS_SEQ_[CC_NN_NNS_IN_JJ],DEP_PATH_POS_[dep-dep|FW-appos|NNP@prep_in-appos|NNS],VERB_DEP_PATH_[associate]_[dep-dep|(-appos|NIT-nsubjpass|sd@]_[prep_in-appos|mutation-nsubjpass|sd@],"WORD_SEQ_[and braf mutation in advanced]",DEP_PATH_[dep-dep|(-appos|NIT@prep_in-appos|mutation],VERB_DEP_PATH_POS_[associate]_[dep-dep|FW-appos|NNP-nsubjpass|NN@]_[prep_in-appos|NNS-nsubjpass|NN@]}	{0.635656,0.326711,0,0,0,0}
journal.pone.0007591.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0007591.pdf_39_39_31_31_34_36_UNSUP	EDARADD/HP:0007607|Hypohidrotic ectodermal dysplasia	{31}	{34,35,36}	{Mutations,affecting,signalling,through,the,cell,surface,receptor,EDAR,(,OMIM,#,604095,),",",either,by,mutation,of,EDAR,itself,or,of,the,genes,encoding,its,interaction,partners,EDA,or,EDARADD,",",cause,hypohidrotic,ectodermal,dysplasia,(,also,known,as,anhidrotic,ectodermal,dysplasia,or,Christ-Siemens-Touraine,syndrome,),[,2,],.}	{"n PLoS ONE | www .","p | osone.org the result that single gene mutations can have pleiotropic effects on multiple glands , and also on the distribution and structure of teeth and hairs ."}	{"Outwardly , hypohidrotic ectodermal dysplasia ( HED ) in humans is characterised by the presence of sparse hair , the absence of many teeth and the peg-like or conical shape of the teeth that do develop .","In addition to these externally visible characteristics , HED also results in an absence of eccrine sweat glands and the reduction or absence of the many glands that secrete onto the surfaces of the craniofacial region ( eyes , nasal passage , mouth and upper airway ) ."}	0.878	0.034	0.996	{"WORD_SEQ_[, cause]",VERB_DEP_PATH_[cause]_[conj_or-xcomp|EDA-xcomp|encode-dep|affect@]_[amod-dobj|(@],VERB_DEP_PATH_[encode]_[conj_or-xcomp|EDA@]_[amod-dobj|(@xcomp-dep|affect],VERB_DEP_PATH_[affect]_[conj_or-xcomp|EDA-xcomp|encode@]_[amod-dobj|(@dep],VERB_DEP_PATH_POS_[cause]_[conj_or-xcomp|NNP-xcomp|VBG-dep|VBG@]_[amod-dobj|NN@],VERB_DEP_PATH_POS_[affect]_[conj_or-xcomp|NNP-xcomp|VBG@]_[amod-dobj|NN@dep],DEP_PATH_POS_[conj_or-xcomp|NNP-xcomp|VBG-dep|VBG@amod-dobj|NN],VERB_DEP_PATH_POS_[encode]_[conj_or-xcomp|NNP@]_[amod-dobj|NN@xcomp-dep|VBG],DEP_PATH_[conj_or-xcomp|EDA-xcomp|encode-dep|affect@amod-dobj|(],"POS_SEQ_[,_VBP]"}	{0.943498,0.133017,0.133017,0.133017,0.133017,0.133017,0.133017,0.133017,0.133017,-0.0329885}
journal.pone.0102957.pdf	RELATION_GENEHPOTERM_journal.pone.0102957.pdf_664_664_17_17_20_20	AGO2/HP:0002861|Melanoma	{17}	{20}	{Voller,D,",",Reinders,J,",",lV1eister,G,",",Bosserholf,AK,(,2013,),Strong,reduction,of,AGO2,expression,in,melanoma,and,cellular,consequences,.}	{"A\\\\/Io YY , lV1oschos SJ ( 2005 ) Targeting Ul ) c9 for cancer therapy .","Expert Opin Ther Targets 9 : 120341216 ."}	{"BrJ Cancer .","Deril ) e YL , Pawson T , Dikic 1 ( 2010 ) Post ~ translational modiﬁcations in signal integration ."}	0.762	0.51	0.984	{DEP_PATH_POS_[nn-prep_of|NN-dobj|NN@nn-prep_in|NNS],POS_SEQ_[NN_IN],"WORD_SEQ_[expression in]",DEP_PATH_[nn-prep_of|expression-dobj|reduction@nn-prep_in|consequence]}	{1.14987,-0.989443,0.913978,0}
journal.pone.0004637.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0004637.pdf_33_33_4_4_15_16_UNSUP	HD/HP:0004305|Involuntary movements	{4}	{15,16}	{Huntington,’s,disease,(,HD,),is,an,autosomaly,inherited,neurodegenerative,disorder,characterized,by,abnormal,involuntary,movements,(,chorea,),",",cognitive,decline,and,psychiatric,symptoms,associated,with,neurodegeneration,",",which,affects,mainly,the,striatum,[,1,],.}	{"broui | | et@cea.fr",Introduction}	{"HD is caused by an expansion of GAG trinucleotide repeats in the HD gene that codes for huntingtin ( Htt ) [ 2 ] .","When glutamine ( poly @ repeats located in the N-terminal part of Htt are higher than approximately 38 repeats , they cause disease , while unaffected individuals can have repeats lengths of up to 35 repeats ."}	0.722	0.014	1	{DEP_PATH_POS_[nn-nsubj|NN@agent-partmod|VBN-nsubj|NN-ccomp|VBP-amod|JJ],"WORD_SEQ_[) be a autosomaly inherit neurodegenerative disorder characterize by abnormal]",POS_SEQ_[NN_VBZ_DT_JJ_VBN_JJ_NN_VBN_IN_JJ],DEP_PATH_[nn-nsubj|)@agent-partmod|characterize-nsubj|disorder-ccomp|(-amod|autosomaly]}	{0.265061,0.265061,0.265061,0.265061}
journal.pone.0072337.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0072337.pdf_342_342_0_0_4_4_UNSUP	ZNF644/HP:0000545|Myopia	{0}	{4}	{ZNF644,mutations,in,high,myopia,.}	{"29 .","Shi Y , Li Y , Zhang D , Zhang H , Lu F , et al. ( 201 1 ) Exome sequencing identifies"}	{"PLoS Genet 7 : el002084 .","30 ."}	0.896	0.706	0.976	{"WORD_SEQ_[mutation in high]",DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NNS_IN_JJ]}	{1.1227,0.374951,0.356655,-0.169784}
journal.pone.0028895.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0028895.pdf_317_317_9_9_14_14_UNSUP	PAX6/HP:0000526|Aniridia	{9}	{14}	{If,the,corneal,endothelium,and,/,or,stroma,of,PAX6,+,/,_,human,aniridia,patients,are,affected,like,the,Pax6,+,/,_,mice,described,here,",",this,might,have,important,clinical,implications,and,could,underlie,some,of,the,abnormal,phenotypes,associated,with,aniridia-related,keratopathy,.}	{"Excessive hydration may cause corneal stromal haze or corneal oedema , as in some human corneal stromal dystrophies .","Similar corneal endothelial and stromal keratocyte vacuolation also occurs in human macular corneal dystrophy [ 58,59 ] ."}	{"Effects of Pax6 on corneal epithelial cell movement and maintenance The normal radial striped corneal epithelial pattern of \\\\ / V T Xinactivation mosaics was disrupted in Pax6 + / _ mosaics , implying that corneal epithelial cell movement is abnormal [ 51 ] but it is unclear whether this is caused by some intrinsic abnormality or a response to chronic wounding of a thin and fragile cornea .","Although maintenance of the PAX 7 7 7 ; ’ / _ corneal epithelium is not entirely normal ( Table 2 ) , PAX777 ; ' / _ mosaics had completely normal radial striped patterns , implying that centripetal cell movement is unaffected by the higher Pax6 dose ."}	0.848	0.266	1	{DEP_PATH_POS_[prep_of-dep|NN-prep_if|NN-ccomp|VBN@nn-nsubjpass|NNS-ccomp|VBN],VERB_DEP_PATH_[have]_[prep_of-dep|stroma-prep_if|endothelium-ccomp|affect@]_[nn-nsubjpass|patient-ccomp|describe@],DEP_PATH_[prep_of-dep|stroma-prep_if|endothelium-ccomp|affect@nn-nsubjpass|patient-ccomp|describe],VERB_DEP_PATH_POS_[have]_[prep_of-dep|NN-prep_if|NN-ccomp|VBN@]_[nn-nsubjpass|NNS-ccomp|VBN@],VERB_DEP_PATH_POS_[affect]_[prep_of-dep|NN-prep_if|NN@]_[nn-nsubjpass|NNS-ccomp|VBN@ccomp],"WORD_SEQ_NER_[+ / NUMBER human]",VERB_DEP_PATH_[affect]_[prep_of-dep|stroma-prep_if|endothelium@]_[nn-nsubjpass|patient-ccomp|describe@ccomp],POS_SEQ_[CC_:_CD_JJ],"WORD_SEQ_[+ / _ human]"}	{0.178835,0.178835,0.178835,0.178835,0.178835,0.178835,0.178835,0.178835,0.178835}
journal.pone.0055180.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0055180.pdf_400_400_14_14_29_30_UNSUP	BMPR2/HP:0002092|Pulmonary hypertension	{14}	{29,30}	{Our,ﬁndings,support,the,idea,that,there,is,a,molecular,connection,between,a,hypomorphic,BMPR2,",",asthma-like,responses,and,pulmonary,hypertension,as,previously,suggested,by,studies,performed,in,pediatric,pulmonary,hypertension,patients,[,61,],.}	{"In addition , signals through BMPR2 have been reported to be important for the development of T cells from thymocytes [ 60 ] .","In conclusion , our study suggests the possibility that exposure via the airways with mild antigens could exacerbate or trigger the pulmonary hypertension phenotype in patients carrying a BMPR2 mutation , causing an unusual immune response phenotype , and potentially mal-adaptive responses in the right ventricle ."}	{"These intriguing ﬁndings require further in-depth mechanistic analysis .","Materials and Methods"}	0.864	0.236	1	{VERB_DEP_PATH_[suggest]_[prep_between@dep]_[amod-prep_in|patient-partmod|perform-prep_by|study@],"WORD_SEQ_[, asthma-like response and pulmonary hypertension as previously suggest by study perform in pediatric]",DEP_PATH_[prep_between@amod-prep_in|patient-partmod|perform-prep_by|study-dep|suggest],VERB_DEP_PATH_POS_[suggest]_[prep_between@dep]_[amod-prep_in|NNS-partmod|VBN-prep_by|NNS@],"POS_SEQ_[,_JJ_NNS_CC_JJ_NN_IN_RB_VBN_IN_NNS_VBN_IN_JJ]",VERB_DEP_PATH_POS_[perform]_[prep_between@partmod-prep_by|NNS-dep|VBN]_[amod-prep_in|NNS@],DEP_PATH_POS_[prep_between@amod-prep_in|NNS-partmod|VBN-prep_by|NNS-dep|VBN],"WORD_SEQ_NER_[, asthma-like response and pulmonary hypertension as DATE suggest by study perform in pediatric]",VERB_DEP_PATH_[perform]_[prep_between@partmod-prep_by|study-dep|suggest]_[amod-prep_in|patient@]}	{0.221543,0.221543,0.221543,0.221543,0.221543,0.221543,0.221543,0.221543,0.221543}
journal.pone.0085591.pdf	RELATION_GENEHPOTERM_journal.pone.0085591.pdf_446_446_16_16_18_18	miR-137/HP:0100843|Glioblastoma	{16}	{18}	{In,the,current,study,",",we,also,used,a,dual,strategy,to,evaluate,the,impact,of,miR-137,in,glioblastoma,cells,.}	{"Although in silica predictions are becoming more accurate , they will never substitute biological methods .","No single approach is comprehensive enough ; the advantages of employing dual approaches can be illustrated by the miR-122 target analysis that we conducted using luciferasebased screening in combination with APEX shotgun proteomics [ 44 ] ."}	{"The novelty was the usage of PABP as a reporter of miRNA activity .","This concept is in line with recent results from Mathias Hentze ’s group that show PABP as a central player in miRNA function ."}	0.706	0.056	0.996	{POS_SEQ_[IN],WORD_SEQ_[in],DEP_PATH_POS_[prep_of-dobj|NN@nn-prep_in|NNS],VERB_DEP_PATH_POS_[use]_[prep_of-dobj|NN-xcomp|VB@]_[nn-prep_in|NNS-xcomp|VB@],VERB_DEP_PATH_POS_[evaluate]_[prep_of-dobj|NN@]_[nn-prep_in|NNS@],VERB_DEP_PATH_[evaluate]_[prep_of-dobj|impact@]_[nn-prep_in|cell@],DEP_PATH_[prep_of-dobj|impact@nn-prep_in|cell],VERB_DEP_PATH_[use]_[prep_of-dobj|impact-xcomp|evaluate@]_[nn-prep_in|cell-xcomp|evaluate@]}	{-1.75808,1.42594,0.920263,0.326857,0,0,0,0}
gb-2012-13-3-r24.pdf	RELATION_GENEHPOTERM_gb-2012-13-3-r24.pdf_903_903_6_6_14_14	TF/HP:0000526|Aniridia	{6}	{14}	{For,instance,",",mutations,in,the,TF,PAX6,are,causal,for,the,genetic,disorder,aniridia,[,42,],.}	{"Ultimately , an article is tagged with a list of MeSH terms , and also a list of genes .","In TFe , we have leveraged these annotations to infer associations between TFs and certain diseases ."}	{"An automated analysis of all PAX6referring articles identifies the term ‘ Aniridia ’ as appearing far more often than expected by chance ( Fisher ’s exact P-value 3.2 x 1048 “ ) .","In the end , we generated 58,807 predicted TFtodisease associations for the TFs in TFe ( mean of 74.2 associations per TF ) with a scoring threshold of 0.05 ."}	0.794	0.724	0.998	{DEP_PATH_POS_[nn-prep_in|NN-nsubj|NNS@prep_for],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NN-nsubj|NNS@cop]_[prep_for@cop],DEP_PATH_[nn-prep_in|pax6-nsubj|mutation@prep_for],POS_SEQ_[NN_VBP_JJ_IN_DT_JJ_NN],"WORD_SEQ_[pax6 be causal for the genetic disorder]",VERB_DEP_PATH_[be]_[nn-prep_in|pax6-nsubj|mutation@cop]_[prep_for@cop]}	{0.978555,0.475738,0,0,0,0}
journal.ppat.1002972.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.ppat.1002972.pdf_703_703_24_24_36_36_UNSUP	p53/HP:0002665|Lymphoma	{24}	{36}	{Chen,VV,",",Hilton,IB,",",Staudt,1,"\\\\",’,IR,",",Burd,CE,",",Dittmer,DP,(,2010,),Distinct,p.,53,",",p53,:,LANA,",",and,LANA,complexes,in,Kaposi,’s,sarcoma-associated,herpesvirus,lymphomas,.}	{"Ye F , Lattif AA , Xie J , VVeinberg A , Gao S ( 2012 ) Nutlin-3 induces apoptosis , disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells .","Cell Cycle 11 : 1393 — 9 ."}	{"J Virol 84 : 3898 — 3908 .","Charvet C , VViss1er 1\\\\/I , Brauns-Schubert P , \\\\ / Vang SJ , Tang Y , et al. ( 2011 ) Phosphorylation of Tip60 by GSK ~ 3 determines the induction of PU1 \\\\ ’ IA and apoptosis by p53 ."}	0.736	0.082	0.808	{DEP_PATH_[appos@prep_in-conj_and|complex-dep|PERSON],DEP_PATH_POS_[appos@prep_in-conj_and|NNS-dep|NNP],"WORD_SEQ_NER_[: PERSON , and ORGANIZATION complex in PERSON ’s sarcoma-associated herpesvirus]","POS_SEQ_[:_NNP_,_CC_NNP_NNS_IN_NN_POS_JJ_NN]","WORD_SEQ_[: LANA , and LANA complex in kaposus ’s sarcoma-associated herpesvirus]"}	{0.208185,0.208185,0.208185,0.208185,0.208185}
journal.pone.0081624.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0081624.pdf_249_249_3_3_6_6	BRAF/HP:0002861|Melanoma	{3}	{6}	{But,also,in,BRAF,V600,wild-type,melanoma,immunotherapy,might,be,preferred,compared,to,(,poly,),chemotherapy,as,a,ﬁrst,line,treatment,in,patients,with,both,markers,within,the,normal,range,.}	{"In these patients , it might be beneﬁcial to postpone treatment with vemurafenib or MEK-inhibitors and initially start with immunotherapy .","Immunotherapy is characterized by longer treatment durations to achieve clinical responses as compared to inhibitor treatments ."}	{"In conclusion , the SIOOB serum level predicts overall survival in unresectable melanoma patients receiving systemic treatment .","Its relative impact is similar to LDH serum levels and the presence of brain metastases , both of which represented additional independent prognostic factors ."}	0.762	0.444	1	{POS_SEQ_[NN_JJ],DEP_PATH_POS_[nn-prep_in|NN@nn-nsubjpass|NN],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NN@auxpass]_[nn-nsubjpass|NN@auxpass],DEP_PATH_[nn-prep_in|v600@nn-nsubjpass|immunotherapy],VERB_DEP_PATH_POS_[compare]_[nn-prep_in|NN@prep]_[nn-nsubjpass|NN@prep],VERB_DEP_PATH_[prefer]_[nn-prep_in|v600@]_[nn-nsubjpass|immunotherapy@],"WORD_SEQ_[v600 wild-type]",VERB_DEP_PATH_POS_[prefer]_[nn-prep_in|NN@]_[nn-nsubjpass|NN@],VERB_DEP_PATH_[be]_[nn-prep_in|v600@auxpass]_[nn-nsubjpass|immunotherapy@auxpass],VERB_DEP_PATH_[compare]_[nn-prep_in|v600@prep]_[nn-nsubjpass|immunotherapy@prep]}	{1.2672,-0.143773,-0.143773,0,0,0,0,0,0,0}
journal.pone.0080393.pdf	RELATION_GENEHPOTERM_journal.pone.0080393.pdf_405_405_26_26_30_32	ED1/HP:0007607|Hypohidrotic ectodermal dysplasia	{26}	{30,31,32}	{Vincent,l,"\\\\",’,1C,",",Biancalana,V,",",Ginisty,D,",","l\\\\/Iandel",",",],L,",",Calvas,P,(,2001,),lV1utational,spectrum,of,the,ED1,gene,in,X-linked,hypohidrotic,ectodermal,dysplasia,.}	{"Functional Domains in the Tumor Necrosis Factor Family l \\\\ ’ 1ember Ectodysplasin-A. , ] ournal of Biological Chemistry 276 : 18819418827 .",.}	{"Eur ] Hum Genet 9 : 3554363 .",.}	0.706	0.244	0.982	{DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NN_IN_JJ],"WORD_SEQ_[gene in x-linked]"}	{0.374951,0.356655,0.199886,0}
SCPDFS_24765.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_24765.pdf_23_23_5_5_14_14_UNSUP	RB/HP:0009919|Retinoblastoma	{5}	{14}	{Keywords,:,RBI,CC,;,RB,],-,inducible,coiled-coil,1,;,RB,;,Retinoblastoma,1,;,Cloning,;,Mapping}	{"Conserved sequence motifs and nuclear localization suggest that the RBICCI proteins function as transcription factors .","© 2002 Elsevier Science B.V. All rights reserved ."}	{"1 .",Introduction}	0.716	0.016	0.718	{"WORD_SEQ_NER_[] - inducible coiled-coil NUMBER ; rb ;]",POS_SEQ_[SYM_:_JJ_JJ_CD_:_NN_:],DEP_PATH_[dep-rcmod|cc@dep-dep|rb],"WORD_SEQ_[] - inducible coiled-coil 1 ; rb ;]",DEP_PATH_POS_[dep-rcmod|NN@dep-dep|NN]}	{0.214633,0.214633,0.214633,0.214633,0.214633}
journal.pone.0089541.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0089541.pdf_65_65_26_26_14_14_UNSUP	CF/HP:0002090|Pneumonia	{26}	{14}	{Saliva,concentration,influences,S.,pneumoniae,growth,and,survival,In,order,to,test,if,S.,pneumoniae,can,survive,in,human,saliva,",",104,colony,forming,units,(,CF,U,),ml_1,of,strain,Spainw-3,(,SP195,),were,incubated,with,100,%,",",50,%,",",25,%,",",12.5,%,",",6.25,%,and,o,%,saliva,in,phosphate-buffered,saline,(,PBS,),.}	{"Finally , the roles of individual genes identiﬁed by Tn-seq were validated in single and competitive in zxitra growth in human saliva .","Results and Discussion"}	{"Viable bacterial counts at t = o , t = 4 and t = 24 h post-inoculation were determined for two testing conditions : RT without CO2 and 37 ° C with 5 % CO2 .","At RT without CO2 , S. pneumoniae survived in 100 % saliva and no signiﬁcant differences in viable bacterial counts between different saliva concentrations were observed at t = 4 h ( not shown ) ."}	0.77	0.016	0.68	{"INV_POS_SEQ_[MD_VB_IN_JJ_NN_,_CD_NN_VBG_NNS_CD]",INV_DEP_PATH_[prep-dobj|unit-partmod|form-appos|colony-prep_in|saliva@dep-nsubj|S.],"INV_WORD_SEQ_NER_[can survive in human saliva , NUMBER colony form unit NUMBER]","INV_WORD_SEQ_[can survive in human saliva , 104 colony form unit (]",INV_DEP_PATH_POS_[prep-dobj|NNS-partmod|VBG-appos|NN-prep_in|NN@dep-nsubj|NNP]}	{0.221178,0.221178,0.221178,0.221178,0.221178}
journal.pone.0064420.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0064420.pdf_30_30_0_0_9_9_UNSUP	MYC/HP:0002664|Neoplasm	{0}	{9}	{MYC,expression,is,often,elevated,or,deregulated,in,human,neoplasms,[,4,],",",and,seems}	{com,"| nt | - oduction MYC deregulation due to gene ampliﬁcation [ 8,9 ] , chromosomal translocation or insertion [ lo , ll ] , mutations [ 12 ] , and epigenetic modiﬁcations [ l3 , l4 ] , has been reported in different types of cancers , especially in gastric cancer ."}	{"Gastric cancer is the fourth most frequent type of cancer and remains the second leading cause of cancer-related death worldwide [ 1 ] .","This cancer is usually diagnosed at advanced Stages and the Single enranVe tner 3133 ’ amllable requires Snrgleal to be at the crossroad of several important pathways and processes resection [ 2 ] ."}	0.836	0.694	1	{DEP_PATH_POS_[nn-nsubjpass|NN@prep_in-conj_or|VBN],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_in-conj_or|VBN@auxpass],DEP_PATH_[nn-nsubjpass|expression@prep_in-conj_or|deregulate],VERB_DEP_PATH_[deregulate]_[nn-nsubjpass|expression@conj_or]_[prep_in@],VERB_DEP_PATH_[be]_[nn-nsubjpass|expression@auxpass]_[prep_in-conj_or|deregulate@auxpass],POS_SEQ_[NN_VBZ_RB_JJ_CC_VBN_IN_JJ],VERB_DEP_PATH_POS_[deregulate]_[nn-nsubjpass|NN@conj_or]_[prep_in@],"WORD_SEQ_[expression be often elevated or deregulate in human]"}	{0.215109,0.215109,0.215109,0.215109,0.215109,0.215109,0.215109,0.215109}
SCPDFS_44075.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_44075.pdf_162_162_10_10_13_14_UNSUP	APC/HP:0003003|Colon cancer	{10}	{13,14}	{It,is,not,known,if,mutant,alleles,of,MCC,and,APC,contribute,to,colon,cancer,by,a,dominant,—,negative,mechanism,(,Herskowitz,",",1987,),or,by,gene,dosage,",",or,if,unidentiﬁed,mutations,inactivate,the,normal,allele,(,Bourne,",",1991,),.}	{"This possibility is consistent with data derived from studies of the mutations in colon cancer ( MCC ) and adenomatous polyposis coli ( APC ) genes on chromosome band 5q21 ( Bourne , 1991 ; N ishi — sho et al. , 1991 ) .","DNA sequence analysis demonstrated retention of one wild-type allele in 8 of 10 tumors with mutations of MCC or APC ( Nishisho et al. , 1991 ) ."}	{"Recent evidence also implicates gene dosage in some cases of familial retinoblastoma ( RB ) ( Sakai et al. , 1991 ) .","Two different mutations in the 5 ’ untranslated region of the RBI gene have been identiﬁed in families who showed both frequent asymptomatic carriers of the mutation and affected individuals with unilateral disease ."}	0.814	0.968	1	{DEP_PATH_POS_[prep_of-nsubj|NNS@prep_to],POS_SEQ_[VBP_TO],VERB_DEP_PATH_[know]_[prep_of-nsubj|allele-dep|contribute@]_[prep_to-dep|contribute@],VERB_DEP_PATH_POS_[know]_[prep_of-nsubj|NNS-dep|VBP@]_[prep_to-dep|VBP@],VERB_DEP_PATH_[be]_[prep_of-nsubj|allele-dep|contribute@auxpass]_[prep_to-dep|contribute@auxpass],VERB_DEP_PATH_POS_[be]_[prep_of-nsubj|NNS-dep|VBP@auxpass]_[prep_to-dep|VBP@auxpass],VERB_DEP_PATH_POS_[inactivate]_[prep_of-nsubj|NNS@conj_or]_[prep_to@conj_or],VERB_DEP_PATH_[inactivate]_[prep_of-nsubj|allele@conj_or]_[prep_to@conj_or],DEP_PATH_[prep_of-nsubj|allele@prep_to],VERB_DEP_PATH_[contribute]_[prep_of-nsubj|allele@]_[prep_to@],"WORD_SEQ_[contribute to]",VERB_DEP_PATH_POS_[contribute]_[prep_of-nsubj|NNS@]_[prep_to@]}	{-0.267161,-0.252476,0.224596,0.224596,0.224596,0.224596,0.224596,0.224596,0.224596,0.224596,0.223545,0.0545673}
journal.pone.0012262.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0012262.pdf_318_318_0_0_13_14_UNSUP	BRCA2/HP:0012125|Prostate cancer	{0}	{13,14}	{BRCA2,loss,of,function,due,to,mutations,is,linked,to,poor,survival,in,prostate,cancer,[,55,],and,rare,germline,mutations,have,been,associated,with,early-onset,of,prostate,cancer,[,56,],.}	{"+ + PLoS ONE | www .","p | osone.org cancer BRCA2 has been associated to promotion of invasion through upregulation of MMP9 [ 54 ] ."}	{"CCL2/MCP -1 ( chemokine ( C-C motif ) ligand 2 ) .","Bone is one of the most common sites of prostate cancer metastasis ; close to 85 % of men who die of prostate cancer have bone metastasis [ 57 ] ."}	0.79	0.236	1	{DEP_PATH_[nn-nsubjpass|loss@prep_in],VERB_DEP_PATH_[associate]_[nn-nsubjpass|loss-dep|link@]_[prep_in-dep|link@],VERB_DEP_PATH_POS_[have]_[nn-nsubjpass|NN-dep|VBN@aux]_[prep_in-dep|VBN@aux],VERB_DEP_PATH_[have]_[nn-nsubjpass|loss-dep|link@aux]_[prep_in-dep|link@aux],"WORD_SEQ_[loss of function due to mutation be link to poor survival in]",POS_SEQ_[NN_IN_NN_JJ_TO_NNS_VBZ_VBN_TO_JJ_NN_IN],VERB_DEP_PATH_[be]_[nn-nsubjpass|loss-dep|link@auxpass]_[prep_in-dep|link@auxpass],VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NN-dep|VBN@]_[prep_in-dep|VBN@],VERB_DEP_PATH_POS_[link]_[nn-nsubjpass|NN@]_[prep_in@],VERB_DEP_PATH_[be]_[nn-nsubjpass|loss@auxpass]_[prep_in@auxpass],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN-dep|VBN@auxpass]_[prep_in-dep|VBN@auxpass],VERB_DEP_PATH_[link]_[nn-nsubjpass|loss@]_[prep_in@],DEP_PATH_POS_[nn-nsubjpass|NN@prep_in],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_in@auxpass]}	{0.118347,0.118347,0.118347,0.118347,0.118347,0.118347,0.118347,0.118347,0.118347,0.118347,0.118347,0.118347,-0.082323,0.0439902}
journal.pone.0095993.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0095993.pdf_42_42_29_29_16_16_UNSUP	JAK2/HP:0001909|Leukemia	{29}	{16}	{In,addition,",","\\\\",/,V,P1066,is,effective,in,viva,against,highly,malignant,melanomas,and,leukemias,that,are,positive,for,the,JAK2-V617F,+,mutation,",",which,promotes,constitutive,JAK2,kinase,activation,[,"19,20,21,22",],.}	{"These observations suggest that JAK2 and STAT3 present promising targets for designing therapeutic antagonists to suppress IL-ll/STAT3 signalling in human gastric cancer .","Recently the caffeic acid derivative WP1066 , structurally related to the low potency tyrosine kinase inhibitor AG490 , has been shown to be a highly potent inhibitor of the JAK2/STAT3 pathway in transformed brain glioma [ 17 ] and renal carcinoma [ 18 ] cell lines , leading to growth inhibition and induction of classical pro-apoptotic pathways ."}	{"Unpublished studies indicate that WP1066 is not an ATP-competitive inhibitor , and can block expression of phosphorylated JAK2 and STAT3 ; in addition , p-STAT3-Y705 can be inhibited independently of the JAK2 status .","Thus , WP1066 presents a unique opportunity to inhibit both p - ] AK and p-STAT3 , and subsequently potently block JAK2/STAT3 signalling pathway and STAT3 transcriptional activity ."}	0.722	0.782	1	{INV_DEP_PATH_POS_[nn-nsubj|NN-xcomp|NN-rcmod|VBZ-conj_+|NN-prep_for|NN-rcmod|JJ-prep_against|NNS@prep_against],"INV_WORD_SEQ_[that be positive for the jak2-v617f + mutation , which promote constitutive]",INV_DEP_PATH_[nn-nsubj|activation-xcomp|]-rcmod|promote-conj_+|mutation-prep_for|jak2-v617f-rcmod|positive-prep_against|melanoma@prep_against],"INV_POS_SEQ_[WDT_VBP_JJ_IN_DT_NN_CC_NN_,_WDT_VBZ_JJ]"}	{0.246356,0.246356,0.246356,0.246356}
journal.pone.0021529.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0021529.pdf_45_45_19_19_4_5_UNSUP	PAX2/HP:0000089|Renal hypoplasia	{19}	{4,5}	{These,defects,mirror,the,renal,hypoplasia,and,VUR,phenotypes,of,Renal-Coloboma,syndrome,patients,",",resulting,from,mutations,in,the,PAX2,gene,[,6,],.}	{"In the mouse , homozygous gene inactivation of Pane ?","leads to renal agenesis and other developmental anomalies , while heterozygous mice show kidney hypoplasia and VUR on an outbred genetic background [ 4,5 ] ."}	{"Inactivation of Emx2 in the mouse arrests kidney development following ureter budding and invasion of the metanephric mesenchyme [ 7 ] .","Other gene mutations result in CAKUT phenotypes in human and mouse [ 3,8,9 ] ."}	0.786	0.582	0.994	{INV_DEP_PATH_POS_[nn-prep_in|NN-prep_from|NNS-partmod|VBG@dobj],INV_DEP_PATH_[nn-prep_in|]-prep_from|mutation-partmod|result@dobj],INV_VERB_DEP_PATH_POS_[mirror]_[nn-prep_in|NN-prep_from|NNS-partmod|VBG@]_[dobj@],"INV_POS_SEQ_[CC_NN_NNS_IN_NN_NN_NNS_,_VBG_IN_NNS_IN_DT]",INV_VERB_DEP_PATH_[mirror]_[nn-prep_in|]-prep_from|mutation-partmod|result@]_[dobj@],INV_VERB_DEP_PATH_POS_[result]_[nn-prep_in|NN-prep_from|NNS@]_[dobj@partmod],"INV_WORD_SEQ_[and vur phenotype of renal-coloboma syndrome patient , result from mutation in the]",INV_VERB_DEP_PATH_[result]_[nn-prep_in|]-prep_from|mutation@]_[dobj@partmod]}	{0.181495,0.181495,0.181495,0.181495,0.181495,0.181495,0.181495,0.181495}
journal.pone.0012897.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0012897.pdf_18_18_25_25_3_3_UNSUP	PLA2G6/HP:0001332|Dystonia	{25}	{3}	{In,contrast,",",dystonia,—,parkinsonism,mutations,do,not,appear,to,directly,impair,catalytic,function,",",but,may,modify,substrate,preferences,or,regulatory,mechanisms,for,PLA2G6,.}	{"Conclusions/Signi ﬁcance : These results indicate that different alterations in PLA2G6 function produce the different disease phenotypes of NBIA/INAD and dystonia — parkinsonism .","INAD/NBIA is caused by loss of the ability of PLA2G6 to catalyze fatty acid release from phospholipids , which predicts accumulation of PLA2G6 phospholipid substrates and provides a mechanistic explanation for the accumulation of membranes in neuroaxonal spheroids previously observed in histopathological studies of INAD/NBIA ."}	{"Citation : Engel LA , Jing Z , O'Brien DE , Sun M , Kotzbauer PT ( 2010 ) Catalytic Function of PLAZG6 Is Impaired by Mutations Associated with Infantile Neuroaxonal Dystrophy but Not Dystonia » Parkinsonism .","PLoS ONE 5 ( 9 ) : e12897 ."}	0.708	0.048	0.97	{INV_WORD_SEQ_[TOO_FAR_AWAY],INV_VERB_DEP_PATH_[impair]_[prep_for-conj_but|modify@xcomp]_[nsubj@xcomp],INV_VERB_DEP_PATH_POS_[appear]_[prep_for-conj_but|VB@]_[nsubj@],INV_VERB_DEP_PATH_[appear]_[prep_for-conj_but|modify@]_[nsubj@],INV_VERB_DEP_PATH_POS_[impair]_[prep_for-conj_but|VB@xcomp]_[nsubj@xcomp],INV_VERB_DEP_PATH_[do]_[prep_for-conj_but|modify@aux]_[nsubj@aux],INV_VERB_DEP_PATH_[modify]_[prep_for@]_[nsubj@conj_but],INV_VERB_DEP_PATH_POS_[do]_[prep_for-conj_but|VB@aux]_[nsubj@aux],INV_VERB_DEP_PATH_POS_[modify]_[prep_for@]_[nsubj@conj_but],INV_DEP_PATH_POS_[prep_for-conj_but|VB@nsubj],INV_DEP_PATH_[prep_for-conj_but|modify@nsubj]}	{-2.15153,0.314364,0.314364,0.314364,0.314364,0.314364,0.314364,0.314364,0.314364,0.314364,0.314364}
journal.pone.0013943.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0013943.pdf_3_3_14_14_7_7_UNSUP	EWS/HP:0100242|Sarcoma	{14}	{7}	{High,ALDH,Activity,Identifies,Chemotherapy-Resistant,Ewing,'s,Sarcoma,Stem,Cells,That,Retain,Sensitivity,to,EWS,.}	{"\\" @ ‘ PLOS one","OPEN 8 ACCESS Freely available online"}	{"— .","FL | 1 Inhibition"}	0.874	0.214	1	{INV_DEP_PATH_POS_[prep_to-rcmod|VB@nn],INV_DEP_PATH_[prep_to-rcmod|retain@nn],INV_VERB_DEP_PATH_[retain]_[prep_to@]_[nn@rcmod],INV_VERB_DEP_PATH_POS_[identify]_[prep_to-rcmod|VB-dobj|NNS@]_[nn-dobj|NNS@],INV_POS_SEQ_[NN_NNS_WDT_VB_NN_TO],INV_VERB_DEP_PATH_[identify]_[prep_to-rcmod|retain-dobj|cell@]_[nn-dobj|cell@],"INV_WORD_SEQ_[stem cell that retain sensitivity to]",INV_VERB_DEP_PATH_POS_[retain]_[prep_to@]_[nn@rcmod]}	{0.228554,0.228554,0.228554,0.228554,0.228554,0.228554,0.228554,0.228554}
SCPDFS_41946.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41946.pdf_52_52_26_26_9_9_UNSUP	CPX/HP:0010296|Ankyloglossia	{26}	{9}	{The,ﬁrst,positional,data,for,X-linked,cleft,palate,and,ankyloglossia,(,CPX,),were,obtained,in,a,genetic,linkage,study,on,the,Icelandic,family,in,which,CPX,was,linked,to,DXYS1X,on,the,proximal,part,of,Xq,(,Moore,et,al.,",",1987,),.}	{"Ankyloglossia ( tongue tied ) is associated with X-linked CP in both affected males and carrier females in the Icelandic family ( Bjornsson et al. , 1989 ) and has also been observed in four other X-linked CP families described by Rollnick and Kaye ( 1986 ) , Hall ( 1987 ) , Gorski et al. ( 1992 ) , and Gorski et al. ( 1994 ) .","The semidominant mode of inheritance of X-linked CP suggests the involvement of a major gene determinant ."}	{"More detailed location data were obtained as more polymorphic markers became available , with the most likely position for CPX between DXS326 and DXYSIX ( Stanier et al. , 1993 ) and , later , DXS1002 / DXS349/DXS95 and DXYSIX ( Forbes et al. , 1995 ) .","Linkage studies on the British Columbian family ( Gorski et al. , 1992 ) and the Manitoba family ( Gorski et al. , 1994 ) coincided with this interval , indicating a localization between PGK1 and DXYS 1X and between DXS159 and DXS3 , respectively ."}	0.83	0.208	0.988	{INV_WORD_SEQ_[TOO_FAR_AWAY],INV_VERB_DEP_PATH_[be]_[nsubjpass-rcmod|link-prep_on|family@auxpass]_[prep_for-nsubjpass|datum@auxpass],INV_DEP_PATH_[nsubjpass-rcmod|link-prep_on|family@prep_for-nsubjpass|datum],INV_VERB_DEP_PATH_POS_[link]_[nsubjpass@]_[prep_for-nsubjpass|NNS@rcmod-prep_on|NN],INV_VERB_DEP_PATH_[link]_[nsubjpass@]_[prep_for-nsubjpass|datum@rcmod-prep_on|family],INV_VERB_DEP_PATH_POS_[be]_[nsubjpass-rcmod|VBN-prep_on|NN@auxpass]_[prep_for-nsubjpass|NNS@auxpass],INV_VERB_DEP_PATH_[obtain]_[nsubjpass-rcmod|link-prep_on|family@]_[prep_for-nsubjpass|datum@],INV_DEP_PATH_POS_[nsubjpass-rcmod|VBN-prep_on|NN@prep_for-nsubjpass|NNS],INV_VERB_DEP_PATH_POS_[obtain]_[nsubjpass-rcmod|VBN-prep_on|NN@]_[prep_for-nsubjpass|NNS@]}	{-2.15153,0.454128,0.454128,0.454128,0.454128,0.454128,0.454128,0.454128,0.454128}
journal.pone.0035153.pdf	RELATION_GENEHPOTERM_journal.pone.0035153.pdf_686_686_25_25_31_32	PTEN/HP:0012125|Prostate cancer	{25}	{31,32}	{In,prostate,cancer,",",the,loss,of,the,PTEN,protein,is,correlated,with,tumors,of,high,grade,and,stage,",",suggesting,that,alterations,in,the,PTEN,gene,may,be,associated,with,prostate,cancer,progression,[,"21,39",],.}	{"The difference clearly indicated the powerful role of PTEN .","In addition , PTEN has been identiﬁed as the inactivating alteration in multiple human cancer types , such as glioma , breast , lung , prostate , bladder , melanoma and kidney tumors , astrocytoma , and leukemia [ 38 ] ."}	{"Wu et al. established a mouse model with prostate-speciﬁc deletion of PTEN [ 40 ] .","This mouse model recapitulates prostate cancer progression in humans : initiation of prostate cancer with prostatic intraepithelial neoplasia , followed by progression to invasive adenocarcinoma and subsequent metastasis ."}	0.812	0.582	1	{VERB_DEP_PATH_POS_[associate]_[nn-prep_in|NN-nsubjpass|NNS@]_[nn-prep_with|NN@],VERB_DEP_PATH_POS_[be]_[nn-prep_in|NN-nsubjpass|NNS@auxpass]_[nn-prep_with|NN@auxpass],DEP_PATH_POS_[nn-prep_in|NN-nsubjpass|NNS@nn-prep_with|NN],POS_SEQ_[NN_MD_VB_VBN_IN],"WORD_SEQ_[gene may be associate with]",VERB_DEP_PATH_POS_[suggest]_[nn-prep_in|NN-nsubjpass|NNS-ccomp|VBN@]_[nn-prep_with|NN-ccomp|VBN@],VERB_DEP_PATH_[associate]_[nn-prep_in|gene-nsubjpass|alteration@]_[nn-prep_with|progression@],VERB_DEP_PATH_[be]_[nn-prep_in|gene-nsubjpass|alteration@auxpass]_[nn-prep_with|progression@auxpass],DEP_PATH_[nn-prep_in|gene-nsubjpass|alteration@nn-prep_with|progression],VERB_DEP_PATH_[suggest]_[nn-prep_in|gene-nsubjpass|alteration-ccomp|associate@]_[nn-prep_with|progression-ccomp|associate@]}	{0.560866,0.560866,0.560866,-0.315399,0,0,0,0,0,0}
journal.pone.0103852.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0103852.pdf_458_458_9_9_21_21_UNSUP	NP/HP:0002090|Pneumonia	{9}	{21}	{Stewart,CR,",",i,"\\\\",Iuthye,V,",",Cianciotto,NP,(,2012,),Legionella,pneumophila,persists,within,bioﬁlms,formed,by,Klebsiella,pneumoniae,",",Flavobacterium,sp.,",",and,Pseudomonas,ﬂuorescens,under,dynamic,flow,conditions,.}	{"journal of applied microbiology 107 : 368 — 378 .","9 ."}	{"PloS one 7 : e50560 .","10 ."}	0.71	0.002	0.996	{DEP_PATH_POS_[nsubj-parataxis|VBD@dobj],DEP_PATH_[nsubj-parataxis|(@dobj],VERB_DEP_PATH_[persist]_[nsubj-parataxis|(@]_[dobj@],VERB_DEP_PATH_[form]_[nsubj-parataxis|(@partmod-prep_within|bioﬁlms]_[dobj@partmod-prep_within|bioﬁlms],POS_SEQ_[VBD_CD_CD_NN_NN_VBZ_IN_NNS_VBN_IN_NN],"WORD_SEQ_[( 2012 ) legionellum pneumophilum persist within bioﬁlms form by klebsiellum]",VERB_DEP_PATH_POS_[persist]_[nsubj-parataxis|VBD@]_[dobj@],VERB_DEP_PATH_POS_[form]_[nsubj-parataxis|VBD@partmod-prep_within|NNS]_[dobj@partmod-prep_within|NNS],"WORD_SEQ_NER_[( DATE NUMBER legionellum pneumophilum persist within bioﬁlms form by klebsiellum]"}	{-0.338577,-0.30357,0.234043,0.234043,0.234043,0.234043,0.234043,0.234043,0.234043}
journal.pone.0054173.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0054173.pdf_53_53_11_11_22_22_UNSUP	PAX6/HP:0000526|Aniridia	{11}	{22}	{Functional,deﬁcits,in,PAX6-expressing,tissues,have,been,observed,in,patients,with,PAX6,haploinsufﬁciency,",",most,notably,associated,with,the,developmental,eye,anomaly,aniridia,(,absence,of,the,iris,),",",where,corneal,limbal,stem,cell,defects,[,25,],and,deﬁcits,of,olfactory,function,and,neurological,organisation,[,26,],have,been,reported,[,22,],.}	{"However , there is evidence , for example for Pdxl [ 17 ] and for the non-pancreas-expressed gene Sox2 [ 18 ] , that such genes also function in tissue maintenance .","Pax6 is expressed in a number of adult tissues , including pancreatic islet cells [ 19,20,21 ] , as well as brain [ 22 ] , olfactory [ 23 ] and ocular cells [ 24 ] ."}	{"There have also been reports of glucose intolerance and predisposition to diabetes in some individuals , and in some rodent models , with heterozygous PAX6 mutations [ 19,20,21,27,28 ] .","Because of the multiple essential functions fulﬁlled by Pax6 during development , it is difficult to dissect its role in adult tissues where Pax6 expression is maintained ."}	0.876	0.338	0.998	{VERB_DEP_PATH_POS_[have]_[nn-prep_with|NN-prep_in|NNS@aux]_[prep_with-dep|VBN@aux],VERB_DEP_PATH_[associate]_[nn-prep_with|haploinsufﬁciency-prep_in|patient@dep]_[prep_with@],VERB_DEP_PATH_POS_[be]_[nn-prep_with|NN-prep_in|NNS@auxpass]_[prep_with-dep|VBN@auxpass],VERB_DEP_PATH_[be]_[nn-prep_with|haploinsufﬁciency-prep_in|patient@auxpass]_[prep_with-dep|associate@auxpass],DEP_PATH_POS_[nn-prep_with|NN-prep_in|NNS@prep_with-dep|VBN],VERB_DEP_PATH_POS_[associate]_[nn-prep_with|NN-prep_in|NNS@dep]_[prep_with@],VERB_DEP_PATH_[have]_[nn-prep_with|haploinsufﬁciency-prep_in|patient@aux]_[prep_with-dep|associate@aux],VERB_DEP_PATH_[observe]_[nn-prep_with|haploinsufﬁciency-prep_in|patient@]_[prep_with-dep|associate@],DEP_PATH_[nn-prep_with|haploinsufﬁciency-prep_in|patient@prep_with-dep|associate],VERB_DEP_PATH_POS_[observe]_[nn-prep_with|NN-prep_in|NNS@]_[prep_with-dep|VBN@],"POS_SEQ_[NN_,_RBS_RB_VBN_IN_DT_JJ_NN_NN]","WORD_SEQ_[haploinsufﬁciency , most notably associate with the developmental eye anomaly]"}	{0.137963,0.137963,0.137963,0.137963,0.137963,0.137963,0.137963,0.137963,0.137963,0.137963,0.137963,0.137963}
SCPDFS_19582.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_19582.pdf_45_45_35_35_24_26_UNSUP	C6/HP:0005430|Recurrent Neisserial infections	{35}	{24,25,26}	{A,deﬁciency,of,C6,",",as,well,as,of,the,other,proteins,participating,in,the,formaﬁon,of,the,MAC,",",is,frequently,associated,with,recurrent,neisserial,infections,",",especially,meningitis,caused,by,Neisseria,meningitidis,(,C6,deﬁciency,;,MIM,217050,),(,Lim,et,al.,",",1976,),.}	{"Eberhard , 1986 ; Nauta et al. , 2002 ) .","The membranolytic activity of the MAC is important for host defence against invading microorganisms ."}	{"Complement component C6 deﬁciency has been diagnosed relatively frequently in Western Cape South Africans but is reported relatively rarely in white individuals living in Europe or North America , and so the defects are probably rare in South African Whites ( Orren et al. , 2012 ) .","To date , 9 different molecular defects ( 2 nonsense , 2 splicing and 5 small deletions ) leading to total or subtotal C6 deﬁciency have"}	0.832	0.144	1	{INV_VERB_DEP_PATH_[associate]_[nn-dobj|deﬁciency@dep]_[prep_with@],INV_VERB_DEP_PATH_[be]_[nn-dobj|deﬁciency@auxpass-dep|associate]_[prep_with@auxpass],INV_VERB_DEP_PATH_[meningitidi]_[nn-dobj|deﬁciency@]_[prep_with-dep|associate@],"INV_POS_SEQ_[,_RB_NN_VBN_IN_NNP_VBZ_CD]","INV_WORD_SEQ_[, especially meningitis cause by Neisseria meningitidi (]",INV_VERB_DEP_PATH_POS_[meningitidi]_[nn-dobj|NN@]_[prep_with-dep|VBN@],INV_VERB_DEP_PATH_POS_[be]_[nn-dobj|NN@auxpass-dep|VBN]_[prep_with@auxpass],"INV_WORD_SEQ_NER_[, especially meningitis cause by Neisseria meningitidi NUMBER]",INV_DEP_PATH_[nn-dobj|deﬁciency@prep_with-dep|associate],INV_DEP_PATH_POS_[nn-dobj|NN@prep_with-dep|VBN],INV_VERB_DEP_PATH_POS_[associate]_[nn-dobj|NN@dep]_[prep_with@]}	{0.144361,0.144361,0.144361,0.144361,0.144361,0.144361,0.144361,0.144361,0.144361,0.137261,0.137261}
SCPDFS_26868.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_26868.pdf_383_383_2_2_10_11_UNSUP	CHOP/HP:0012268|Myxoid liposarcoma	{2}	{10,11}	{Fusion,of,CHOP,to,a,novel,RNA-binding,protein,in,human,myxoid,liposarcoma,with,t,(,12,;,16,),(,q13,;,p11,),.}	{"Oncogene 18 , 229 — 235 .","Crozat , A.Y. , Aman , P. , Mandahl , N. , Ron , D. , 1993 ."}	{"Nature 363 , 640 — 644 .","Delattre , o. , Zucman , J. , Plougastel , B. , Desmaze , C. , Melot , T. , Peter , M. , Kovar , H. , Joubert , I. , de Jong , P. , Rouleau , G. , Aurias , A. , Thomas , G. , 1992 ."}	0.846	0.13	1	{POS_SEQ_[TO_DT_JJ_JJ_NN_IN_JJ],"WORD_SEQ_[to a novel rna-binding protein in human]",DEP_PATH_POS_[@prep_in-prep_to|NN],DEP_PATH_[@prep_in-prep_to|protein]}	{0.893949,0.893949,-0.310547,0.0224539}
SCPDFS_19544.pdf	RELATION_GENEHPOTERM_SCPDFS_19544.pdf_379_379_6_6_10_11	AIRE/HP:0002229|Alopecia areata	{6}	{10,11}	{Role,of,the,autoimmune,regulator,(,AIRE,),gene,in,alopecia,areata,:,strong,association,of,a,potentially,functional,AIRE,polymorphism,with,alopecia,universalis,.}	{"— .","Ahnini , R. , et al. , 2002 ."}	{"Tissue Antigens 60 , 489-495 .","Teraki , Y. , Imanishi , I ( ."}	0.756	0.066	0.952	{"WORD_SEQ_[) gene in]",POS_SEQ_[CD_NN_IN],DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],"WORD_SEQ_NER_[NUMBER gene in]"}	{1.2918,-1.0553,0.374951,0.356655,0}
journal.pone.0104568.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0104568.pdf_620_620_20_20_23_23_UNSUP	SOX2/HP:0000528|Anophthalmia	{20}	{23}	{Hagstrom,SA,",",Pauer,GJ,",",Reid,J,",",Simpson,E,",",Crowe,S,",",et,al.,(,2005,),SOX2,mutation,causes,anophthalmia,",",hearing,loss,",",and,brain,anomalies,.}	{"Ragge NK , Lorenz B , Schneider A , Bush1 ) y K , de Sanctis L , et al. ( 2005 ) SOX2 anophthalmia syndrome .","Americanjournal of medical genetics Part A 135 : l * 7 ; discussion 8 ."}	{"American journal of medical genetics Part A 138A : 95 * 98 .",.}	0.828	0.868	1	{"WORD_SEQ_[mutation cause]",POS_SEQ_[NN_VBZ],DEP_PATH_[nn-dep|mutation-dep|(-appos|et-nsubj|ORGANIZATION@dobj],DEP_PATH_POS_[nn-dep|NN-dep|FW-appos|FW-nsubj|NNP@dobj]}	{1.78405,-0.490893,0.368854,-0.183593}
journal.pone.0090833.pdf	RELATION_GENEHPOTERM_journal.pone.0090833.pdf_331_331_23_23_27_29	FUS/HP:0007354|Amyotrophic lateral sclerosis	{23}	{27,28,29}	{Corrado,L,",",Del,Bo,R,",",Castellotti,B,",",Ratti,A,",",Cereda,C,",",et,al.,(,2010,),Nfutations,of,FUS,gene,in,sporadic,amyotrophic,lateral,sclerosis,.}	{"Sproviero VV , La Bella V , Nfazzei R , Valentino P , Rodolico C , et al. ( 2012 ) FUS mutations in sporadic amyotrophic lateral sclerosis : clinical and genetic analysis .","Neurobiol Aging 33 : 837 e8314835 ."}	{"J l \\\\ ’ 1ed Genet 47 : 1904194 .","Vance C , Rogelj B , Hortobagyi T , De Vos KJ , Nishimura AL , et al. ( 2009 ) Nfutations in FUS , an RNA processing protein , cause familial amyotrophic lateral sclerosis type 6 ."}	0.888	0.428	0.998	{"WORD_SEQ_[gene in sporadic]",DEP_PATH_POS_[nn-prep_of|NN-dobj|NNS@prep_in],POS_SEQ_[NN_IN_JJ],DEP_PATH_[nn-prep_of|gene-dobj|nfutation@prep_in]}	{1.3377,0.591312,0.199886,0}
journal.pone.0008689.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0008689.pdf_384_384_27_27_34_34_UNSUP	RAX/HP:0000528|Anophthalmia	{27}	{34}	{Voronina,VA,",",Kozhemyakina,EA,",",O’Kernick,CIVI,",",Kahn,ND,",",VVenger,SL,",",et,al.,(,2004,),l,"\\\\",’,1utations,in,the,human,RAX,homeobox,gene,in,a,patient,with,anophthalmia,and,sclerocornea,.}	{"AmJ Hum Genet 76 : 100841022 .","7 ."}	{"Hum 1VIol Genet 13 : 3154322 .","8 ."}	0.856	0.962	0.988	{"WORD_SEQ_[homeobox gene in a patient with]",DEP_PATH_POS_[nn-prep_in|NN-dobj|NN@prep_with],POS_SEQ_[NN_NN_IN_DT_NN_IN],DEP_PATH_[nn-prep_in|gene-dobj|l@prep_with]}	{1.30564,0.85641,-0.466601,0.154754}
journal.pone.0028078.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0028078.pdf_360_360_23_23_28_30_UNSUP	KIT/HP:0004808|Acute myeloid leukemia	{23}	{28,29,30}	{Fuster,O,",",Barragan,E,",",Bolufer,P,",",Cervera,J,",",Larrayoz,lVlJ,",",et,al.,(,2009,),Rapid,detection,of,KIT,mutations,in,core-binding,factor,acute,myeloid,leukemia,using,high,~,resolution,melting,analysis,.}	{"Clin Cancer Res 14 ( 15 ) : 475144757 .","Franklin VVA , Haney J , Sugita 1V1 , Bemis L , Jimeno A , et al. ( 2010 ) KRAS mutation : comparison of testing methods and tissue sampling techniques in colon cancer \\\\ X \\" l \\\\ ’ Iol Diagn 12 ( 1 ) : 43450 ."}	{"J lVlol Diagn 11 ( 5 ) : 4584463 .","VVillmore-Payne C , Holden JA , Tripp S , Layfield LJ ( 2005 ) Human malignant melanoma : detection of BRAF - and c-kit — activating mutations by high-resolution amplicon melting analysis ."}	0.736	0.916	0.986	{POS_SEQ_[NNS_IN_JJ_NN],DEP_PATH_[nn-prep_of|mutation-nsubj|detection@],VERB_DEP_PATH_POS_[use]_[nn-prep_of|NNS-nsubj|NN@partmod]_[@partmod],"WORD_SEQ_[mutation in core-binding factor]",VERB_DEP_PATH_[use]_[nn-prep_of|mutation-nsubj|detection@partmod]_[@partmod],DEP_PATH_POS_[nn-prep_of|NNS-nsubj|NN@]}	{-0.685022,0.339304,0.339304,0.339304,0.339304,0.189385}
journal.pone.0052167.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0052167.pdf_319_319_22_22_12_12_UNSUP	ATRX/HP:0002863|Myelodysplasia	{22}	{12}	{Somatic,mutations,in,ATRX,were,identiﬁed,in,patients,with,o,(,thalassemia,myelodysplasia,(,ATMDS,),but,recent,work,has,shown,that,ATRX,is,also,mutated,in,pancreatic,neuroendocrine,tumours,and,glioblastomas,[,"28,29,30",],.}	{"However , while cell death and brain size was rescued in the double knock-out animals , the animals still died peri-natally suggesting that Atrx may have other neuronal functions , perhaps in transcriptional regulation of speciﬁc target genes .","Certainly , further work is required to determine the role of Atrx in maintaining genomic integrity and how it intersects with the p53 pathway [ 42,43,44,45 ] ."}	{"The sensitivity of multiple cell types that lack the Atrx protein to 5-FU , cisplatin , and UV light suggests that human cancers containing ATRX mutations may be similarly sensitive to these DNA damaging agents .","Moreover , 5-FU and cisplatin are widely employed in the treatment of many cancers [ 33,52 ] ."}	0.824	0.692	0.888	{"INV_WORD_SEQ_[( atmd ) but recent work have show that]",INV_VERB_DEP_PATH_POS_[identiﬁed]_[nsubjpass-ccomp|VBN-conj_but|VBN@]_[nn-dep|NN-prep_with|NNP-prep_in|NNS@],INV_VERB_DEP_PATH_[identiﬁed]_[nsubjpass-ccomp|mutate-conj_but|show@]_[nn-dep|)-prep_with|thalassemia-prep_in|patient@],INV_DEP_PATH_[nsubjpass-ccomp|mutate-conj_but|show@nn-dep|)-prep_with|thalassemia-prep_in|patient],INV_DEP_PATH_POS_[nsubjpass-ccomp|VBN-conj_but|VBN@nn-dep|NN-prep_with|NNP-prep_in|NNS],INV_POS_SEQ_[CD_NN_NN_CC_JJ_NN_VBZ_VBN_IN],"INV_WORD_SEQ_NER_[NUMBER atmd ) but recent work have show that]"}	{0.212806,0.212806,0.212806,0.212806,0.212806,0.212806,0.212806}
journal.pone.0088276.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0088276.pdf_569_569_23_23_32_33_UNSUP	CASK/HP:0001321|Cerebellar hypoplasia	{23}	{32,33}	{Saitsu,H,",",Kato,l,"\\\\",’,I,",",Osaka,H,",",lVIoriyama,N,",",Horita,H,",",et,al.,(,2012,),CASK,aberrations,in,male,patients,with,Ohtahara,syndrome,and,cerebellar,hypoplasia,.}	{"Proceedings of the National Academy of Sciences of the United States of America 101 : 606243067 .","6 ."}	{"Epilepsia 53 : 1441 — 1449 .","7 ."}	0.728	0.508	1	{DEP_PATH_POS_[nn-dobj|NNS-rcmod|CD-dep|FW@conj_and],POS_SEQ_[NNS_IN_JJ_NNS_IN_NN_NN_CC],"WORD_SEQ_[aberration in male patient with ohtahara syndrome and]",DEP_PATH_[nn-dobj|aberration-rcmod|NUMBER-dep|(@conj_and]}	{0.25615,0.25615,0.25615,0.25615}
journal.pone.0015522.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0015522.pdf_549_549_33_33_39_40_UNSUP	alpha-synuclein/HP:0100315|Lewy bodies	{33}	{39,40}	{Takeda,A,",",Hashimoto,1,"\\\\",’,I,",",1,"\\\\",’,Ial1ory,1,"\\\\",’,I,",",Sundsumo,1,"\\\\",’,I,",",Hansen,L,",",et,al.,(,2000,),Cterminal,alpha-synuclein,immunoreactivity,in,structures,other,than,Lewy,bodies,in,neurodegenerative,disorders,.}	{"VVakabayashi K , Hayashi S , Yoshimoto 1 \\\\ ’ I , Kudo H , Takahashi H ( 2000 ) NACP/alpha » synuc1ein-positive ﬁlamentous inclusions in astrocytes and oligo » dendrocytes of Parkinson ’s disease brains .","Acta Neuropathol 99 : 14 » 20 ."}	{"Acta Neuropathol 99 : 296 — 304 .","Terada S , Ishizu H , Haraguchi T , Takehisa Y , Tanal ) e Y , et al. ( 2000 ) Tau » negative astrocytic star » like inclusions and coiled bodies in dementia with Lewy bodies ."}	0.71	0.952	0.984	{POS_SEQ_[NN_IN_NNS_JJ_IN],"WORD_SEQ_[immunoreactivity in structure other than]",DEP_PATH_POS_[nn@prep_than-prep_in|NNS],DEP_PATH_[nn@prep_than-prep_in|structure]}	{0.248659,0.220064,0.220064,0.220064}
journal.pone.0009220.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0009220.pdf_426_426_18_18_30_30_UNSUP	APOB/HP:0003124|Hypercholesterolemia	{18}	{30}	{Fouchier,SVV,",",Huijgen,R,",",Vis,K,",",Defesche,JC,",",KasteleinJJ,(,2009,),Identification,of,APOB,and,PC,',SI,"{",.9,mutations,causing,a,non-autosomal,dominant,hypercholesterolemia,(,ADH,),phenotype,in,molecular,diagnosed,ADH,patients,.}	{"Hum l \\\\ ’ Iutat 30 : E682 — 69l .",.}	{"Atherosclerosis Supplement 2009 10 : P870 .",.}	0.772	0.05	0.998	{"WORD_SEQ_NER_[and pc ' si { NUMBER mutation cause a non-autosomal dominant]","WORD_SEQ_[and pc ' si { .9 mutation cause a non-autosomal dominant]",DEP_PATH_POS_[prep_of-dep|NN-conj_and|NNP@nn-dobj|NN-partmod|VBG],POS_SEQ_[CC_NN_''_FW_FW_NN_NNS_VBG_DT_JJ_JJ],VERB_DEP_PATH_POS_[cause]_[prep_of-dep|NN-conj_and|NNP@partmod]_[nn-dobj|NN@],DEP_PATH_[prep_of-dep|identification-conj_and|KasteleinJJ@nn-dobj|phenotype-partmod|cause],VERB_DEP_PATH_[cause]_[prep_of-dep|identification-conj_and|KasteleinJJ@partmod]_[nn-dobj|phenotype@]}	{0.190028,0.190028,0.190028,0.190028,0.190028,0.190028,0.190028}
journal.pone.0047663.pdf	RELATION_GENEHPOTERM_journal.pone.0047663.pdf_94_94_43_43_57_57	EZH2/HP:0009592|Astrocytoma	{43}	{57}	{lmmunohistochemistry,Formalin-ﬁxed,parafﬁn-embedded,tissue,of,human,diffuse,astrocytomas,(,WHO,grade,II,",",n,=,4,for,AXL,staining,",",all,Isocitrate,dehydrogenase,1,(,IDH1,),mutated,(,IDHlRl32H,as,evidenced,by,immunohistochemistry,[,26,],),;,n,=,10,for,EZH2,staining,",",7,with,identiﬁed,IDH1,mutation,",",remaining,unknown,),",",anaplastic,astrocytomas,(,WHO,grade,III,",",n,=,5,for,AXL,staining,",",all,IDH1,mutated,;,n,=,15,for,EZH2,staining,",",8,IDH1,mutated,",",remaining,unknown,),and,glioblastoma,(,VV,HO,grade,IV,",",n,=,12,for,AXL,and,EZH2,staining,",",one,IDHl,mutant,and,11,wild,type,),were,provided,by,the,Department,of,Neuropathology,",",Institute,of,Pathology,",",University,Hospital,Heidelberg,",",Germany,.}	{"— .","Aldrich ) overnight at 4 ° C. Staining with secondary horseradish peroxidase conjugated anti-mouse or anti-rabbit antibody at dilutions of 125000 ( both GE Healthcare , Buckinghamshire , UK ) was followed by immunodetection with ECL Plus reagent ( GE Healthcare ) ."}	{"Written informed consent was given by patients and the analyses were approved by the local ethics committee approving the biobanking and tissue analyses .","Sections cut to 3 um were processed using a Ventana BenchMark XT ® immunostainer ( V entana Medical Systems , Tucson , AZ , USA ) ."}	0.86	0.746	1	{VERB_DEP_PATH_[mutate]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[mutate]_[dep@dep]_[dep@dep],DEP_PATH_[dep@dep],DEP_PATH_POS_[dep@dep],VERB_DEP_PATH_[remain]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[remain]_[dep@dep]_[dep@dep],VERB_DEP_PATH_[provide]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[provide]_[dep@dep]_[dep@dep],VERB_DEP_PATH_POS_[be]_[dep@dep]_[dep@dep],VERB_DEP_PATH_[be]_[dep@dep]_[dep@dep],VERB_DEP_PATH_[evidence]_[dep@dep]_[dep@dep],"WORD_SEQ_NER_[staining , NUMBER with identiﬁed idh1 mutation , remain unknown ) , anaplastic]","WORD_SEQ_[staining , 7 with identiﬁed idh1 mutation , remain unknown ) , anaplastic]","POS_SEQ_[NN_,_CD_IN_JJ_NN_NN_,_VBG_JJ_NN_,_JJ]",VERB_DEP_PATH_POS_[evidence]_[dep@dep]_[dep@dep]}	{0.644912,0.644912,-0.565225,-0.558096,0.472396,0.472396,0.236878,0.236878,0.153798,0.143801,0,0,0,0,0}
SCPDFS_1131.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_1131.pdf_60_60_34_34_24_24_UNSUP	PAX6/HP:0000526|Aniridia	{34}	{24}	{The,essential,role,of,long,range,regulatory,elements,in,control,of,PAX6,expression,was,brought,to,light,by,the,discovery,of,a,subset,of,aniridia,patients,carrying,chromosomal,abnormalities,near,",",but,not,in,PAX6,that,remove,a,large,part,of,the,gene,regulatory,domain,(,Fantes,et,al.,",",1995,;,Kleinjan,et,al.,",",2001,;,Lauderdale,et,al.,",",2000,),.}	{"Detailed dissection of the tissue — and stage — speciﬁc roles of Pax6 in development and tissue maintenance therefore remains of great interest , yet is hampered by its pleiotropy and the intricate connectivity of developmental processes and tissues .","The wide functional activity spectrum of PAX6 is achieved through strict control of spatio — temporal expression , requiring the activities of a large number of long — range cis — regulatory elements residing in a large and complex regulatory domain around the gene ."}	{"All aniridia — associated breakpoints identiﬁed to date are located downstream of PAX6 , within the large ﬁnal intron of the adjacent ELP4 gene , indicating the critical role of this region for expression of PAX6 in the eye .","Several studies have investigated the transcriptional control of Pax6 expression ( Grifﬁn et al. , 2002 ; Kammandel et al. , 1999 ; Kim and Lauderdale , 2006 ; Kleinjan et al. , 2004 , 2006 ; McBride et al. , 2011 ; Plaza et al. , 1995 ; Williams et al. , 1998 ; Xu et al. , 1999 ) , resulting in the identiﬁcation of several cis — regulatory elements located immediately upstream of the promoters , within the introns of the gene , and in the extended domain downstream of the gene , within the ELP4 introns ( Grifﬁn et al. , 2002 ; Kleinjan et al. , 2006 , 2001 ; McBride et al. , 2011 ) ."}	0.72	0.002	0.994	{"INV_WORD_SEQ_[patient carry chromosomal abnormality near , but not in]","INV_POS_SEQ_[NNS_VBG_JJ_NNS_IN_,_CC_RB_IN]",INV_DEP_PATH_[prep_in@nn-prep_of|patient-prep_of|subset-nsubj|discovery-agent|carry],INV_DEP_PATH_POS_[prep_in@nn-prep_of|NNS-prep_of|NN-nsubj|NN-agent|VBG]}	{0.219499,0.219499,0.219499,0.219499}
journal.pone.0068041.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0068041.pdf_238_238_12_12_25_25_UNSUP	NHL/HP:0002665|Lymphoma	{12}	{25}	{Amongst,the,recorded,hematologic,malignancies,",",such,as,non-Hodgkin,’s,lymphoma,(,NHL,),",",there,was,a,higher,risk,of,leukemia,",",Hodgkin,’s,lymphoma,",",colorectal,cancer,",",and,lung,cancer,in,patients,<,45,years,of,age,[,35,],.}	{"The higher risk of secondary malignancies in younger cancer patients than other populations has been documented with respect to other cancers , including ovarian borderline tumors , breast cancer , and non-Hodgkin ’s lymphoma [ 32 — 35 ] .","The risk of a second malignancy in patients with MM might result from genetic susceptibility , various medical treatments , or environmental co-risk factors of secondary malignancies ."}	{"The current study showed an age-related risk of secondary hematologic cancer ; the risk decreased with age for patients with MM , which has not been documented in another populationbased study .","The mean survival time of MM patients who died within this study period was 0.33 years ( SD = 0.02 ) , and the mean follow-up ( survival ) time of MM patients was 2.18 years ( SD = 0.04 ) ."}	0.788	0.222	0.954	{DEP_PATH_POS_[nn-prep_such_as|NN-prep_amongst|NNS@nn-conj_and|NN-nsubj|NN],VERB_DEP_PATH_[be]_[nn-prep_such_as|)-prep_amongst|malignancy@]_[nn-conj_and|cancer-nsubj|risk@],"WORD_SEQ_NER_[) , there be a higher risk of leukemia , PERSON ’s]","POS_SEQ_[NN_,_EX_VBD_DT_JJR_NN_IN_NN_,_NN_POS]",VERB_DEP_PATH_POS_[be]_[nn-prep_such_as|NN-prep_amongst|NNS@]_[nn-conj_and|NN-nsubj|NN@],"WORD_SEQ_[) , there be a higher risk of leukemia , hodgkin ’s]",DEP_PATH_[nn-prep_such_as|)-prep_amongst|malignancy@nn-conj_and|cancer-nsubj|risk]}	{0.188203,0.188203,0.188203,0.188203,0.188203,0.188203,0.188203}
journal.pmed.0030156.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pmed.0030156.pdf_290_290_20_20_42_42	SDHB/HP:0002666|Pheochromocytoma	{20}	{42}	{Since,then,",",the,role,of,mitochondria,in,cancer,is,further,highlighted,through,identiﬁcation,of,over,100,mutations,in,the,SDHB,",",SDH,C,",",and,SDHD,subunit,genes,in,hundreds,of,index,cases,and,families,with,hereditary,and,sporadic,paragangliomas,and,pheochromocytomas,[,3,],.}	{"March 2006 | Vo | ume3 | | ssue3 | e167 | e156","The causal link between mitochondrial abnormalities and tumorigenesis was provided by the positional cloning of the hereditary paraganglioma gene at chromosome band llq23 as the SDHD subunit gene of mitochondrial complex II ( succinate dehydrogenase ) in the year 2000 [ 2 ] ."}	{"Furthermore , fumarase gene mutations in a distinct hereditary tumor syndrome characterized by multiple skin and uterine leiomyomatosis and renal cell cancer — hereditary leiomyomatosis renal cancer ( HLRCC ) .","— ."}	0.76	0.228	1	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[highlight]_[prep_in-prep_of|mutation-prep_through|identiﬁcation@]_[prep_with@],VERB_DEP_PATH_POS_[highlight]_[prep_in-prep_of|NNS-prep_through|NN@]_[prep_with@],DEP_PATH_[prep_in-prep_of|mutation-prep_through|identiﬁcation@prep_with],DEP_PATH_POS_[prep_in-prep_of|NNS-prep_through|NN@prep_with],VERB_DEP_PATH_[be]_[prep_in-prep_of|mutation-prep_through|identiﬁcation@auxpass]_[prep_with@auxpass],VERB_DEP_PATH_POS_[be]_[prep_in-prep_of|NNS-prep_through|NN@auxpass]_[prep_with@auxpass]}	{-2.70289,0.655047,0.655047,0.655047,0.655047,0.655047,0.655047}
journal.pone.0069513.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0069513.pdf_532_532_26_26_34_36_UNSUP	HERG/HP:0001657|Prolonged QT interval	{26}	{34,35,36}	{Yuill,KH,",",Borg,JJ,",",Ridley,JM,",",Milnes,JT,",",Witchel,HJ,et,al.,(,2004,),Potent,inhibition,of,human,cardiac,potassium,(,HERG,),channels,by,the,antiestrogen,agent,clomiphene-without,QT,interval,prolongation,.}	{"doi :10.1093 / nar/gkr777 .","PubMed : 21948594 ."}	{"Biochem Biophys Res Commun 318 : 556-561 .","doi :10.1016 / j. bbrc .2004.04.063 ."}	0.706	0.024	0.572	{DEP_PATH_[nn-dep|channel-prep_of|potassium-dobj|inhibition@dep-prep_by|agent],"WORD_SEQ_[) channel by the antiestrogen agent clomiphene-without]",POS_SEQ_[NN_NNS_IN_DT_JJ_NN_JJ],DEP_PATH_POS_[nn-dep|NNS-prep_of|NN-dobj|NN@dep-prep_by|NN]}	{0.22311,0.22311,0.22311,0.22311}
journal.pone.0043563.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0043563.pdf_29_29_14_14_10_10_UNSUP	MJD/HP:0001251|Ataxia	{14}	{10}	{Joseph,disease,(,MJD,),",",also,known,as,spinocerebellar,ataxia,type,3,@,MJD,is,a,polyglutamine,disorder,",",one,of,a,group,of,nine,neurodegenerative,diseases,that,share,a,common,genetic,cause,:,an,expansion,of,a,CAG,trinucleotide,repeat,in,the,coding,region,of,the,respective,disease,genes,[,5,—,7,],.}	{"Ataxin-3 was first recognized as the protein implicated in Machado .","— ."}	{"In the case of MJD , the pathogenic expansion occurs in the ATXN3 gene , which encodes a deubiquitinating enzyme ( DUB ) , ataxin — 3 .","When expanded the CAG repeat encodes an abnormally long polyglutamine ( poly @ track near the C-terminus of ataxin — 3 [ 8 — 9 ] ."}	0.808	0.004	1	{INV_DEP_PATH_POS_[nsubj-dep|NN-rcmod|VBP@],"INV_WORD_SEQ_NER_[type NUMBER @]",INV_DEP_PATH_[nsubj-dep|disorder-rcmod|[@],INV_VERB_DEP_PATH_POS_[be]_[nsubj@cop]_[@cop-dep|NN-rcmod|VBP],"INV_WORD_SEQ_[type 3 @]",INV_POS_SEQ_[NN_CD_SYM],INV_VERB_DEP_PATH_[know]_[nsubj-dep|disorder-rcmod|[-prep_as|ataxia@]_[prep_as@],INV_VERB_DEP_PATH_[be]_[nsubj@cop]_[@cop-dep|disorder-rcmod|[],INV_VERB_DEP_PATH_POS_[know]_[nsubj-dep|NN-rcmod|VBP-prep_as|NN@]_[prep_as@]}	{0.17118,0.17118,0.17118,0.17118,0.17118,0.17118,0.17118,0.17118,0.17118}
journal.pone.0009259.pdf	RELATION_GENEHPOTERM_journal.pone.0009259.pdf_96_96_35_35_25_26	TIMELESS/HP:0002360|Sleep disturbance	{35}	{25,26}	{Single-locus,analysis,of,females,(,n,=,967,),suggested,an,association,(,P,<,0.05,),between,depression,and,depression,accompanied,by,signs,of,disturbed,sleep,with,14,SNPs,from,six,circadian-related,genes,:,TIMELESS,",",ARNT,L,",",RORA,",",nuclear,factor,",",interleukin,3,regulated,(,NFIL3,),",",CSNKIE,",",and,CR1,”,?}	{"Complete data from permutation-based allelic association analyses for depression and its subtypes , linear regression analysis for global seasonality score ( GSS ) , and linkage disequilibrium ( LD ) patterns for all genotyped genes are available in Tables S1 , S2 , S3 and S4 , respectively .","Association to Depression in Females Single-locus analyses in cases and controls ."}	{"( Table 1 ; full data available in Table S1 ) .","The statistically strongest evidence was for the association of TIMELESS rs7486220 with depression and fatigue ( pointwise P : 0.000099 , odds ratio ( OR ) = 1.66 ) ."}	0.838	0.346	0.996	{INV_POS_SEQ_[IN_CD_NNS_IN_CD_JJ_NNS_:],"INV_WORD_SEQ_NER_[with NUMBER snp from NUMBER circadian-related gene :]",INV_DEP_PATH_[dep@prep_of-prep_by|sign-xcomp|accompany-rcmod|suggest-prep_of|female],INV_VERB_DEP_PATH_[suggest]_[dep@rcmod-prep_of|female]_[prep_of-prep_by|sign-xcomp|accompany@],"INV_WORD_SEQ_[with 14 snp from six circadian-related gene :]",INV_VERB_DEP_PATH_[accompany]_[dep@xcomp-rcmod|suggest-prep_of|female]_[prep_of-prep_by|sign@],INV_DEP_PATH_POS_[dep@prep_of-prep_by|NNS-xcomp|VBN-rcmod|VBD-prep_of|NNS],INV_VERB_DEP_PATH_POS_[accompany]_[dep@xcomp-rcmod|VBD-prep_of|NNS]_[prep_of-prep_by|NNS@],INV_VERB_DEP_PATH_POS_[suggest]_[dep@rcmod-prep_of|NNS]_[prep_of-prep_by|NNS-xcomp|VBN@]}	{0.188691,0.188691,0.188691,0.188691,0.188691,0.188691,0.188691,0.188691,0.188691}
SCPDFS_20182.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_20182.pdf_201_201_27_27_31_31	ATM/HP:0001009|Telangiectasia	{27}	{31}	{Although,not,recognized,in,the,gene,ontology,",",the,ﬁve,member,cluster,is,enriched,for,genetic,diseases,:,Werner,syndrome,(,WRN,),",",ataxia,telangiectasia,(,ATM,),",",ataxia,telangiectasia,like,disorder,(,MRE11A,),",",Kabuki,syndrome,(,MLL2,),and,susceptibility,to,Alzheimer,disease,(,PAXIP1,),.}	{"Interacting proteins encoded by transcripts recovered in the screens with the UTRs from polyQ SCA mRNAs .","A. Interacting proteins from the ATXN1 UTR screen ."}	{"B. Interacting proteins from the screen with CACNA1A UTRs .","C. Clusters of interacting proteins from the ATXN3 UTR screen ."}	0.72	0.004	1	{DEP_PATH_POS_[dep-conj_and|NN@conj_and],"WORD_SEQ_NER_[NUMBER , ataxia]","POS_SEQ_[CD_,_NN]","WORD_SEQ_[) , ataxia]",VERB_DEP_PATH_[enrich]_[dep-conj_and|telangiectasium-dep|syndrome-parataxis|)@]_[conj_and-dep|syndrome-parataxis|)@],DEP_PATH_[dep-conj_and|telangiectasium@conj_and],VERB_DEP_PATH_POS_[enrich]_[dep-conj_and|NN-dep|NN-parataxis|NN@]_[conj_and-dep|NN-parataxis|NN@]}	{-0.9626,0.68488,0.580237,0.465072,0,0,0}
journal.pgen.1000870.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1000870.pdf_234_234_13_13_22_22_UNSUP	PAX6/HP:0000526|Aniridia	{13}	{22}	{Furthermore,",",mutation,of,the,corresponding,threonine,(,T63P,),in,the,human,PAX6,gene,results,in,a,relatively,mild,form,of,aniridia,characterized,by,subtle,iris,hypoplasia,",",cataract,and,keratopathy,along,with,nystagmus,[,34,],.}	{"mouse and is absolutely conserved in the Pax2/PAX2 sequence across several species .","Mutation at this residue has been described in individuals with PRS [ 15 ] ."}	{"Lastly , our atomic modeling and in vitro functional studies suggest that this murine mutation , as well as the other human PAX2 mutations reported in this region , mildly disrupt normal protein structure and result in hypomorphic alleles .","The mechanism by which Pax2/PAX2 function is reduced in the three mutations tested is a reduced level of steady — state Pax2 / PAX2 protein , likely due to a decrease in protein stability ."}	0.836	0.67	0.998	{DEP_PATH_POS_[nn-prep_in|NN-prep_of|NN-nsubj|NN@prep_of-prep_in|NN],"WORD_SEQ_[gene result in a relatively mild form of]",POS_SEQ_[NN_VBZ_IN_DT_RB_JJ_NN_IN],VERB_DEP_PATH_[result]_[nn-prep_in|gene-prep_of|)-nsubj|mutation@]_[prep_of-prep_in|form@],VERB_DEP_PATH_POS_[result]_[nn-prep_in|NN-prep_of|NN-nsubj|NN@]_[prep_of-prep_in|NN@],DEP_PATH_[nn-prep_in|gene-prep_of|)-nsubj|mutation@prep_of-prep_in|form]}	{0.24152,0.24152,0.24152,0.24152,0.24152,0.24152}
journal.pgen.1000423.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1000423.pdf_34_34_0_0_14_14_UNSUP	BWS/HP:0000158|Macroglossia	{0}	{14}	{BWS,is,a,congenital,overgrowth,syndrome,",",characterised,by,prenatal,and,postnatal,overgrowth,",",macroglossia,and,anterior,abdominal,wall,defects,.}	{"Molecular genetic analysis of rare human imprinting disorders has played a critical role in elucidating the mechanisms of genomic imprinting .","In particular , studies of the imprinting disorder Beckwith-Wiedemann syndrome ( BWS MIM 130650 ) have provided important insights into the structure and function of imprinting centres [ 2 ] ."}	{"Additionally , variable features include organomegaly , neonatal hypoglycaemia , hemihypertrophy , urogenital abnormalities and in about 5 % of children , embryonal tumours ( most frequently Wilms ’ tumour ) .","The genetics of BWS are complex , but involve mutation or altered expression of several closely linked genes associated with cell cycle and growth control in the imprinted 1lpl5 .5 chromosomal region ."}	0.792	0.016	0.982	{"WORD_SEQ_[be a congenital overgrowth syndrome , characterise by prenatal and postnatal overgrowth ,]","POS_SEQ_[VBZ_DT_JJ_NN_NN_,_VBN_IN_JJ_CC_JJ_NN_,]",DEP_PATH_POS_[nsubj@agent-partmod|VBN],VERB_DEP_PATH_POS_[be]_[nsubj@cop]_[agent-partmod|VBN@cop],VERB_DEP_PATH_[be]_[nsubj@cop]_[agent-partmod|characterise@cop],VERB_DEP_PATH_[characterise]_[nsubj@partmod]_[agent@],DEP_PATH_[nsubj@agent-partmod|characterise],VERB_DEP_PATH_POS_[characterise]_[nsubj@partmod]_[agent@]}	{0.240652,0.240652,0.165338,0.165338,0.104981,0.104981,0.104981,0.104981}
SCPDFS_45973.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_45973.pdf_38_38_15_15_6_7_UNSUP	MAPT/HP:0002145|Frontotemporal dementia	{15}	{6,7}	{Disorders,closely,related,to,AD,include,frontotemporal,dementia,(,FTD,),",",and,mutations,in,MAPT,and,granulin,(,GRN,),genes,have,been,observed,in,these,disorders,.}	{"The genes most frequently involved in AD include presenilin ( PS ) and tau ( MAPT ) .","Accumulation of amyloid beta peptide ( AB ) and hyperphosphorylated tau filaments has been observed in AD autopsy tissue ."}	{"PD is characterized by degeneration and loss of dopaminergic neurons in the substantia nigra .","A number of genes have been found to be mutated in PD , including synuclein ( SNC ) , PINK1 , parkin ( PARK ) and DJ — 1 ."}	0.848	0.878	1	{INV_VERB_DEP_PATH_[include]_[prep_in-conj_and|mutation-dobj|dementia@]_[dobj@],INV_VERB_DEP_PATH_POS_[observe]_[prep_in-conj_and|NNS-dobj|NN-dep|VBP@]_[dobj-dep|VBP@],INV_VERB_DEP_PATH_[observe]_[prep_in-conj_and|mutation-dobj|dementia-dep|include@]_[dobj-dep|include@],INV_DEP_PATH_[prep_in-conj_and|mutation@],INV_VERB_DEP_PATH_POS_[include]_[prep_in-conj_and|NNS-dobj|NN@]_[dobj@],INV_DEP_PATH_POS_[prep_in-conj_and|NNS@],"INV_WORD_SEQ_NER_[NUMBER ORGANIZATION NUMBER , and mutation in]","INV_WORD_SEQ_[( FTD ) , and mutation in]","INV_POS_SEQ_[CD_NNP_CD_,_CC_NNS_IN]"}	{0.288749,0.288749,0.288749,0.288749,0.288749,-0.176848,0.172744,0.172744,-0.10728}
journal.pone.0075393.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0075393.pdf_48_48_3_3_10_11_UNSUP	FAD/HP:0002185|Neurofibrillary tangles	{3}	{10,11}	{Both,SAD,and,FAD,share,speciﬁc,neuropathologic,features,",",including,neurofibrillary,tangles,",",amyloid,-,[,3,oW,plaques,",",neuronal,loss,","}	{"The exact cause of AD is still largely unknown despite over 100 years of extensive research , and still no curative treatments are available .","Aging is recognized as the main risk factor for the late-onset sporadic form of AD ( SAD ) , while early-onset familial AD ( FAD ) has been linked to autosomal dominant mutations in the gene for the amyloid - [ 3 precursor protein ( ABPP ) and the genes for the presenilin 1 ( PS1 ) and presenilin 2 ( PS2 ) proteins [ 1,2 ] ."}	{"decades , the production and accumulation of the AB peptide has been proposed to be the primary trigger of the pathological cascade leading to neurodegeneration and the development of AD .","Besides A [ 3 , several other ( risk ) factors have been proposed to play an important role in the development of AD ."}	0.742	0.13	0.998	{DEP_PATH_[conj_and-amod|sad-nsubj|share@prep_including],"WORD_SEQ_[share speciﬁc neuropathologic feature , include]",DEP_PATH_POS_[conj_and-amod|JJ-nsubj|NN@prep_including],"POS_SEQ_[NN_NN_JJ_NNS_,_VBG]"}	{0.256962,0.256962,0.256962,0.256962}
journal.pone.0078259.pdf	RELATION_GENEHPOTERM_journal.pone.0078259.pdf_613_613_38_38_44_45	CD24/HP:0003002|Breast carcinoma	{38}	{44,45}	{Mylona,E,",",Giannopoulou,I,",",Fasomytakis,E,",",Nomikos,A,",",Magkou,C,et,al.,(,2008,),The,clinicopathologic,and,prognostic,signiﬁcance,of,CD44,+,/,CD24,(,-,/,low,),and,CD44,-,/,CD24,+,tumor,cells,in,invasive,breast,carcinomas,.}	{"doi :10.1186 / 1756-9966-31-59 .","PubMed : 22762532 ."}	{"Hum Pathol 39 : 1096-1102 .","doi :10.1016 / j. humpath ."}	0.806	0.89	1	{POS_SEQ_[CC_NN_NNS_IN_JJ],DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],"WORD_SEQ_[+ tumor cell in invasive]"}	{0.635656,0.374951,0.356655,0}
journal.pgen.1002708.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1002708.pdf_469_469_15_15_7_7_UNSUP	FGF23/HP:0002148|Hypophosphatemia	{15}	{7}	{Additionally,",",the,Fam20c,cKO,mice,developed,hypophosphatemia,with,a,remarkable,elevation,of,the,serum,FGF23,level,.}	{"This belief is based on the following observations : 1 ) deleting exons 6 — 9 ( majority of the CCD ) in the Fam20c cKO mice was most likely to inactivate this molecule ; 2 ) the inheritance of the phenotypic changes in Fam20c cKO mice occurred in an autosomal recessive trait , while the gain-of-function is usually inherited in an autosomal dominant manner ; 3 ) transgenic mice overexpressing the Fam20c transgene were normal ; 4 ) the overexpression of the Fam20c transgene fully rescued the phenotypic changes in the Fam20c cKO mice ; and 5 ) recombinant FAMQOC promoted the differentiation and mineralization of MC3T3-El cells in a dose-dependent manner .","These data combined with a signiﬁcant downregulation of osteoblast differentiation markers in cKO mice suggest that FAMQOC is essential to the differentiation of mineralizing cells and promotes the formation and mineralization of hard tissues , and thus , inactivation of this molecule leads to differentiation failure of the cells forming these tissues ."}	{"We believe that a combination of cell differentiation failure and hypophosphatemia caused by the","Bone appositional rate ( um/day ) \\""}	0.802	0.902	0.998	{INV_DEP_PATH_POS_[nn-prep_of|NN-prep_with|NN@dobj],INV_DEP_PATH_[nn-prep_of|level-prep_with|elevation@dobj],INV_VERB_DEP_PATH_[develop]_[nn-prep_of|level-prep_with|elevation@]_[dobj@],"INV_WORD_SEQ_[with a remarkable elevation of the serum]",INV_POS_SEQ_[IN_DT_JJ_NN_IN_DT_NN],INV_VERB_DEP_PATH_POS_[develop]_[nn-prep_of|NN-prep_with|NN@]_[dobj@]}	{0.630225,0.307821,0.307821,0.307821,-0.167875,0.0535742}
journal.pone.0004471.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0004471.pdf_541_541_25_25_33_36	SLC26A4/HP:0011387|Enlarged vestibular aqueduct	{25}	{33,35,36}	{Yang,T,",",Vidarsson,H,",",Rodrigo,~,B1omqvist,S,",",Rosengren,SS,",",Enerback,S,",",et,al.,(,2007,),Transcriptional,control,of,SLC26A4,is,involved,in,Pendred,syndrome,and,nonsyndromic,enlargement,of,vestibular,aqueduct,(,DFNB4,),.}	{"1 \\\\ ’ 1ed Genet 39 : 796 * 803 .","19 ."}	{"Am ] Hum Genet 80 : 1055 — 1063 .",.}	0.808	0.048	0.998	{"WORD_SEQ_[be involve in pendred syndrome and nonsyndromic]",POS_SEQ_[VBZ_VBN_IN_JJ_NN_CC_JJ],DEP_PATH_POS_[prep_of-dep|NN-nsubjpass|FW@dep-conj_and|NN],VERB_DEP_PATH_POS_[involve]_[prep_of-dep|NN-nsubjpass|FW@]_[dep-conj_and|NN@],DEP_PATH_[prep_of-dep|control-nsubjpass|(@dep-conj_and|)],VERB_DEP_PATH_[involve]_[prep_of-dep|control-nsubjpass|(@]_[dep-conj_and|)@],VERB_DEP_PATH_POS_[be]_[prep_of-dep|NN-nsubjpass|FW@auxpass]_[dep-conj_and|NN@auxpass],VERB_DEP_PATH_[be]_[prep_of-dep|control-nsubjpass|(@auxpass]_[dep-conj_and|)@auxpass]}	{0.28817,0.173059,0.16826,0.16826,0.16826,0.16826,0.16826,0.16826}
SCPDFS_40490.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_40490.pdf_893_893_24_24_18_22_UNSUP	MODY/HP:0004904|Maturity-onset diabetes of the young	{24}	{18,19,22}	{A,genetic,map,of,chromosome,20q12-q13,.1,:,Multiple,highly,polymorphic,microsatellite,and,RFLP,markers,linked,to,the,maturity-onset,diabetes,of,the,young,(,MODY,),locus,.}	{"Rothschild , C. B. , Akots , G. , Hayworth , R. , Pettenati , M. J .",", Rao , P. N. , Wood , P. , Stolz , F. M. , Hansmann , I. , Serino , K. , Keith , T. P. , Fajans , S. S. , and Bowden , D. W. ( 1993 ) ."}	{"Am .","J. Hum ."}	0.742	0.032	0.822	{INV_WORD_SEQ_[(],INV_POS_SEQ_[CD],INV_DEP_PATH_[nn-prep_of|locus@],INV_WORD_SEQ_NER_[NUMBER],INV_DEP_PATH_POS_[nn-prep_of|NN@],INV_VERB_DEP_PATH_POS_[link]_[nn-prep_of|NN-prep_to|NN@]_[prep_to@],INV_VERB_DEP_PATH_[link]_[nn-prep_of|locus-prep_to|diabetes@]_[prep_to@]}	{1.56902,-1.55299,1.31962,-1.27274,-1.08108,1.026,1.026}
journal.pone.0045217.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0045217.pdf_152_152_2_2_9_9_UNSUP	XDH/HP:0010934|Xanthinuria	{2}	{9}	{Mutations,in,XDH,in,man,give,rise,to,classical,xanthinuria,type,I,",",a,rare,genetic,disorder,characterised,by,elevated,serum,and,urinary,concentration,of,xanthine,and,renal,xanthine,calculi,",",in,association,with,undetectable,levels,of,uric,acid,[,8,—,12,],.}	{"In addition , the ENU hypomorphic Foxc ] mice , when compared to Foam ] deﬁcient mice , had greater similarity to patients with Axenfeld-Rieger syndrome ( ARS ) that is due to Faxcl mutations [ 17 ] .","These differences between the ENU-induced RENF and Xo ) ’ / _ mouse models highlight the advantages of having two allelic variants that provide the opportunity of elucidating further the relationships between the phenotype and the likely protein structure and its in viva function [ 18 ] ."}	{"Mutations detected in man have included nonsense mutations at codons 228 and 722 [ 8 , ll ] , frameshifting insertions and deletions [ 8,9 , l2 ] , and missense mutations [ 10,12 ] .","One patient with a nonsense mutation ( R228X ) was found to have an absence of XDH protein [ 8 ] , whilst assays of XDH activity in duodenal mucosa biopsy samples from patients with a frameshift insertion at codon 569 and a missense mutation ( Rl49C ) showed ~ 5 % and undetectable XDH activities , respectively [ 9 , l0 ] ."}	0.816	0.774	0.812	{DEP_PATH_POS_[prep_in-nsubj|NNS@nn-prep_to|NN-dep|VB],POS_SEQ_[IN_NN_VB_VB_TO_JJ],VERB_DEP_PATH_POS_[rise]_[prep_in-nsubj|NNS@dep]_[nn-prep_to|NN@],VERB_DEP_PATH_POS_[give]_[prep_in-nsubj|NNS@]_[nn-prep_to|NN-dep|VB@],VERB_DEP_PATH_[give]_[prep_in-nsubj|mutation@]_[nn-prep_to|type-dep|rise@],VERB_DEP_PATH_[rise]_[prep_in-nsubj|mutation@dep]_[nn-prep_to|type@],DEP_PATH_[prep_in-nsubj|mutation@nn-prep_to|type-dep|rise],"WORD_SEQ_[in man give rise to classical]"}	{0.203807,0.203807,0.203807,0.203807,0.203807,0.203807,0.203807,0.203807}
journal.pgen.0030096.pdf	RELATION_GENEHPOTERM_journal.pgen.0030096.pdf_314_314_0_0_11_12	HD/HP:0000855|Insulin resistance	{0}	{11,12}	{HD,genes,),and,their,constellated,cofactors,was,differentially,associated,with,insulin,resistance,and,DM2,.}	{"NR .","— ."}	{"NR .","— ."}	0.788	0.418	1	{VERB_DEP_PATH_POS_[associate]_[nn-nsubjpass|NN@]_[prep_with@],VERB_DEP_PATH_[associate]_[nn-nsubjpass|)@]_[prep_with@],VERB_DEP_PATH_[be]_[nn-nsubjpass|)@auxpass]_[prep_with@auxpass],DEP_PATH_[nn-nsubjpass|)@prep_with],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[prep_with@auxpass],DEP_PATH_POS_[nn-nsubjpass|NN@prep_with],"WORD_SEQ_[gene ) and they constellate cofactor be differentially associate with]",POS_SEQ_[NNS_NN_CC_PRP$_VBN_NNS_VBD_RB_VBN_IN],VERB_DEP_PATH_POS_[constellate]_[nn@partmod-conj_and|PRP$]_[prep_with@partmod-conj_and|PRP$-nsubjpass|NN],VERB_DEP_PATH_[constellate]_[nn@partmod-conj_and|they]_[prep_with@partmod-conj_and|they-nsubjpass|)]}	{0.707044,0.560782,0.334899,0.334899,-0.219543,-0.219543,0,0,0,0}
journal.pone.0071266.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0071266.pdf_367_367_26_26_33_35_UNSUP	FLT3/HP:0004808|Acute myeloid leukemia	{26}	{33,34,35}	{Schnittger,S,",",Schoch,C,",",Dugas,1,"\\\\",’,1,",",Kern,VV,",",Staib,P,",",et,al.,(,2002,),Analysis,o,‘,FLT3,length,mutations,in,1003,patients,with,acute,myeloid,leukemia,:,correlation,to,cytogenetics,",",FAB,subtype,",",and,prognosis,in,the,A1,"\\\\",lLCG,study,and,usefulness,as,a,marker,for,the,detection,of,minimal,residual,disease,.}	{"Blood 100 : 437244380 .","5 ."}	{"Blooc 100 : 59 — 66 .","6 ."}	0.848	0.002	1	{DEP_PATH_POS_[nn@prep_with-prep_in|NNS],"WORD_SEQ_[length mutation in 1003 patient with]","WORD_SEQ_NER_[length mutation in DATE patient with]",DEP_PATH_[nn@prep_with-prep_in|patient],POS_SEQ_[NN_NNS_IN_CD_NNS_IN]}	{0.691039,0.51439,0.51439,-0.369499,0.306303}
journal.pone.0078025.pdf	RELATION_GENEHPOTERM_journal.pone.0078025.pdf_322_322_25_25_36_36	VEGF/HP:0100602|Preeclampsia	{25}	{36}	{Sundrani,DP,",",Reddy,US,",",Joshi,AA,",",Mehendale,SS,",",Chavan-Gautam,PM,et,al.,(,2013,),Differential,placental,methylation,and,expression,of,VEGF,",",FLT-1,and,KDR,genes,in,human,term,and,preterm,preeclampsia,.}	{"doi :10.1053 / plac .2001.0778 .","PubMed : 11969342 ."}	{"Clin .","Epigenetics 5 ( 1 ) : 6 ."}	0.87	0.814	0.45	{DEP_PATH_POS_[nn-prep_of|NNS-dobj|NN@prep_in],DEP_PATH_[nn-prep_of|gene-dobj|methylation@prep_in],"POS_SEQ_[,_NN_CC_NN_NNS_IN_JJ_NN_CC_NN]","WORD_SEQ_[, flt-1 and kdr gene in human term and preterm]"}	{1.64848,0,0,0}
SCPDFS_3276.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_3276.pdf_409_409_16_16_29_30_UNSUP	PAX6/HP:0000525|Abnormality of the iris	{16}	{29,30}	{Studies,on,human,carriers,of,chromosomal,duplications,and,on,transgenic,mice,have,suggested,that,overexpression,of,PAX6,/,Pax6,can,result,in,a,variety,of,ocular,phenotypes,",",including,iris,abnormalities,(,Falk,et,al.,",",1973,;,Lavedan,et,al.,",",1989,;,Palmer,et,al.,",",1976,;,Sanchez,et,al.,",",1974,;,Schedl,et,al.,",",1996,;,Strobel,et,al.,",",1980,),.}	{"Overexpression of the canonical form of Pax6 leads to maldevelopment of the CB and hyperplasia of the iris sphincter","The sensitivity of the iris to a reduction in Pax6 expression raised the question of whether the iris would be sensitive to an elevation in Pax6 dosage as well ."}	{"But , the question of the tissue speciﬁc functions has remained unsolved .","Another aspect that has never been addressed is whether the iris defects are caused by an excess of the canonical splice variant of Pax6 ( Pax6 — can ) or by its alternative splice variant Pax6 — 5a ( Duncan et al. , 2000 ; Singh et al. , 2002 ) ."}	0.756	0.796	1	{"POS_SEQ_[:_NN_MD_VB_IN_DT_NN_IN_JJ_NNS_,_VBG]",VERB_DEP_PATH_POS_[result]_[prep_of@dep]_[prep_including-prep_in|NN@],"WORD_SEQ_[/ pax6 can result in a variety of ocular phenotype , include]",DEP_PATH_[prep_of@prep_including-prep_in|variety-dep|result],VERB_DEP_PATH_[result]_[prep_of@dep]_[prep_including-prep_in|variety@],DEP_PATH_POS_[prep_of@prep_including-prep_in|NN-dep|VB]}	{0.206375,0.206375,0.206375,0.206375,0.206375,0.206375}
journal.pone.0056134.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0056134.pdf_509_509_22_22_28_28_UNSUP	BRAF/HP:0002861|Melanoma	{22}	{28}	{Hingorani,SR,",",Jacobetz,"1\\\\/IA",",",Robertson,GP,",",Herlyn,l,"\\\\",’,I,",",Tuveson,DA,(,2003,),Suppression,of,BRAF,(,V599E,),in,human,melanoma,abrogates,transformation,.}	{"Nature 417 : 949e954 .","21 ."}	{"Cancer Res 63 : 5l98e5202 .","22 ."}	0.874	0.102	0.994	{DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],"WORD_SEQ_[( v599e ) in human]","WORD_SEQ_NER_[NUMBER v599e ) in human]",VERB_DEP_PATH_POS_[abrogate]_[nn-prep_of|NN-nsubj|NN@]_[prep_in-prep_of|NN-nsubj|NN@],VERB_DEP_PATH_[abrogate]_[nn-prep_of|)-nsubj|suppression@]_[prep_in-prep_of|)-nsubj|suppression@],POS_SEQ_[CD_NN_NN_IN_JJ]}	{0.374951,0.356655,0.292714,0.292714,0.243603,0.243603,0.220835}
SCPDFS_41605.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_41605.pdf_270_270_26_26_17_19_UNSUP	NPM/HP:0004808|Acute myeloid leukemia	{26}	{17,18,19}	{The,t,(,3,;,5,),(,q25,.1,;,q34,),of,myelodysplastic,syndrome,and,acute,myeloid,leukemia,produces,a,novel,fusion,gene,",",NPM,—,MLF1,.}	{"Blood 86 : 1525-1533 .","Yoneda-Kato , N. , Look , A. T. , Kirstein , M. N. , Valentine , M. B. , Raimondi , S. C. , Cohen , K. J. , Carroll , A. J. , and Morris , S. W. ( 1996 ) ."}	{"Oncogene 12 : 265-275 ."}	0.714	0.482	0.98	{INV_VERB_DEP_PATH_POS_[produce]_[nn-appos|NN-dobj|NN@]_[nsubj@],INV_VERB_DEP_PATH_[produce]_[nn-appos|mlf1-dobj|gene@]_[nsubj@],INV_DEP_PATH_[nn-appos|mlf1-dobj|gene@nsubj],"INV_POS_SEQ_[VBZ_DT_JJ_NN_NN_,]","INV_WORD_SEQ_[produce a novel fusion gene ,]",INV_DEP_PATH_POS_[nn-appos|NN-dobj|NN@nsubj]}	{0.216273,0.216273,0.216273,0.172789,0.172789,0.00966282}
journal.pone.0010350.pdf	RELATION_GENEHPOTERM_journal.pone.0010350.pdf_406_406_26_26_29_29	PI3K/HP:0009733|Glioma	{26}	{29}	{Activation,of,PI3K,is,associated,with,increased,metabolism,",",suggesting,potential,dependence,of,cancer,cells,on,PI3K,signaling,",",and,raising,the,possibility,that,blockade,of,PI3K,signaling,in,glioma,should,effectively,kill,these,cells,[,53,],.}	{"Our results are in accordance with the previous reports that downregulation of XIAP did result in the downregulation of Akt and inhibition of glioma cell growth .","Activation of PI3K occurs commonly in cancers including glioblastoma , the most common primary brain tumor ."}	{"PTEN encodes a phosphatase that dephosphorylates phosphatidylinositol-3 ,4,5 triphosphate to convert it to phosphatidylinositol-4 , 5 bisphosphate .","Therefore , inactivation of PTEN leads to increased levels of phosphatidylinositol-3 ,4,5 triphosphate and increased Akt activation [ 33 ] ."}	0.842	0.778	0.996	{"WORD_SEQ_[signaling in]",POS_SEQ_[NN_IN],DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],VERB_DEP_PATH_[raise]_[nn-prep_of|signaling-nsubj|blockade-ccomp|kill@]_[prep_in-prep_of|signaling-nsubj|blockade-ccomp|kill@],VERB_DEP_PATH_[kill]_[nn-prep_of|signaling-nsubj|blockade@]_[prep_in-prep_of|signaling-nsubj|blockade@],VERB_DEP_PATH_POS_[raise]_[nn-prep_of|NN-nsubj|NN-ccomp|VB@]_[prep_in-prep_of|NN-nsubj|NN-ccomp|VB@],VERB_DEP_PATH_POS_[kill]_[nn-prep_of|NN-nsubj|NN@]_[prep_in-prep_of|NN-nsubj|NN@]}	{1.98883,-0.989443,0.374951,0.356655,0,0,0,0}
SCPDFS_38696.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_38696.pdf_522_522_14_14_23_24_UNSUP	FBN2/HP:0002803|Congenital contracture	{14}	{23,24}	{E.A.,Putnam,",",H.,Zhang,",",F.,Ramirez,",",D.M.,Milewicz,",",Fibrillin-2,(,FBN2,),mutations,result,in,the,Marfan-like,disorder,",",congenital,contractural,arachnodactyly,",",Nat,.}	{"Mutat .","20 ( 2002 ) 153-161 ."}	{"Genet .","11 ( 1995 ) 456-458 ."}	0.824	0.052	0.986	{"POS_SEQ_[NN_NNS_VBP_IN_DT_JJ_NN_,]","WORD_SEQ_NER_[) mutation result in the MISC disorder ,]","WORD_SEQ_[) mutation result in the marfan-like disorder ,]",DEP_PATH_POS_[nn-dep|NNS-appos|NN-nsubj|NNP@amod-appos|NN-prep_in|NN],VERB_DEP_PATH_[result]_[nn-dep|mutation-appos|fibrillin-2-nsubj|PERSON@]_[amod-appos|arachnodactyly-prep_in|disorder@],DEP_PATH_[nn-dep|mutation-appos|fibrillin-2-nsubj|PERSON@amod-appos|arachnodactyly-prep_in|disorder],VERB_DEP_PATH_POS_[result]_[nn-dep|NNS-appos|NN-nsubj|NNP@]_[amod-appos|NN-prep_in|NN@]}	{0.399467,0.399467,0.399467,0.124034,0.124034,0.124034,0.124034}
SCPDFS_38413.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_38413.pdf_35_35_34_34_46_48_UNSUP	SRY/HP:0012245|Sex reversal	{34}	{46,48}	{Proof,that,SRY,is,the,testis-deterrnining,factor,came,from,two,major,sources,",",ﬁrst,it,induces,testis,formation,and,male,development,in,XX,transgenic,mice,[,3,],",",and,second,",",mutations,in,SRY,are,found,associated,with,some,cases,of,XY,male,—,to-female,sex,—,reversed,patients,[,"4,5",],.}	{"Mammalian sex differentiation depends on the presence or absence of the SRY gene , the sex — deterrnining region of Y chromosome [ 1 ] .","SR Y encodes an HMG domain protein likely to act as a transcription factor , and in vitro studies of SRY protein suggest that DNA binding and subsequent bending of the target are important features of its ﬁmction [ 2 ] ."}	{"Unexpectedly , from its discovery in 1990 and despite many studies , the molecular targets of SRY remain unknown .","In this quest for SRY targets , we have studied XX sex — reversed animals , following the hypothesis"}	0.804	0.376	0.996	{VERB_DEP_PATH_[associate]_[prep_in-appos|mutation-nsubjpass|ORDINAL@dep]_[rcmod-prep_of|male-prep_with|case@],POS_SEQ_[VBP_VBN_VBN_IN_DT_NNS_IN_NN_NN_CD_JJ],DEP_PATH_POS_[prep_in-appos|NNS-nsubjpass|JJ@rcmod-prep_of|NN-prep_with|NNS-dep|VBN],VERB_DEP_PATH_POS_[find]_[prep_in-appos|NNS-nsubjpass|JJ@]_[rcmod-prep_of|NN-prep_with|NNS-dep|VBN@],"WORD_SEQ_[be find associate with some case of xy male — to-female]",DEP_PATH_[prep_in-appos|mutation-nsubjpass|ORDINAL@rcmod-prep_of|male-prep_with|case-dep|associate],VERB_DEP_PATH_[find]_[prep_in-appos|mutation-nsubjpass|ORDINAL@]_[rcmod-prep_of|male-prep_with|case-dep|associate@],VERB_DEP_PATH_POS_[associate]_[prep_in-appos|NNS-nsubjpass|JJ@dep]_[rcmod-prep_of|NN-prep_with|NNS@],"WORD_SEQ_NER_[be find associate with some case of xy male NUMBER to-female]"}	{0.158641,0.158641,0.158641,0.158641,0.158641,0.158641,0.158641,0.158641,0.158641}
SCPDFS_21289.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_21289.pdf_32_32_20_20_29_29_UNSUP	PKAN/HP:0001332|Dystonia	{20}	{29}	{We,investigated,the,transcriptional,regulation,of,PANK2,",",the,causative,gene,for,pantothenate,kinase,—,associated,neurodegenera,—,tion,(,PKAN,),",",an,autosomal,recessive,disease,characterized,by,dystonia,and,retinal,degeneration,(,Zhou,et,al.,",",2001a,),.}	{"— .","CoA and palmitoylcarnitine ( Rock et al. , 2000 ; Hortnagel et al. , 2003 ; Johnson et al. , 2004 ; Leonardi et al. , 2007a ) ."}	{"A critical question in PKAN pathogenesis is why disruption of a ubiquitously expressed gene causes a neurological — speciﬁc disease .","Thus we sought to identify regulatory factors controlling PANK2 expression ."}	0.764	0.038	1	{VERB_DEP_PATH_POS_[characterize]_[nn@partmod-appos|NN]_[agent@],VERB_DEP_PATH_[associate]_[nn-dobj|)@]_[agent-partmod|characterize-appos|disease-dobj|)@],"POS_SEQ_[NN_,_DT_JJ_JJ_NN_VBN_IN]","WORD_SEQ_[) , a autosomal recessive disease characterize by]",VERB_DEP_PATH_POS_[associate]_[nn-dobj|NN@]_[agent-partmod|VBN-appos|NN-dobj|NN@],DEP_PATH_POS_[nn@agent-partmod|VBN-appos|NN],DEP_PATH_[nn@agent-partmod|characterize-appos|disease],VERB_DEP_PATH_[characterize]_[nn@partmod-appos|disease]_[agent@]}	{0.234106,0.232892,0.232892,0.232892,0.232892,-0.153692,-0.0296718,-0.0296718}
journal.pone.0058031.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0058031.pdf_464_464_35_35_29_29_UNSUP	ALK1/HP:0001009|Telangiectasia	{35}	{29}	{Kuehl,HK,",",Caselitz,IVI,",",Hasenkamp,S,",",VVagner,S,",",El-Harith,EA,",",et,al.,(,2005,),Hepatic,manifestation,is,associated,with,ALK1,in,hereditary,hemorrhagic,telangiectasia,:,identiﬁcation,of,ﬁve,novel,ALK1,and,one,novel,ENG,mutation,.}	{"J l \\\\ ’ Ied Genet 40 : 585490 .","7 ."}	{"Hum Mutat 25 : 320 .","8 ."}	0.806	0.54	1	{INV_VERB_DEP_PATH_POS_[be]_[prep_of-dep|NN@auxpass-rcmod|VBN]_[prep_in-prep_with|NN@auxpass],INV_VERB_DEP_PATH_[be]_[prep_of-dep|identiﬁcation@auxpass-rcmod|associate]_[prep_in-prep_with|alk1@auxpass],INV_POS_SEQ_[:_NN_IN_NN_JJ],INV_DEP_PATH_[prep_of-dep|identiﬁcation@prep_in-prep_with|alk1-rcmod|associate],"INV_WORD_SEQ_[: identiﬁcation of ﬁve novel]",INV_VERB_DEP_PATH_POS_[associate]_[prep_of-dep|NN@rcmod]_[prep_in-prep_with|NN@],INV_VERB_DEP_PATH_[associate]_[prep_of-dep|identiﬁcation@rcmod]_[prep_in-prep_with|alk1@],INV_DEP_PATH_POS_[prep_of-dep|NN@prep_in-prep_with|NN-rcmod|VBN]}	{0.183927,0.183927,0.183927,0.183927,0.183927,0.183927,0.183927,0.183927}
journal.pgen.1003516.pdf	RELATION_GENEHPOTERM_journal.pgen.1003516.pdf_728_728_29_29_22_22	IKAP/HP:0002459|Dysautonomia	{29}	{22}	{Anderson,SL,",",Coli,R,",",Daly,IVV,",",Kichula,EA,",",Rork,NI,],",",et,al.,(,2001,),Familial,dysautonomia,is,caused,by,mutations,of,the,IKAP,gene,.}	{"Slaugenhaupt SA , Blumenfeld A , Gill SP , Leyne 1 \\\\ ’ I , 1VIullJ , et al. ( 2001 ) Tissue » speciﬁc expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia .","Am ] Hum Genet 68 : 5984305 ."}	{"Amj Hum Genet 68 : 753 — 758 .","Dietrich P , Alli S , Shanmugasundaram R , Dragatsis I ( 2012 ) IKAP expression levels modulate disease severity in a mouse model of familial dysautonomia ."}	0.832	0.684	1	{"INV_WORD_SEQ_[be cause by mutation of the]",INV_POS_SEQ_[VBZ_VBN_IN_NNS_IN_DT],INV_DEP_PATH_POS_[nn-prep_of|NN-agent|NNS@dep-nsubjpass|NNP],INV_VERB_DEP_PATH_POS_[cause]_[nn-prep_of|NN-agent|NNS@]_[dep-nsubjpass|NNP@],INV_VERB_DEP_PATH_POS_[be]_[nn-prep_of|NN-agent|NNS@auxpass]_[dep-nsubjpass|NNP@auxpass],INV_VERB_DEP_PATH_[be]_[nn-prep_of|gene-agent|mutation@auxpass]_[dep-nsubjpass|SL@auxpass],INV_VERB_DEP_PATH_[cause]_[nn-prep_of|gene-agent|mutation@]_[dep-nsubjpass|SL@],INV_DEP_PATH_[nn-prep_of|gene-agent|mutation@dep-nsubjpass|SL]}	{0.607035,0.1674,0.147451,0.147451,0.147451,0.147451,0.147451,0.147451}
journal.pone.0016191.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0016191.pdf_414_414_31_31_29_29	HERG/HP:0011675|Arrhythmia	{31}	{29}	{Sanguinetti,IVIC,",",Jiang,C,",",Curran,i,"\\\\",IE,",",Keating,l,"\\\\",’,IT,(,1995,),A,mechanistic,link,between,an,inherited,and,an,acquired,cardiac,arrhythmia,:,HERG,encodes,the,IKr,potassium,channel,.}	{"W'rote the paper : CAN lVlJH l\\\\/IDP PVVK DS GFKJIV .","References ll ."}	{"Cell 81 : 299 — 307 .","Vandenberg JI , VValker BD , Campbell TJ ( 2001 ) HERG K + channels : friend and foe ."}	0.848	0.016	0.974	{INV_POS_SEQ_[:],INV_WORD_SEQ_[:],INV_VERB_DEP_PATH_POS_[acquire]_[nsubj-parataxis|VBZ@amod-conj_and|NN]_[@amod],INV_VERB_DEP_PATH_[encode]_[nsubj@]_[conj_and@parataxis],INV_VERB_DEP_PATH_[acquire]_[nsubj-parataxis|encode@amod-conj_and|arrhythmium]_[@amod],INV_VERB_DEP_PATH_POS_[encode]_[nsubj@]_[conj_and@parataxis],INV_DEP_PATH_[nsubj-parataxis|encode@conj_and],INV_DEP_PATH_POS_[nsubj-parataxis|VBZ@conj_and]}	{-1.26501,0.559071,0.44142,0.44142,0.44142,0.44142,0.44142,0.44142}
SCPDFS_23036.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_23036.pdf_1545_1545_5_5_20_20_UNSUP	EWS/HP:0100242|Sarcoma	{5}	{20}	{A,novel,chimera,gene,between,EWS,and,E1A-F,",",encoding,the,adenovirus,E1A,enhancerbinding,protein,",",in,extraosseous,Ewing,’s,sarcoma,.}	{"Urano , F. , Umezawa , A. , Hong , W. , Kikuchi , H. , Hata , J .",", 1996 ."}	{"Biochem .","Biophys ."}	0.818	0	0.998	{DEP_PATH_POS_[prep_between-nsubj|NN@prep_in-partmod|VBG-dobj|NN],VERB_DEP_PATH_[enhancerbind]_[prep_between-nsubj|gene@partmod-dobj|e1a]_[prep_in@],VERB_DEP_PATH_POS_[enhancerbind]_[prep_between-nsubj|NN@partmod-dobj|NN]_[prep_in@],VERB_DEP_PATH_[encode]_[prep_between-nsubj|gene@]_[prep_in-partmod|enhancerbind-dobj|e1a@],DEP_PATH_[prep_between-nsubj|gene@prep_in-partmod|enhancerbind-dobj|e1a],VERB_DEP_PATH_POS_[encode]_[prep_between-nsubj|NN@]_[prep_in-partmod|VBG-dobj|NN@],"POS_SEQ_[CC_NN_,_VBG_DT_NN_NN_VBG_NN_,_IN_JJ_NNP_POS]","WORD_SEQ_[and e1a-f , encode the adenovirus e1a enhancerbind protein , in extraosseous Ewing ’s]"}	{0.211798,0.211798,0.211798,0.211798,0.211798,0.211798,0.174071,0.174071}
journal.pone.0002722.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0002722.pdf_86_86_4_4_12_12_UNSUP	MYC/HP:0002665|Lymphoma	{4}	{12}	{Our,global,mapping,of,MYC,binding,sites,in,a,human,B,cell,lymphoma,model,identiﬁed,over,2000,binding,sites,with,668,direct,Myc,target,genes,gleaned,from,accompanying,microarray,gene,expression,analysis,[,33,],.}	{"Although Myc ’s regulation of glucose metabolism has been well delineated , the connection between Myc and purine or pyrimidine metabolism is not well understood .","It stands to reason , however , that a master regulator such as Myc must somehow couple cell cycle traversal through S-phase with regulation of nucleotide metabolism and energy generation ."}	{"Among the direct Myc target genes is a statistically over-represented small set involved in nucleotide metabolism .","This observation led us to determine comprehensively whether genes involved in both purine and pyrimidine synthesis pathways are directly regulated by Myc ."}	0.74	0.712	1	{DEP_PATH_[nn@nn-prep_in|model],DEP_PATH_POS_[nn@nn-prep_in|NN],VERB_DEP_PATH_[identiﬁed]_[nn-prep_of|site-nsubj|mapping@]_[nn-prep_in|model-prep_of|site-nsubj|mapping@],"WORD_SEQ_[binding site in a human b cell]",POS_SEQ_[NN_NNS_IN_DT_JJ_NN_NN],VERB_DEP_PATH_POS_[identiﬁed]_[nn-prep_of|NNS-nsubj|NN@]_[nn-prep_in|NN-prep_of|NNS-nsubj|NN@]}	{1.1719,0.0140987,0,0,0,0}
SCPDFS_29941.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_29941.pdf_174_174_17_17_25_26_UNSUP	SRY/HP:0012245|Sex reversal	{17}	{25,26}	{Levilliers,",",J.,",",Van,der,Auwera,",",B.,and,Goodfellow,",",P.N.,:,Mutational,analysis,of,SRY,:,nonsense,and,missense,mutations,in,XY,sex,reversal,.}	{"Hawkins .","J.R. , Taylor , A. , Berta , P. ."}	{"Hum .","Genet ."}	0.896	0.118	0.998	{DEP_PATH_POS_[prep_of-dep|NN@prep_in-dep|NNS],"WORD_SEQ_[: nonsense and missense mutation in xy]",POS_SEQ_[:_NN_CC_NN_NNS_IN_NN],DEP_PATH_[prep_of-dep|analysis@prep_in-dep|mutation]}	{0.73382,0.577234,0.577234,0.253085}
SCPDFS_321.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_321.pdf_349_349_17_17_8_9_UNSUP	p53/HP:0003003|Colon cancer	{17}	{8,9}	{The,same,conclusion,was,further,confirmed,using,another,colon,cancer,cell,line,RKO,that,expresses,a,wild-type,p53,gene,.}	{"Moreover , we found that treatment of cells with the proteasome-specific inhibitor MG132 protected SIRT6 from degradation ( Figure 3 | ) , suggesting that S | RT6 protein degradation occurs through the proteasomal pathway .","Taken together , our results indicate that USP10 is a S | RT6 — specific deubiquitinase that protects S | RT6 protein from ubiquitin-mediated degradation through the proteasomal pathway ."}	{"As shown in Figure S3 , overexpression of USP10 but not its CA mutant prolonged SIRT6 halflife .","In contrast , knockdown of USP10 but not USP22 in RKO cells promoted SIRT6 degradation ."}	0.834	0.62	1	{INV_VERB_DEP_PATH_POS_[express]_[nn-dobj|NN@]_[nn@rcmod],INV_DEP_PATH_POS_[nn-dobj|NN-rcmod|VBZ@nn],INV_POS_SEQ_[NN_NN_NN_WDT_VBZ_DT_JJ],INV_DEP_PATH_[nn-dobj|gene-rcmod|express@nn],INV_VERB_DEP_PATH_POS_[use]_[nn-dobj|NN-rcmod|VBZ-dobj|NN@]_[nn-dobj|NN@],INV_VERB_DEP_PATH_[use]_[nn-dobj|gene-rcmod|express-dobj|rko@]_[nn-dobj|rko@],"INV_WORD_SEQ_[cell line rko that express a wild-type]",INV_VERB_DEP_PATH_[express]_[nn-dobj|gene@]_[nn@rcmod]}	{0.58861,-0.550096,0.233557,0.233557,0.233557,0.233557,0.233557,0.233557}
journal.pone.0025489.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0025489.pdf_35_35_15_15_10_11_UNSUP	PITX2/HP:0001087|Congenital glaucoma	{15}	{10,11}	{Nine,different,human,genes,have,been,associated,with,ASD,or,congenital,glaucoma,including,FOXC1,",",PITX2,",",PITX3,",",FOXE3,",",PAX6,",",MAF,",",CTPIBI,and,LMXIB,.}	{"Malformation of tissue speciﬁcally at the iridocorneal angle ( iridogoniodysgenesis anomaly ) or in the anterior stroma of the iris - contribute to the glaucoma phenotype [ 3,4 ] .","Anterior segment dysgenesis ( ASD ) phenotypes are inherited as autosomal dominant traits with variable expressivity and incomplete penetrance , pointing to a complex etiology [ 5,6 ] ."}	{"Mutations in the FOXC1 gene [ 7 ] , or dosage effects due to deletions [ 8 ] or duplications [ 9 , lO ] in the 6p25 region that surrounds FOXC1 can all cause iridogoniodysgenesis ; as can mutations in the PITX2/RIEG ] gene [ ll ] .","Patients with FOXC1 mutations have a milder average prognosis for glaucoma development than do patients with any one of the known PITX2 mutations [ 12 ] ."}	0.816	0.364	1	{INV_VERB_DEP_PATH_POS_[include]_[prep_including-prep_with|NN-_|VBN@ROOT@_]_[prep_with-_|VBN@ROOT@_],INV_DEP_PATH_POS_[prep_including@],INV_DEP_PATH_[prep_including@],INV_VERB_DEP_PATH_[have]_[prep_including-prep_with|glaucoma@aux]_[prep_with@aux],INV_VERB_DEP_PATH_[include]_[prep_including-prep_with|glaucoma-_|associate@ROOT@_]_[prep_with-_|associate@ROOT@_],INV_VERB_DEP_PATH_[be]_[prep_including-prep_with|glaucoma@auxpass]_[prep_with@auxpass],INV_VERB_DEP_PATH_POS_[have]_[prep_including-prep_with|NN@aux]_[prep_with@aux],"INV_WORD_SEQ_[include foxc1 ,]",INV_VERB_DEP_PATH_[associate]_[prep_including-prep_with|glaucoma@]_[prep_with@],INV_VERB_DEP_PATH_POS_[associate]_[prep_including-prep_with|NN@]_[prep_with@],"INV_POS_SEQ_[VBG_NN_,]",INV_VERB_DEP_PATH_POS_[be]_[prep_including-prep_with|NN@auxpass]_[prep_with@auxpass]}	{0.508456,-0.480273,-0.480273,0.303437,0.303437,0.303437,0.303437,0.303437,0.303437,0.229414,-0.0815257,0.0243948}
SCPDFS_44255.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_44255.pdf_7_7_21_21_19_19_UNSUP	AN/HP:0000526|Aniridia	{21}	{19}	{Phenotypic,parallels,and,genetic,evidence,from,comparative,mapping,suggest,that,the,murine,Small,eye,(,Sey,),and,human,aniridia,(,AN,),disorders,are,homologous,.}	{"Department of Biochemistry and Molecular Biology , University of Texas M. D. Anderson Cancer Center , Houston , Texas 77030","Received October 29 , 1991 ; revised January 31 , 1992"}	{"This report describes the isolation of a murine embryonic cDNA that is structurally homologous to the AN cDNA We recently cloned .","The murine cDNA detects a 2.7-kb transcript in the adult mouse eye and cerebellum and in human glioblastomas , suggesting a neuroectodermal involvement in the etiology of Sey/AN ."}	0.75	0.018	0.526	{INV_WORD_SEQ_[(],INV_POS_SEQ_[CD],INV_WORD_SEQ_NER_[NUMBER],INV_VERB_DEP_PATH_[suggest]_[det-dep|disorder-nsubj|aniridium-ccomp|homologous@]_[nsubj-ccomp|homologous@],INV_DEP_PATH_POS_[det-dep|NNS@],INV_VERB_DEP_PATH_POS_[suggest]_[det-dep|NNS-nsubj|NN-ccomp|JJ@]_[nsubj-ccomp|JJ@],INV_VERB_DEP_PATH_POS_[be]_[det-dep|NNS-nsubj|NN@cop]_[nsubj@cop],INV_VERB_DEP_PATH_[be]_[det-dep|disorder-nsubj|aniridium@cop]_[nsubj@cop],INV_DEP_PATH_[det-dep|disorder@]}	{1.56902,-1.55299,-1.27274,0.377785,0.377785,0.377785,0.377785,0.377785,0.377785}
journal.pone.0004243.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0004243.pdf_568_568_29_29_22_25_UNSUP	beta-catenin/HP:0003002|Breast carcinoma	{29}	{22,25}	{Prasad,CP,",",Gupta,SD,",",Rath,G,",",Ralhan,R,(,2007,),"\\\\",/,Vnt,signaling,pathway,in,invasive,ductal,carcinoma,of,the,breast,:,relationship,between,beta-catenin,",",dishevelled,and,cyclin,D1,expression,.}	{"Shekhar NIP , Tait L , Gerard B ( 2006 ) Essential role ofT-cell factor/beta-catenin in regulation of Rad6B : a potential mechanism for Rad6B overexpression in breast cancer cells .","Mol Cancer Res 4 : 729 — 745 ."}	{"Oncology 73 : 1124117 .",.}	0.834	0.006	1	{"INV_WORD_SEQ_[: relationship between]",INV_DEP_PATH_POS_[prep_between-dep|NN@prep_in],INV_DEP_PATH_[prep_between-dep|relationship@prep_in],INV_POS_SEQ_[:_NN_IN]}	{0.608675,0.348289,0.348289,0.205999}
journal.pone.0038449.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0038449.pdf_731_731_29_29_17_17_UNSUP	CDPX2/HP:0001596|Alopecia	{29}	{17}	{Three,of,these,syndromes,",",CHILD,",",CDPX2,and,desmosterolosis,",",exhibit,multiple,cutaneous,abnormalities,",",including,alopecia,",",and,there,are,reports,of,scarring,alopecia,in,patients,with,CDPX2,[,41,],.}	{"Although its role in the skin and skin appendages is incompletely understood , cholesterol is essential for epidermal barrier function [ 39 ] and forms an integral component of the hair follicle [ 40 ] .","Several human malformation syndromes are caused by inherited enzyme defects in cholesterol biosynthesis and lead to a deﬁciency of cholesterol as well as increased levels of bioactive or toxic precursor sterols [ 41 ] ."}	{"Recent studies by Evers et al [ 42 ] described hair growth defects in an Insig-deﬁcient mouse model .","These mice display defects in postnatal hair follicle cycling that result from the accumulation of cholesterol precursors ; the defects could be rescued after treatment with simvastatin ."}	0.82	0.058	1	{INV_DEP_PATH_[prep_with-prep_in|patient-prep_of|alopecia-nsubj|report-conj_and|be@prep_including-dobj|abnormality],INV_VERB_DEP_PATH_[be]_[prep_with-prep_in|patient-prep_of|alopecia-nsubj|report@]_[prep_including-dobj|abnormality@conj_and],"INV_POS_SEQ_[,_CC_EX_VBP_NNS_IN_NN_NN_IN_NNS_IN]","INV_WORD_SEQ_[, and there be report of scarring alopecia in patient with]",INV_DEP_PATH_POS_[prep_with-prep_in|NNS-prep_of|NN-nsubj|NNS-conj_and|VBP@prep_including-dobj|NNS],INV_VERB_DEP_PATH_POS_[be]_[prep_with-prep_in|NNS-prep_of|NN-nsubj|NNS@]_[prep_including-dobj|NNS@conj_and]}	{0.232588,0.232588,0.232588,0.232588,0.232588,0.232588}
journal.pone.0007618.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0007618.pdf_49_49_2_2_14_15_UNSUP	FMR1/HP:0000708|Behavioral abnormality	{2}	{14,15}	{Over-expression,of,FMR1,in,a,mouse,model,system,has,been,shown,to,result,in,abnormal,behavioral,and,neurological,activities,[,"18,19",],.}	{"p | osone.org highest levels seen in neurons and the Drosophila germ line [ l5 , l6 , 17 ] .","Like its human counterpart , regulation of dﬁnr ] is required for normal neuronal development and function ."}	{"Analogously , over-expression of dFMRl in the brain causes behavioral defects , axon guidance and extension defects , and dendritic branching abnormalities [ 20,2 l ,22,23,24 ] .","Both the human and Drasap/zila fragile X proteins bind their own mRNA and are involved in translational regulation [ 25,26,27 ] ."}	0.796	0.828	0.998	{VERB_DEP_PATH_POS_[result]_[prep_of-nsubjpass|NN@xcomp]_[nsubj-advcl|VBP@],VERB_DEP_PATH_[have]_[prep_of-nsubjpass|over-expression@aux]_[nsubj-advcl|[-xcomp|result@aux],VERB_DEP_PATH_[show]_[prep_of-nsubjpass|over-expression@]_[nsubj-advcl|[-xcomp|result@],"WORD_SEQ_[in a mouse model system have be show to result in]",VERB_DEP_PATH_POS_[show]_[prep_of-nsubjpass|NN@]_[nsubj-advcl|VBP-xcomp|VB@],VERB_DEP_PATH_[result]_[prep_of-nsubjpass|over-expression@xcomp]_[nsubj-advcl|[@],DEP_PATH_[prep_of-nsubjpass|over-expression@nsubj-advcl|[-xcomp|result],POS_SEQ_[IN_DT_NN_NN_NN_VBZ_VBN_VBN_TO_VB_IN],VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[nsubj-advcl|VBP-xcomp|VB@auxpass],VERB_DEP_PATH_[be]_[prep_of-nsubjpass|over-expression@auxpass]_[nsubj-advcl|[-xcomp|result@auxpass],DEP_PATH_POS_[prep_of-nsubjpass|NN@nsubj-advcl|VBP-xcomp|VB],VERB_DEP_PATH_POS_[have]_[prep_of-nsubjpass|NN@aux]_[nsubj-advcl|VBP-xcomp|VB@aux]}	{0.127258,0.127258,0.127258,0.127258,0.127258,0.127258,0.127258,0.127258,0.127258,0.127258,0.127258,0.127258}
journal.pone.0098128.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0098128.pdf_152_152_27_27_15_15_UNSUP	NP/HP:0002090|Pneumonia	{27}	{15}	{Prevalence,of,pneumococcal,carriage,among,children,was,estimated,considering,number,of,children,colonized,by,S.,pneumoniae,in,the,numerator,",",and,number,of,children,surveyed,for,whom,NP,swabs,were,collected,and,processed,in,the,denominator,.}	{"Data analysis Statistical analyses were performed using the STATA software , version 12.0 ( Stata Corp , College Station , TX ) .","The distribution of children according to age-group at recruitment and at 1 “ PCVlo dose was compared ."}	{"Pneumococcal serotypes identiﬁed by Quellung reaction were described ( including those present in PCV10 and PCV13 composition ) .","The main outcome of interest ( exposure variable ) was pneumococcal carriage of PCV10 vaccine type ."}	0.82	0.026	0.774	{INV_VERB_DEP_PATH_POS_[collect]_[nn-nsubjpass|NNS@]_[@prepc_for-partmod|VBN-prep_of|NNS-prep_in|NN],INV_DEP_PATH_POS_[nn-nsubjpass|NNS-prepc_for|VBN-partmod|VBN-prep_of|NNS-prep_in|NN@],INV_VERB_DEP_PATH_[collect]_[nn-nsubjpass|swab@]_[@prepc_for-partmod|survey-prep_of|child-prep_in|numerator],INV_VERB_DEP_PATH_POS_[process]_[nn-nsubjpass|NNS-prepc_for|VBN@prepc_for]_[@prepc_for-partmod|VBN-prep_of|NNS-prep_in|NN],"INV_WORD_SEQ_[in the numerator , and number of child survey for whom]",INV_VERB_DEP_PATH_[process]_[nn-nsubjpass|swab-prepc_for|collect@prepc_for]_[@prepc_for-partmod|survey-prep_of|child-prep_in|numerator],INV_VERB_DEP_PATH_[survey]_[nn-nsubjpass|swab-prepc_for|collect@]_[@partmod-prep_of|child-prep_in|numerator],"INV_POS_SEQ_[IN_DT_NN_,_CC_NN_IN_NNS_VBN_IN_WP]",INV_VERB_DEP_PATH_POS_[survey]_[nn-nsubjpass|NNS-prepc_for|VBN@]_[@partmod-prep_of|NNS-prep_in|NN],INV_DEP_PATH_[nn-nsubjpass|swab-prepc_for|collect-partmod|survey-prep_of|child-prep_in|numerator@]}	{0.16012,0.16012,0.16012,0.16012,0.16012,0.16012,0.16012,0.16012,0.16012,0.16012}
journal.pgen.1001306.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1001306.pdf_306_306_20_20_29_30_UNSUP	WMS/HP:0001083|Ectopia lentis	{20}	{29,30}	{Recently,",",mutations,were,found,in,other,members,of,the,ADAMTS,superfamily,",",ADAM,TS,],7,in,autosomal,recessive,WMS,[,29,],and,ADAM,TSL4,in,isolated,ectopia,lentis,[,35,],",",supporting,a,role,for,ADAMTS,family,members,in,microﬁbril,structure,and,function,.}	{"This notion is supported by another common ocular manifestation in WMS and Marfan syndrome , ectopia lentis ( dislocated or malpositioned lens ) .","Consistent with a defect in microﬁbril structure or function , ectopia lentis is caused by defects in the zonule ﬁbers that hold the lens in place and are composed of ﬁbrillin-containing microﬁbrils [ 34 ] ."}	{"Ultrastructural studies of human trabecular meshwork have shown changes with age that are more pronounced in POAG patients , including a thickening of sheaths that surround elastin ﬁbers and are composed of extracellular matrix , including ﬁbrillin and ﬁne ﬁbrils , as well as an accumulation of sheath-derived plagues in the aqueous humor outﬂow pathway [ 36 ] .","We have previously described similar changes in the trabecular meshwork of POAG-affected Beagles [ 37 ] , which could be explained by microﬁbril defects caused by the G1y661Arg variant in the ADAZVITSIO gene ."}	0.872	0.588	0.988	{DEP_PATH_POS_[@prep_in-conj_and|NN],VERB_DEP_PATH_[be]_[prep_in@auxpass]_[prep_in-conj_and|tsl4-prep_in|WMS@auxpass],VERB_DEP_PATH_[find]_[prep_in@]_[prep_in-conj_and|tsl4-prep_in|WMS@],POS_SEQ_[CD_CD_NN_CC_NNP_NN_IN_VBN],VERB_DEP_PATH_POS_[support]_[prep_in@partmod]_[prep_in-conj_and|NN-prep_in|NNP@partmod],"WORD_SEQ_[[ 29 ] and ADAM tsl4 in isolate]",VERB_DEP_PATH_POS_[find]_[prep_in@]_[prep_in-conj_and|NN-prep_in|NNP@],VERB_DEP_PATH_POS_[be]_[prep_in@auxpass]_[prep_in-conj_and|NN-prep_in|NNP@auxpass],VERB_DEP_PATH_POS_[isolate]_[@amod-prep_in|NN-conj_and|NN]_[@amod],VERB_DEP_PATH_[isolate]_[@amod-prep_in|lenti-conj_and|tsl4]_[@amod],DEP_PATH_[@prep_in-conj_and|tsl4],"WORD_SEQ_NER_[NUMBER NUMBER ] and ORGANIZATION tsl4 in isolate]",VERB_DEP_PATH_[support]_[prep_in@partmod]_[prep_in-conj_and|tsl4-prep_in|WMS@partmod]}	{-0.50469,0.189596,0.189596,0.189596,0.189596,0.189596,0.189596,0.189596,0.189596,0.189596,0.189596,0.189596,0.189596}
journal.pone.0080849.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0080849.pdf_387_387_24_24_30_30_UNSUP	ATM/HP:0001009|Telangiectasia	{24}	{30}	{Li,J,",",Chen,J,",",Ricupero,CL,",",Hart,RP,",",Schwartz,MS,et,al.,(,2012,),Nuclear,accumulation,of,HDAC4,in,ATM,deficiency,promotes,neurodegeneration,in,ataxia,telangiectasia,.}	{"Contributed reagents/materials/analysis tools : MPS JCS .","Wrote the manuscript : MM MPS JCS GPB ."}	{"Nat Med 18 : 783-790 .","doi : 10.1038 / nm .2709 ."}	0.852	0.894	0.858	{VERB_DEP_PATH_POS_[promote]_[prep_in-prep_of|NN-dep|NN@]_[prep_in-dobj|NN@],DEP_PATH_[prep_in-prep_of|hdac4-dep|accumulation@prep_in-dobj|neurodegeneration],VERB_DEP_PATH_[promote]_[prep_in-prep_of|hdac4-dep|accumulation@]_[prep_in-dobj|neurodegeneration@],"WORD_SEQ_[deficiency promote neurodegeneration in ataxia]",DEP_PATH_POS_[prep_in-prep_of|NN-dep|NN@prep_in-dobj|NN],POS_SEQ_[NN_VBZ_NN_IN_NN]}	{0.291907,0.291907,0.291907,0.291907,0.291907,0.0646626}
journal.pone.0006603.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0006603.pdf_12_12_13_13_5_5_UNSUP	ATM/HP:0001251|Ataxia	{13}	{5}	{At,molecular,level,",",the,ataxia,—,te,|,angectasia,—,mutated,(,ATM,),kinase,",",the,homeodomain,—,interacting,protein,kinase,—,2,(,HIPK2,),and,p53,were,found,activated,along,a,pro,—,apoptotic,signalling,pathway,while,p2IWa,“,',“‘,P,"\\"",“,"\\"",‘,was,prevented,from,its,protective,action,.}	{"Remarkably , the application of a S5 of 12 dyne/cm2 did not protect endothelial cells but markedly accelerated apoptosis compared to controls kept in static culture and in the presence of Bleo .","Experiments with the inducible nitric oxide synthase ( iNOS ) inhibitor GW274I5O significantly reduced the SS — dependent apoptosis indicating that the production of NO was relevant for this effect ."}	{"RNA interference experiments revealed that HIPK2 and p53 were both important for this process , however , only the forced expression p21Wa “ ' ° i \\" \\" 5d ” fully restored the SS — dependent pro — surviva | function .","Conclusions : This study provides the first evidence that , in the presence of genotoxic damage , laminar flow contributes to endothelial toxicity and death and identifies molecular targets potentially relevant in endothelial dysfunction and cardiovascular disease pathogenesis ."}	0.84	0.334	0.95	{INV_POS_SEQ_[CD_NN_NN_NN_CD_VBN_CD],"INV_WORD_SEQ_NER_[NUMBER te | angectasium NUMBER mutate NUMBER]",INV_DEP_PATH_POS_[nn-dobj|NN-partmod|VBN-nsubjpass|CD-rcmod|VBN@nn],INV_VERB_DEP_PATH_POS_[mutate]_[nn-dobj|NN@]_[nn@partmod-nsubjpass|CD-rcmod|VBN],"INV_WORD_SEQ_[— te | angectasium — mutate (]",INV_DEP_PATH_[nn-dobj|kinase-partmod|mutate-nsubjpass|NUMBER-rcmod|find@nn],INV_VERB_DEP_PATH_[find]_[nn-dobj|kinase-partmod|mutate-nsubjpass|NUMBER@]_[nn@rcmod],INV_VERB_DEP_PATH_POS_[find]_[nn-dobj|NN-partmod|VBN-nsubjpass|CD@]_[nn@rcmod],INV_VERB_DEP_PATH_[mutate]_[nn-dobj|kinase@]_[nn@partmod-nsubjpass|NUMBER-rcmod|find]}	{0.37688,0.132489,0.132489,0.132489,0.132489,0.132489,0.132489,0.132489,0.132489}
journal.pone.0087918.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0087918.pdf_442_442_41_41_3_3_UNSUP	p53/HP:0100242|Sarcoma	{41}	{3}	{The,examination,of,sarcoma,cells,illustrates,that,hypoxia,can,has,an,active,and,p53-dependent,role,in,the,cellular,response,to,differentially,impact,the,PLK,promoter,methylation,patterns,hypoxia,by,indirectly,restraining,the,mTOR,signaling,pathway,between,cell,types,",",and,that,p53,may,not,have,the,same,impact,during,hypoxia,",",so,it,was,expected,that,we,would,see,an,increase,on,the,epigenetic,regulation,of,the,PLK3,in,all,cells,.}	{"5c , d ) .","A study by Matthew et al. revealed that PLK2 i ) ."}	{"HIFIa in PLK2 in U2-OS and not Saos-2 [ 48 ] .","\\\\ / Vhen examining the transcript levels were examined and were found to be elevated by remaining P118 ‘ , PLK3 ’s promoter region did not appear to change 1.5-2 fold in both cell types ( Figure S2a ) ."}	0.704	0.206	0.996	{INV_WORD_SEQ_[TOO_FAR_AWAY],INV_VERB_DEP_PATH_POS_[have]_[nsubj@]_[nn-prep_of|NNS-nsubj|NN@ccomp],INV_VERB_DEP_PATH_POS_[have]_[nsubj-ccomp|VB@ccomp]_[nn-prep_of|NNS-nsubj|NN@ccomp],INV_VERB_DEP_PATH_[illustrate]_[nsubj-ccomp|have@]_[nn-prep_of|cell-nsubj|examination@],INV_VERB_DEP_PATH_[expect]_[nsubj-ccomp|have@ccomp]_[nn-prep_of|cell-nsubj|examination@ccomp],INV_VERB_DEP_PATH_[have]_[nsubj@]_[nn-prep_of|cell-nsubj|examination@ccomp],INV_DEP_PATH_[nsubj-ccomp|have@nn-prep_of|cell-nsubj|examination],INV_VERB_DEP_PATH_POS_[illustrate]_[nsubj-ccomp|VB@]_[nn-prep_of|NNS-nsubj|NN@],INV_VERB_DEP_PATH_[have]_[nsubj-ccomp|have@ccomp]_[nn-prep_of|cell-nsubj|examination@ccomp],INV_VERB_DEP_PATH_POS_[expect]_[nsubj-ccomp|VB@ccomp]_[nn-prep_of|NNS-nsubj|NN@ccomp],INV_DEP_PATH_POS_[nsubj-ccomp|VB@nn-prep_of|NNS-nsubj|NN]}	{-2.15153,0.30223,0.30223,0.30223,0.30223,0.30223,0.30223,0.30223,0.30223,0.30223,0.12987}
journal.pone.0008018.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0008018.pdf_40_40_5_5_7_7_UNSUP	CBS/HP:0002156|Homocystinuria	{5}	{7}	{In,humans,",",mutations,in,CBS,cause,homocystinuria,",",associated,with,vascular,disease,[,13,],",",with,>,130,CBS,mutations,identiﬁed,in,patients,[,14,],.}	{"In yeast , loss of Cys4p leads to cysteine auxotrophy [ 10 ] , while even in rich media cell proliferation is delayed by ~ 41-fold [ 1 1 ] .","Among natural yeast isolates CTS4 polymorphisms are the most common cause of sensitivity to pharmacological compounds [ 12 ] ."}	{"Interestingly , a hyperactive CBS allele that encodes a truncated CBS suppresses other disease — causing mutations [ 15 ] .","CBS activity positively correlates with cell proliferation in humans and yeast [ 16 ] ."}	0.82	0.818	1	{POS_SEQ_[VB],WORD_SEQ_[cause],DEP_PATH_POS_[prep_in-nsubj|NNS@dobj],DEP_PATH_[prep_in-nsubj|mutation@dobj],VERB_DEP_PATH_POS_[cause]_[prep_in-nsubj|NNS@]_[dobj@],VERB_DEP_PATH_POS_[associate]_[prep_in-nsubj|NNS@partmod-dobj|NN]_[@partmod],VERB_DEP_PATH_[associate]_[prep_in-nsubj|mutation@partmod-dobj|homocystinurium]_[@partmod],VERB_DEP_PATH_[cause]_[prep_in-nsubj|mutation@]_[dobj@]}	{-3.7261,2.98967,1.18359,1.06317,-0.336977,0.286617,0.124315,-0.100025}
journal.pone.0042644.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0042644.pdf_69_69_34_34_22_22_UNSUP	DYT1/HP:0001332|Dystonia	{34}	{22}	{To,test,this,hypothesis,",",we,administered,the,irreversible,complexII,inhibitor,3-nitroproprionic,acid,(,3-NP,),",",a,toxin,known,to,cause,dystonia,in,rodents,",",primates,and,humans,[,19,],",",to,DYT1,/,mac,/,"{",in,(,KI,),mice,.}	{"Collectively , these reports suggest that challenges to the neuronal energy/redox states could be a trigger for the pathogenic cascade in DYT1 .","Based on this information , we hypothesized that the mammalian DYT1 brain is sensitized to the effects of energy depletion and oxidative stress caused by disruption of the mitochondrial respiratory chain , which would trigger the disease phenotype ."}	{"Materials and Methods","Ethics Statement This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health ."}	0.832	0.26	0.998	{"INV_POS_SEQ_[IN_NNS_,_NNS_CC_NNS_VBP_CD_CD_,_TO]",INV_VERB_DEP_PATH_[know]_[prep_to@partmod-nsubj|toxin]_[dobj-xcomp|cause@],INV_DEP_PATH_POS_[prep_to@dobj-xcomp|VB-partmod|VBN-nsubj|NN],INV_VERB_DEP_PATH_POS_[cause]_[prep_to@xcomp-partmod|VBN-nsubj|NN]_[dobj@],"INV_WORD_SEQ_NER_[in rodent , primate and human [ NUMBER NUMBER , to]",INV_VERB_DEP_PATH_[cause]_[prep_to@xcomp-partmod|know-nsubj|toxin]_[dobj@],INV_DEP_PATH_[prep_to@dobj-xcomp|cause-partmod|know-nsubj|toxin],"INV_WORD_SEQ_[in rodent , primate and human [ 19 ] , to]",INV_VERB_DEP_PATH_POS_[know]_[prep_to@partmod-nsubj|NN]_[dobj-xcomp|VB@]}	{0.184231,0.184231,0.184231,0.184231,0.184231,0.184231,0.184231,0.184231,0.184231}
journal.pone.0087904.pdf	RELATION_GENEHPOTERM_journal.pone.0087904.pdf_185_185_0_0_4_6	MCT4/HP:0002860|Squamous cell carcinoma	{0}	{4,5,6}	{MCT4,expression,in,oral,squamous,cell,carcinoma,by,immunohistochemistry,.}	{"To dissect the mechanisms underlying MCT4 knock-down-mediated inhibition of cell proliferation , signaling molecules closely associated with cell proliferation , including two major proliferation pathways , AKT and MEK-ER_Kl / 2 , were","Figure 1 ."}	{"Representative images of tumor and associated stroma ( A , C .","— ."}	0.742	0.858	1	{DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NN_IN_JJ],"WORD_SEQ_[expression in oral]"}	{0.374951,0.356655,0.199886,0}
journal.pone.0050886.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0050886.pdf_39_39_32_32_40_42_UNSUP	LQT2/HP:0001664|Torsade de pointes	{32}	{40,41,42}	{l,current,IK,",",either,by,genetic,mutations,or,more,commonly,by,pharmacological,block,results,in,a,prolongation,of,the,ventricular,action,potential,possibly,inducing,a,long,QT,syndrome,type,2,(,LQT2,),which,increases,the,risk,for,lifethreatening,torsade,de,pointes,arrhythmia,[,9,],.}	{"l ( or HERG , human erg ) channels have been investigated in detail concerning their biophysical and pharmacological properties .","In the human heart , reduced function of the repolarizing Kvll ."}	{"In the last few years several “ HERG activators ” were developed which increase the Kvl 1.1 current by different alterations of the biophysical properties of the channels ( reviewed in [ 13 ] ) .","The small molecule compound NS1643 has been shown to activate native and heterologously expressed Kvl 1.1 channels [ l4 ,15 , l6 ,17,18,19 ] as well as Kv1l .2 channels [ 20 ] ."}	0.856	0.008	0.992	{VERB_DEP_PATH_[induce]_[nn-dep|)-dobj|type@]_[dobj-prepc_for|lifethreaten-rcmod|increase-dobj|type@],VERB_DEP_PATH_POS_[lifethreaten]_[nn-dep|NN@prepc_for-rcmod|VBZ]_[dobj@],VERB_DEP_PATH_POS_[induce]_[nn-dep|NN-dobj|NN@]_[dobj-prepc_for|VBG-rcmod|VBZ-dobj|NN@],"WORD_SEQ_[) which increase the risk for lifethreaten]",VERB_DEP_PATH_POS_[increase]_[nn-dep|NN@rcmod]_[dobj-prepc_for|VBG@],POS_SEQ_[NN_WDT_VBZ_DT_NN_IN_VBG],DEP_PATH_[nn-dep|)@dobj-prepc_for|lifethreaten-rcmod|increase],VERB_DEP_PATH_[increase]_[nn-dep|)@rcmod]_[dobj-prepc_for|lifethreaten@],VERB_DEP_PATH_[lifethreaten]_[nn-dep|)@prepc_for-rcmod|increase]_[dobj@],DEP_PATH_POS_[nn-dep|NN@dobj-prepc_for|VBG-rcmod|VBZ]}	{0.172145,0.172145,0.172145,0.172145,0.172145,0.172145,0.172145,0.172145,0.172145,0.172145}
journal.pone.0076951.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0076951.pdf_537_537_11_11_15_15_UNSUP	BRAF/HP:0002861|Melanoma	{11}	{15}	{It,has,been,shown,that,a,p53,mutation,together,with,the,BRAF,mutation,causes,invasive,melanomas,[,55,],",",while,an,overexpression,human,oncogenic,NRAS,(,Q61K,),mutant,in,a,p53,mutant,background,led,to,the,development,of,melanoma,[,60,],.}	{"The tumor cells of these patients also exhibited stem cell-like properties [ 59 ] .","Two of the mutant p53 zebrafish lines were viable and exhibited mutations similar to those found in human cancers ( p53 ( N168K ) and p53 ( M214K ) ) [ 55 ] ."}	{"In this study , we used p53 ( M214K ) fish to generate HBx and src transgenic fish and found that the p53 mutation , together with either HBx or src , induced the development of HCC , while the p53 ( M214K ) single mutant fish did not develop HCC .","The specific mechanism by which p53 mutations interact with HBx and src to promote cancer development is currently under investigation ."}	0.818	0.566	1	{VERB_DEP_PATH_[have]_[nn-prep_together_with|mutation-ccomp|cause@aux]_[nsubj-ccomp|[-ccomp|cause@aux],VERB_DEP_PATH_POS_[cause]_[nn-prep_together_with|NN@]_[nsubj-ccomp|VBP@],VERB_DEP_PATH_POS_[be]_[nn-prep_together_with|NN-ccomp|VBZ@auxpass]_[nsubj-ccomp|VBP-ccomp|VBZ@auxpass],VERB_DEP_PATH_[be]_[nn-prep_together_with|mutation-ccomp|cause@auxpass]_[nsubj-ccomp|[-ccomp|cause@auxpass],VERB_DEP_PATH_[show]_[nn-prep_together_with|mutation-ccomp|cause@]_[nsubj-ccomp|[-ccomp|cause@],DEP_PATH_[nn-prep_together_with|mutation@nsubj-ccomp|[],VERB_DEP_PATH_[cause]_[nn-prep_together_with|mutation@]_[nsubj-ccomp|[@],"WORD_SEQ_[mutation cause invasive]",VERB_DEP_PATH_POS_[show]_[nn-prep_together_with|NN-ccomp|VBZ@]_[nsubj-ccomp|VBP-ccomp|VBZ@],VERB_DEP_PATH_[lead]_[nn-prep_together_with|mutation-ccomp|cause-dep|show@]_[nsubj-ccomp|[-ccomp|cause-dep|show@],DEP_PATH_POS_[nn-prep_together_with|NN@nsubj-ccomp|VBP],VERB_DEP_PATH_POS_[have]_[nn-prep_together_with|NN-ccomp|VBZ@aux]_[nsubj-ccomp|VBP-ccomp|VBZ@aux],VERB_DEP_PATH_POS_[lead]_[nn-prep_together_with|NN-ccomp|VBZ-dep|VBN@]_[nsubj-ccomp|VBP-ccomp|VBZ-dep|VBN@],POS_SEQ_[NN_VBZ_JJ]}	{0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.115177,0.0276716}
journal.pone.0026268.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026268.pdf_547_547_23_23_32_33_UNSUP	SCN9A/HP:0002373|Febrile seizures	{23}	{32,33}	{Singh,NA,",",Pappas,C,",",Dahle,EJ,",",Claes,LRF,",",Pruess,TH,",",et,al.,(,2009,),A,role,of,SCN9A,in,human,epilepsies,",",as,a,cause,of,febrile,seizures,and,as,a,potential,modifier,ofDravet,Syndrome,.}	{"Bant JS , Raman Il \\\\ ’ I ( 2010 ) Control of transient , resurgent , and persistent current by open ~ channel block by Na channel beta4 in cultured cerebellar granule neurons .","Proc Natl Acad Sci U S A 107 : 12357412362 ."}	{"PLoS Genet .5 : e1000649 .","Nlacdonald RL , KangJQ Gallagher NIJ ( 2010 ) l \\\\ ’ Iutations in GABAA receptor subunits associated with genetic epilepsies ."}	0.852	0.604	1	{"POS_SEQ_[IN_JJ_NNS_,_IN_DT_NN_IN]","WORD_SEQ_[in human epilepsy , as a cause of]",DEP_PATH_POS_[prep_of-dep|NN@prep_of-prep_as|NN],DEP_PATH_[prep_of-dep|role@prep_of-prep_as|cause]}	{0.702491,0.702491,0.200261,0.200261}
journal.pone.0027183.pdf	RELATION_GENEHPOTERM_journal.pone.0027183.pdf_115_115_14_14_9_9	MGMT/HP:0009733|Glioma	{14}	{9}	{Employing,a,model,that,resembles,this,situation,",",T98G,glioma,cells,that,express,endogenous,MGMT,were,knocked-down,for,Rad51,.}	{"Although brain tumors usually express low levels of MGMT [ 20 ] , a major fraction of these malignancies do indeed show clinically relevant expression levels of this repair enzyme , making them unsuitable for treatment with O6AA .","To overcome this problem , MGMT inhibitors are being tested in trials for enhancing the effectiveness of TMZ and related agents ."}	{"The MGMT expressing T98G cells were completely resistant to TMZ , irrespective of Rad51 knockdown ( Fig .","4C ) ."}	0.802	0.948	0.992	{INV_POS_SEQ_[NNS_WDT_VBP_JJ],INV_DEP_PATH_[dobj-rcmod|express@nn],INV_VERB_DEP_PATH_[express]_[dobj@]_[nn@rcmod],INV_VERB_DEP_PATH_POS_[express]_[dobj@]_[nn@rcmod],INV_DEP_PATH_POS_[dobj-rcmod|VBP@nn],"INV_WORD_SEQ_[cell that express endogenous]",INV_VERB_DEP_PATH_[be]_[dobj-rcmod|express-nsubj|cell@cop]_[nn-nsubj|cell@cop],INV_VERB_DEP_PATH_POS_[employ]_[dobj-rcmod|VBP-nsubj|NNS@partmod]_[nn-nsubj|NNS@partmod],INV_VERB_DEP_PATH_POS_[be]_[dobj-rcmod|VBP-nsubj|NNS@cop]_[nn-nsubj|NNS@cop],INV_VERB_DEP_PATH_[employ]_[dobj-rcmod|express-nsubj|cell@partmod]_[nn-nsubj|cell@partmod]}	{0.483618,0.367139,0.367139,0.367139,-0.178051,0,0,0,0,0}
journal.pgen.1002544.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pgen.1002544.pdf_339_339_25_25_32_32_UNSUP	UGT1A1/HP:0002904|Hyperbilirubinemia	{25}	{32}	{SugataniJ,",",Yamakawa,K,",",Yoshinari,K,",",lV1achida,T,",",Takagi,H,",",et,al.,(,2002,),Identification,of,a,defect,in,the,UGT1A1,gene,promoter,and,its,association,with,hyperbilirubinemia,.}	{"J Hum Genet 48 : 4474450 .","7 ."}	{"Biochem Biophys Res Commun 292 : 4924497 .","8 ."}	0.808	0.29	0.994	{"WORD_SEQ_[gene promoter and its association with]",POS_SEQ_[NN_NN_CC_PRP$_NN_IN],DEP_PATH_POS_[nn-prep_in|NN-prep_of|NN-dobj|NN@prep_with],DEP_PATH_[nn-prep_in|promoter-prep_of|defect-dobj|identification@prep_with]}	{0.476264,0.476264,0.25157,0.25157}
journal.pone.0010876.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0010876.pdf_832_832_29_29_27_27_UNSUP	HERG/HP:0011675|Arrhythmia	{29}	{27}	{Sanguinetti,lVIC,",",Jiang,C,",",Curran,NIE,",",Keating,1,"\\\\",’,IT,(,1995,),A,mechanistic,link,between,an,inherited,and,an,acquired,cardiac,arrhythmia,:,HERG,encodes,the,1K,",",potassium,channel,.}	{"Science 252 : 156041562 .","2 ."}	{"Cell 81 : 2994307 .","3 ."}	0.844	0.016	0.984	{INV_POS_SEQ_[:],INV_WORD_SEQ_[:],INV_VERB_DEP_PATH_POS_[encode]_[nsubj@]_[appos@dep],INV_DEP_PATH_[nsubj-dep|encode@appos],INV_VERB_DEP_PATH_[encode]_[nsubj@]_[appos@dep],INV_VERB_DEP_PATH_[acquire]_[nsubj-dep|encode@amod-appos|arrhythmium]_[@amod],INV_VERB_DEP_PATH_POS_[acquire]_[nsubj-dep|VBZ@amod-appos|NN]_[@amod],INV_DEP_PATH_POS_[nsubj-dep|VBZ@appos]}	{-1.26501,0.559071,0.44892,0.44892,0.44892,0.44892,0.44892,0.0992442}
SCPDFS_39050.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_39050.pdf_928_928_1_1_13_14	TOR1A/HP:0001304|Torsion dystonia	{1}	{13,14}	{The,TOR1A,(,DYT1,),gene,family,and,its,role,in,early,onset,torsion,dystonia,.}	{"USA 86 : 840 — 844 .","Ozelius , L. I. , et al. ( 1999 ) ."}	{"Genomics 62 : 377 — 384 .","Greene , P. , Kang , U. I. , and Fahn , S. ( 1995 ) ."}	0.856	0.774	0.87	{"WORD_SEQ_NER_[NUMBER dyt1 ) gene family and its role in early onset]","WORD_SEQ_[( dyt1 ) gene family and its role in early onset]",POS_SEQ_[CD_NN_NN_NN_NN_CC_PRP$_NN_IN_JJ_NN],DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in]}	{0.403462,0.403462,0.403462,0.374951,0.356655}
SCPDFS_43204.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_43204.pdf_74_74_7_7_13_14_UNSUP	RDS/HP:0000510|Retinitis pigmentosa	{7}	{13,14}	{A,three-base,pair,deletion,in,peripherin,/,RDS,gene,in,one,form,of,retinitis,pigmentosa,.}	{"1 .","Farrer , G. J. , Kenna , P. , Jordan , S. A. , Kumer-Singh , R. , Humphries , M. M. , Sharp , E. M. , Shields , D. M. , and Humphries , P. ( 1991 ) ."}	{"Nature 354 : 478480 .","2 ."}	0.792	0.782	0.988	{"WORD_SEQ_NER_[gene in NUMBER form of]","WORD_SEQ_[gene in one form of]",DEP_PATH_POS_[nn@prep_of],DEP_PATH_[nn@prep_of],POS_SEQ_[NN_IN_CD_NN_IN]}	{1.06829,1.06829,-0.792973,-0.792725,0.698197}
journal.ppat.1000733.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.ppat.1000733.pdf_256_256_25_25_5_5_UNSUP	p53/HP:0002669|Osteosarcoma	{25}	{5}	{The,C2,mouse,model,of,osteosarcoma,differs,from,genetically,engineered,models,Several,mouse,models,of,osteosarcoma,have,been,developed,based,on,loss,or,alteration,of,p53,or,pRb,.}	{"Thus , treatments targeting either the protease or its upstream regulator result in inhibition of invasion .","These results suggest that operation of an NFAT — > MMP-2 pathway at elevated levels contributes to the metastatic behavior of osteosarcomas in CZ and F1 mice ."}	{"These reﬂect the occurrence of osteosarcoma in families with germlir1e mutations in these tumor suppressor genes and with their frequent somatic alterations in sporadic cases of the disease .","Mice with germline loss of p53 or ones expressing certain gain-of-function mutants develop osteosarcoma along with a variety of other tumors [ 33 — 35 ] ."}	0.714	0.076	0.978	{INV_WORD_SEQ_[TOO_FAR_AWAY],INV_VERB_DEP_PATH_[develop]_[prep_of-pobj|loss@]_[prep_of-nsubj|model@rcmod-prep_from|model],INV_VERB_DEP_PATH_POS_[differ]_[prep_of-pobj|NN-rcmod|VBN-prep_from|NNS@]_[prep_of-nsubj|NN@],INV_DEP_PATH_[prep_of-pobj|loss-rcmod|develop-prep_from|model@prep_of-nsubj|model],INV_VERB_DEP_PATH_POS_[engineer]_[prep_of-pobj|NN-rcmod|VBN@amod]_[prep_of-nsubj|NN@amod-prep_from|NNS],INV_DEP_PATH_POS_[prep_of-pobj|NN-rcmod|VBN-prep_from|NNS@prep_of-nsubj|NN],INV_VERB_DEP_PATH_[differ]_[prep_of-pobj|loss-rcmod|develop-prep_from|model@]_[prep_of-nsubj|model@],INV_VERB_DEP_PATH_POS_[develop]_[prep_of-pobj|NN@]_[prep_of-nsubj|NN@rcmod-prep_from|NNS],INV_VERB_DEP_PATH_[engineer]_[prep_of-pobj|loss-rcmod|develop@amod]_[prep_of-nsubj|model@amod-prep_from|model]}	{-2.15153,0.378668,0.378668,0.378668,0.378668,0.378668,0.378668,0.378668,0.378668}
SCPDFS_3117.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_3117.pdf_632_632_21_21_25_25_UNSUP	DAZ/HP:0000027|Azoospermia	{21}	{25}	{Identiﬁcation,of,a,novel,gene,",",DZIP,(,DAZ,—,interacting,protein,),",",that,encodes,a,protein,that,interacts,with,DAZ,(,deleted,in,azoospermia,),and,is,expressed,in,embryonic,stem,cells,and,germ,cells,.}	{"— .","Pera , R.A. , 2004 ."}	{"Genomics 83 , 834-843 .","Odenthal , J. , van Eeden , F. ] ."}	0.852	0.646	0.998	{POS_SEQ_[CD_VBN_IN],"WORD_SEQ_[( delete in]",DEP_PATH_[TOO_FAR_AWAY],"WORD_SEQ_NER_[NUMBER delete in]"}	{0.926876,0.38468,0.354873,-0.0632723}
journal.pone.0026996.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026996.pdf_330_330_29_29_39_39_UNSUP	alpha-synuclein/HP:0000726|Dementia	{29}	{39}	{Higashi,S,",",Iseki,E,",",Yamamoto,R,",",lVIinegishi,l,"\\\\",’,1,",",Hino,H,",",et,al.,(,2007,),Concurrenee,of,TDP-43,",",tau,and,alpha-synuclein,patholoQ,',in,brains,of,Alzheimer,’s,disease,and,dementia,with,Lewy,bodies,.}	{"Ann Neurol 61 : 4354445 .",.}	{"Brain Res 1 184 : 2844294 .",.}	0.832	0.818	1	{"WORD_SEQ_[patholoq ' in brain of alzheimer ’s disease and]",POS_SEQ_[NN_''_IN_NNS_IN_NN_POS_NN_CC],DEP_PATH_[conj_and-nn|tdp-43@prep_of-prep_in|brain],DEP_PATH_POS_[conj_and-nn|NN@prep_of-prep_in|NNS]}	{0.727568,0.727568,0.151335,-0.0621421}
SCPDFS_42721.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_42721.pdf_51_51_10_10_20_20_UNSUP	SLC3A1/HP:0003131|Cystinuria	{10}	{20}	{These,data,are,in,accordance,with,the,previous,localization,of,SLC3A1,on,chromosome,2p,",",obtained,by,linkage,analysis,with,cystinuria,families,(,8,),.}	{"The localization was established by analysis of 62 metaphases with 149 signals .","Fifty-one mitoses ( 82 % ) showed at least one ﬂuorescent signal on the proximal part of 21121 ; 28 mitoses ( 55 % ) exhibited signals on both chromatids ."}	{"The three markers used for cystinuria gene localization were previously localized on 2p16 , the band immediately distal to 21921 ( ' 7 ) .","This discrepancy is probably due to the relative inaccuracy of linkage mapping ."}	0.788	0.16	0.904	{VERB_DEP_PATH_[obtain]_[prep_of-prep_with|localization@partmod-prep_on|2p]_[nn-nsubj|family-advcl|(@],VERB_DEP_PATH_POS_[obtain]_[prep_of-prep_with|NN@partmod-prep_on|NN]_[nn-nsubj|NNS-advcl|VBP@],"POS_SEQ_[IN_NN_NN_,_VBN_IN_NN_NN_IN]",DEP_PATH_POS_[prep_of-prep_with|NN@nn-nsubj|NNS-advcl|VBP-partmod|VBN-prep_on|NN],"WORD_SEQ_[on chromosome 2p , obtain by linkage analysis with]",DEP_PATH_[prep_of-prep_with|localization@nn-nsubj|family-advcl|(-partmod|obtain-prep_on|2p]}	{0.227477,0.227477,0.227477,0.227477,0.227477,0.227477}
journal.pone.0011499.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0011499.pdf_201_201_8_8_36_37_UNSUP	HADH/HP:0000825|Hyperinsulinemic hypoglycemia	{8}	{36,37}	{It,is,interesting,that,L-3-hydroxyacyl-Coenzyme,A,dehydrogenase,(,HADH,),",",short,chain,",",which,is,part,of,the,beta,oxidation,pathway,in,mitochondria,",",was,downregulated,because,mutations,in,this,gene,have,been,linked,to,hyperinsulinemic,hypoglycemia,[,38,],.}	{"Frozen sections can be subjected to LCM , and enough RNA should be obtained to avoid the ampliﬁcation step .","Lipid metabolism With regard to lipid metabolism ( Table S1 ) , fatty acid synthase ( FASN ) expression was modestly upregulated ."}	{"Another downregulated gene of potential interest was stearoyl-CoA desaturase ( SCD ) , which contrasts with the increase found in Zucker fatty ( ZF ) rats after partial pancreatectomy [ 39 ] .","Channels and adrenergic receptor In the evaluation of channels important for GSIS ( Table S1 ) , KIR6 .2 ( KCNJI I ) had weak signal strength and no differential expression , but SUR1 was highly expressed and downregulated in diabetes ."}	0.778	0.018	1	{WORD_SEQ_[TOO_FAR_AWAY],VERB_DEP_PATH_[link]_[nn-nsubjpass|)@advcl]_[amod-prep_to|]@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass]_[amod-prep_to|NN-advcl|VBN@auxpass],VERB_DEP_PATH_[be]_[nn-nsubjpass|)@auxpass]_[amod-prep_to|]-advcl|link@auxpass],VERB_DEP_PATH_[be]_[nn-nsubjpass|)@auxpass-advcl|link]_[amod-prep_to|]@auxpass],DEP_PATH_[nn-nsubjpass|)@amod-prep_to|]-advcl|link],VERB_DEP_PATH_[have]_[nn-nsubjpass|)@aux-advcl|link]_[amod-prep_to|]@aux],VERB_DEP_PATH_[downregulate]_[nn-nsubjpass|)@]_[amod-prep_to|]-advcl|link@],VERB_DEP_PATH_POS_[link]_[nn-nsubjpass|NN@advcl]_[amod-prep_to|NN@],VERB_DEP_PATH_POS_[be]_[nn-nsubjpass|NN@auxpass-advcl|VBN]_[amod-prep_to|NN@auxpass],VERB_DEP_PATH_POS_[downregulate]_[nn-nsubjpass|NN@]_[amod-prep_to|NN-advcl|VBN@],VERB_DEP_PATH_POS_[have]_[nn-nsubjpass|NN@aux-advcl|VBN]_[amod-prep_to|NN@aux],DEP_PATH_POS_[nn-nsubjpass|NN@amod-prep_to|NN-advcl|VBN]}	{-2.70289,0.339876,0.339876,0.339876,0.339876,0.339876,0.339876,0.339876,0.339876,0.339876,0.339876,0.339876,0.339876}
journal.pone.0026609.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0026609.pdf_551_551_10_10_24_25_UNSUP	alpha-synuclein/HP:0100315|Lewy bodies	{10}	{24,25}	{Kramer,IVIL,",",Schulz-Schaelfer,W1,],(,2007,),Presynaptic,alpha-synuclein,aggre,»,gates,",",not,Lewy,bodies,",",cause,neurodegeneration,in,dementia,with,Lewy,bodies,.}	{"Perez N1 , Santa-l \\\\ ’ Iaria I , Gomez de Barreda E , Zhu X , Cuadros R , et al. ( 2009 ) Tau4an inhibitor of deacetylase HDAC6 function .","J Neurochem 109 : 175641766 ."}	{"J Neurosci 27 : 140541410 .","Lee S-J , Desplats P , Sigurdson C , Tsigelny I , l \\\\ ’ Ias1iah E ( 2010 ) Cell-to-cell transmission of non-prion protein aggregates ."}	0.774	0.36	1	{"WORD_SEQ_[aggre » gate , not Lewy body , cause neurodegeneration in dementia with]",VERB_DEP_PATH_[cause]_[nn-dep|aggre-nsubj|w1@]_[prep_with@],"POS_SEQ_[NN_CD_NNS_,_RB_NNP_NNS_,_VBP_NN_IN_NN_IN]",DEP_PATH_[nn-dep|aggre-nsubj|w1@prep_with],VERB_DEP_PATH_POS_[cause]_[nn-dep|NN-nsubj|NN@]_[prep_with@],"WORD_SEQ_NER_[aggre NUMBER gate , not PERSON body , cause neurodegeneration in dementia with]",DEP_PATH_POS_[nn-dep|NN-nsubj|NN@prep_with]}	{0.208372,0.208372,0.208372,0.208372,0.208372,0.208372,0.117925}
SCPDFS_437.pdf	RELATION_GENEHPOTERM_SCPDFS_437.pdf_330_330_0_0_4_4	TNC/HP:0012197|Insulinoma	{0}	{4}	{TNC,Expression,in,Human,Insulinomas,As,we,demonstrated,a,tumor-promoting,effect,of,TNC,in,the,murine,RT2,insulinoma,model,",",we,assessed,a,potential,clinical,relevance,by,determining,TNC,expression,in,human,insulinomas,using,qRT-PCR,and,immunohistochemical,staining,of,patient,tumor,tissue,.}	{"Because DKK1 blocks angiogenesis in aVEGFA context ( Min et al. , 2011 ) , we investigated whether full-length TNC binds VEGFA .","Indeed , by surface plasmon resonance we observed a dose-dependent binding of VEGFA to TNC ( Figure S7 ) , extending data on binding of VEGFA to the fifth FNIII domain in TNC ( De Laporte et al. , 2013 ) by providing a Kd of 2.7 x 1077 M , which is in the range of a VEGFA/glycosaminoglycan interaction ( 2.4 x 1043 M ) ( Wu et al. , 2009 ) ."}	{"Of note , insulinomas are rare and most are benign , yet a few ( 1 O % .","— ."}	0.802	0.514	0.998	{"WORD_SEQ_[expression in human]",DEP_PATH_[nn@prep_in],DEP_PATH_POS_[nn@prep_in],POS_SEQ_[NN_IN_JJ],VERB_DEP_PATH_POS_[determine]_[nn-dep|NN-advcl|VBD@prepc_by]_[prep_in-dep|NN-advcl|VBD@prepc_by],VERB_DEP_PATH_[determine]_[nn-dep|expression-advcl|demonstrate@prepc_by]_[prep_in-dep|expression-advcl|demonstrate@prepc_by],VERB_DEP_PATH_POS_[assess]_[nn-dep|NN-advcl|VBD@]_[prep_in-dep|NN-advcl|VBD@],VERB_DEP_PATH_POS_[demonstrate]_[nn-dep|NN@]_[prep_in-dep|NN@],VERB_DEP_PATH_[assess]_[nn-dep|expression-advcl|demonstrate@]_[prep_in-dep|expression-advcl|demonstrate@],VERB_DEP_PATH_[demonstrate]_[nn-dep|expression@]_[prep_in-dep|expression@]}	{0.384103,0.374951,0.356655,0.199886,0,0,0,0,0,0}
gb-2011-12-3-218.pdf	RELATION_GENEHPOTERM_gb-2011-12-3-218.pdf_12_12_3_3_17_18	TRP/HP:0002652|Skeletal dysplasia	{3}	{17,18}	{Mutations,in,several,TRP,genes,have,been,implicated,in,diverse,pathological,states,",",including,neurodegenerative,disorders,",",skeletal,dysplasia,",",kidney,disorders,and,pain,",",and,ongoing,research,may,help,ﬁnd,new,therapies,for,treatments,of,related,diseases,.}	{"Activated TRP channels cause depolarization of the cellular membrane , which in : urn activates voltage — dependent ion channels , resulting in a change ofirtracellular Ca “ concentration ; tr ey serve as gatekeepers for transcellular transpor : of several cations ( such as Ca “ and Mg “ ) , and are required for the function of intracellular organelles ( such as endosomes and lysosomes ) .","Because oftheirfunction as intracellular Ca “ release channels , they have an important regulatory role in cellular organelles ."}	{"* Correspondence : grzegorz .","owsianl k@rned.ku leuven ."}	0.85	0.924	1	{VERB_DEP_PATH_POS_[be]_[nn-prep_in|NNS-nsubjpass|NNS@auxpass]_[prep_including@auxpass],VERB_DEP_PATH_POS_[have]_[nn-prep_in|NNS-nsubjpass|NNS@aux]_[prep_including@aux],DEP_PATH_POS_[nn-prep_in|NNS-nsubjpass|NNS@prep_including],VERB_DEP_PATH_[have]_[nn-prep_in|gene-nsubjpass|mutation@aux]_[prep_including@aux],DEP_PATH_[nn-prep_in|gene-nsubjpass|mutation@prep_including],VERB_DEP_PATH_[be]_[nn-prep_in|gene-nsubjpass|mutation@auxpass]_[prep_including@auxpass],VERB_DEP_PATH_POS_[help]_[nn-prep_in|NNS-nsubjpass|NNS@conj_and]_[prep_including@conj_and],"POS_SEQ_[NNS_VBP_VBN_VBN_IN_JJ_JJ_NNS_,_VBG_JJ_NNS_,]",VERB_DEP_PATH_[implicate]_[nn-prep_in|gene-nsubjpass|mutation@]_[prep_including@],"WORD_SEQ_[gene have be implicate in diverse pathological state , include neurodegenerative disorder ,]",VERB_DEP_PATH_[help]_[nn-prep_in|gene-nsubjpass|mutation@conj_and]_[prep_including@conj_and],VERB_DEP_PATH_POS_[implicate]_[nn-prep_in|NNS-nsubjpass|NNS@]_[prep_including@]}	{0.419005,0.419005,0.419005,0.183341,0.183341,0.183341,0,0,0,0,0,0}
journal.pone.0032771.pdf	RELATION_GENEHPOTERM_journal.pone.0032771.pdf_45_45_19_19_15_16	Bcl-2/HP:0012191|B-cell lymphoma	{19}	{15,16}	{The,activation,of,the,caspase,proteins,is,regulated,by,a,variety,of,factors,including,the,B-cell,lymphoma,2,(,Bcl-2,),protein,family,[,1,],.}	{"The mechanisms involved in regulation of apoptosis have been studied extensively during the last decades .","The caspase protein family has been reported to have a central role in apoptosis ."}	{"The anti-apoptosis protein Bcl-2 and the pro-apoptosis protein Bax are well known members of the Bcl-2 family , acting as opposed apoptosis regulators .","Bcl-2 is associated with the outer mitochondrial membrane of viable cells and prevents Bax from perforating the outer mitochondrial membrane , causing cytochrome c to leak out [ 2 — 5 ] ."}	0.806	0.252	0.864	{"INV_WORD_SEQ_[2 (]",INV_DEP_PATH_POS_[nn-dep|NN@],INV_POS_SEQ_[CD_CD],"INV_WORD_SEQ_NER_[NUMBER NUMBER]",INV_DEP_PATH_[nn-dep|family@]}	{2.65695,-0.700848,-0.653649,0.224089,0.0781987}
journal.pone.0082666.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0082666.pdf_566_566_25_25_20_20_UNSUP	FANCA/HP:0001903|Anemia	{25}	{20}	{Yuan,F,",",Qian,L,",",Zhao,X,",",Liu,JY,",",Song,L,et,al.,(,2012,),Fanconi,anemia,complementation,group,A,(,FANCA,),protein,has,intrinsic,affinity,for,nucleic,acids,with,preference,for,single-stranded,forms,.}	{"M101855200 .","PubMed : 11297559 ."}	{"J Biol Chem 287 : 4800-4807 .","doi :10.1074 / jbc ."}	0.756	0.006	1	{"INV_WORD_SEQ_[complementation group a (]",INV_POS_SEQ_[NN_NN_DT_JJ],INV_DEP_PATH_POS_[nn-nsubj|NN@nn-dep|NN-dep|NN],INV_VERB_DEP_PATH_POS_[have]_[nn-nsubj|NN@]_[nn-dep|NN-dep|NN@],INV_DEP_PATH_[nn-nsubj|protein@nn-dep|group-dep|fanconus],INV_VERB_DEP_PATH_[have]_[nn-nsubj|protein@]_[nn-dep|group-dep|fanconus@]}	{0.544788,0.544788,0.090978,0.0576158,0.0576158,0.0576158}
SCPDFS_18540.pdf	RELATION_GENEHPOTERM_SUP_MAP_SCPDFS_18540.pdf_192_192_2_2_13_13_UNSUP	RUNX1/HP:0001909|Leukemia	{2}	{13}	{Mutations,in,RUNX1,seem,to,confer,a,predisposition,to,acute,mye,—,logenous,leukemia,",",but,additional,mutations,appear,to,be,needed,.}	{"An autosomal dominant disorder characterized by qualitative and quantitative platelet defects has been associated with non — sense and miss — sense mutations in RUNX1 gene .","Song and colleagues demonstrated a decrement in megakaryocyte colony formation in bone marrow and peripheral blood cells from affected individuals ."}	{"Finally , a genotypic correlation with the mild intellectual disability and the history of seizures is not obvious , but it 's worthy of consideration that Lindsay et al. ( 2012 ) , who described eight families with loss — of — function mutations of TGFB2 , reported mild developmental delay in two of their patients .","lntriguingly , both these patients carried a microdeletion ( 6.5 Mb and 3.5 Mb , respectively ) ."}	0.778	0.758	0.666	{VERB_DEP_PATH_[seem]_[prep_in-nsubj|mutation@]_[prep_to-xcomp|confer@],"WORD_SEQ_[seem to confer a predisposition to acute mye — logenous]",VERB_DEP_PATH_[need]_[prep_in-nsubj|mutation@xcomp-conj_but|appear]_[prep_to-xcomp|confer@xcomp-conj_but|appear],POS_SEQ_[VBP_TO_VB_DT_NN_TO_JJ_JJ_NN_JJ],VERB_DEP_PATH_POS_[seem]_[prep_in-nsubj|NNS@]_[prep_to-xcomp|VB@],VERB_DEP_PATH_POS_[confer]_[prep_in-nsubj|NNS@xcomp]_[prep_to@],VERB_DEP_PATH_[confer]_[prep_in-nsubj|mutation@xcomp]_[prep_to@],VERB_DEP_PATH_POS_[appear]_[prep_in-nsubj|NNS@conj_but]_[prep_to-xcomp|VB@conj_but],DEP_PATH_[prep_in-nsubj|mutation@prep_to-xcomp|confer],DEP_PATH_POS_[prep_in-nsubj|NNS@prep_to-xcomp|VB],VERB_DEP_PATH_POS_[need]_[prep_in-nsubj|NNS@xcomp-conj_but|VBP]_[prep_to-xcomp|VB@xcomp-conj_but|VBP],VERB_DEP_PATH_[appear]_[prep_in-nsubj|mutation@conj_but]_[prep_to-xcomp|confer@conj_but]}	{0.127555,0.127555,0.127555,0.127555,0.127555,0.127555,0.127555,0.127555,0.127555,0.127555,0.127555,0.127555}
journal.pone.0034839.pdf	RELATION_GENEHPOTERM_journal.pone.0034839.pdf_461_461_23_23_30_33	IL6/HP:0005181|Premature coronary artery disease	{23}	{30,31,32,33}	{Nlaitra,A,",",Shanker,J,",",Dash,D,",",John,S,",",Sannappa,PR,",",et,al.,(,2008,),Polymorphisms,in,the,IL6,gene,in,Asian,India,families,with,premature,coronary,artery,disease,»,the,Indian,atherosclerosis,research,study,.}	{"Jia X , Tian Y , VVang Y , Deng XX , Dong Z , et al. ( 2010 ) Association between the interleukin 6 gene “ .572 G > C and \\" 597 G/A polymorphism and coronary heart disease in the Han Chinese .","1 \\\\ / [ ed Sci 1 \\\\ ’ Ionit 16 : CR1034108 ."}	{"Thromb Haemost 99 : 9444950 .","Park S , Youn JC , Shin DJ , Park C1\\\\/I , Kim JS , et al. ( 2007 ) Genetic polymorphism in the pregnancy ~ associated plasma protein-A associated with acute myocardial infarction ."}	0.734	0.92	0.996	{DEP_PATH_POS_[nn-prep_in|NN-dobj|NNS@prep_with],DEP_PATH_[nn-prep_in|gene-dobj|polymorphism@prep_with],"WORD_SEQ_NER_[gene in LOCATION LOCATION family with]",POS_SEQ_[NN_IN_JJ_NNP_NNS_IN],"WORD_SEQ_[gene in asian India family with]"}	{1.05942,0.100819,0,0,0}
journal.pone.0028578.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0028578.pdf_460_460_14_14_23_23_UNSUP	PH/HP:0100324|Scleroderma	{14}	{23}	{In,addition,",",elevated,serum,IL6,concentrations,have,been,reported,in,patients,with,idiopathic,PH,or,PH,associated,with,inﬂammatory,diseases,such,as,scleroderma,and,lupus,[,3l,",32,33",],.}	{"IL-6 has recently been shown to play a prominent role in the development of pulmonary hypertension .","Overexpression of IL-6 promotes PH in mice , where as IL-6 knockout mice are protected from hypoxia-induced PH [ 29,30 ] ."}	{"Our data suggest that complement activation may play a role in stimulating IL-6 production in pulmonary hypertension since IL-6 expression was increased in hypoxic \\\\ / V T mice but not in C3 — / — mice .","In contrast to IL-6 we found that the ET-1 was increased in response to CH in both WT and C3 ."}	0.786	0.028	1	{DEP_PATH_POS_[prep_with@nn-prep_such_as|NN-prep_with|NNS-partmod|VBN],VERB_DEP_PATH_[associate]_[prep_with@partmod]_[nn-prep_such_as|3l-prep_with|disease@],POS_SEQ_[CC_NN_VBN_IN_JJ_NNS_JJ_IN],VERB_DEP_PATH_POS_[associate]_[prep_with@partmod]_[nn-prep_such_as|NN-prep_with|NNS@],DEP_PATH_[prep_with@nn-prep_such_as|3l-prep_with|disease-partmod|associate],"WORD_SEQ_[or ph associate with inﬂammatory disease such as]"}	{0.214064,0.214064,0.214064,0.214064,0.214064,0.214064}
journal.pone.0013779.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pone.0013779.pdf_215_215_12_12_16_16_UNSUP	MITF/HP:0002861|Melanoma	{12}	{16}	{If,true,",",it,raises,the,possibility,that,one,of,the,ways,MITF,might,also,suppress,melanoma,metastasis,is,through,its,transcriptional,activation,of,rniR-211,via,the,TRPM1,promoter,",",and,the,consequent,negative,post-transcriptional,effects,of,miR,—,211,on,KCNMA1,mRNA,.}	{"As expected , the extent of reduction in MITF transcript levels directly correlated with the reduction in TRPM1 and miR-211 transcript levels ( Figure 7 ) .","In conclusion , the results are consistent with the hypothesis that MITF co-ordinately regulates TRPM1 and rniR-211 expression ."}	{"The effect of miR — 211 on cell proliferation and invasion Since the over-expression of KCNMA ] is often associated with both cell proliferation and cell migration / invasion in various cancers [ 49 — 5 1 ] , we decided to determine whether the depletion of rniR-211 and associated over-expression of KCZMMA ] were important for these processes in melanoma cells .","\\\\ / Ve began by comparing the proliferation rates of melanoma cell lines stably transfected with the miR — 211 expression cassette with those of untransfected melanoma cells and cell lines transfected with the empty expression vector ( Figure 8A ) ( see Methods ) , respectively ."}	0.86	0.444	0.798	{"WORD_SEQ_[might also suppress]",VERB_DEP_PATH_POS_[suppress]_[prep_of-nsubj|CD@]_[nn-nsubj|NN-ccomp|CD@],VERB_DEP_PATH_[suppress]_[prep_of-nsubj|NUMBER@]_[nn-nsubj|metastasis-ccomp|NUMBER@],VERB_DEP_PATH_[be]_[prep_of-nsubj|NUMBER@cop-ccomp|NUMBER]_[nn-nsubj|metastasis@cop],DEP_PATH_POS_[prep_of-nsubj|CD@nn-nsubj|NN-ccomp|CD],DEP_PATH_[prep_of-nsubj|NUMBER@nn-nsubj|metastasis-ccomp|NUMBER],VERB_DEP_PATH_POS_[be]_[prep_of-nsubj|CD@cop-ccomp|CD]_[nn-nsubj|NN@cop],VERB_DEP_PATH_[raise]_[prep_of-nsubj|NUMBER-ccomp|suppress@]_[nn-nsubj|metastasis-ccomp|NUMBER-ccomp|suppress@],VERB_DEP_PATH_POS_[raise]_[prep_of-nsubj|CD-ccomp|VB@]_[nn-nsubj|NN-ccomp|CD-ccomp|VB@],POS_SEQ_[MD_RB_VB]}	{0.179484,0.179484,0.179484,0.179484,0.179484,0.179484,0.179484,0.179484,0.179484,-0.0184304}
journal.pcbi.1000851.pdf	RELATION_GENEHPOTERM_SUP_MAP_journal.pcbi.1000851.pdf_337_337_15_15_5_5_UNSUP	BCL2/HP:0002665|Lymphoma	{15}	{5}	{BCL2,(,B-cell,CLL,/,lymphoma,2,),suppresses,apoptosis,",",and,the,downregulation,of,BCL2,might,be,involved,in,the,acceleration,of,apoptosis,in,cancer,cells,.}	{"PTK2 and SMAD3 play important roles in cell growth and the activation of intracellular signal transduction pathways , suggesting that cell proliferation might accelerate during this stage .","Toggling of PTK2 ( ON ) - BCL2 ( OFF ) was observed in advanced and very advanced stages ."}	{"} + PLoS Computational Biology | www .","p | oscompbio | ."}	0.848	0.886	0.996	{"INV_POS_SEQ_[CD_NN_VBZ_NN_,_CC_DT_NN_IN]","INV_WORD_SEQ_NER_[NUMBER ) suppress apoptosis , and the downregulation of]",INV_VERB_DEP_PATH_POS_[suppress]_[prep_of-nsubjpass|NN-conj_and|VBN@]_[dep-nsubj|NN@],INV_VERB_DEP_PATH_POS_[involve]_[prep_of-nsubjpass|NN@]_[dep-nsubj|NN@conj_and],INV_VERB_DEP_PATH_POS_[be]_[prep_of-nsubjpass|NN@auxpass]_[dep-nsubj|NN@auxpass-conj_and|VBN],INV_DEP_PATH_[prep_of-nsubjpass|downregulation-conj_and|involve@dep-nsubj|cll],INV_DEP_PATH_POS_[prep_of-nsubjpass|NN-conj_and|VBN@dep-nsubj|NN],INV_VERB_DEP_PATH_[involve]_[prep_of-nsubjpass|downregulation@]_[dep-nsubj|cll@conj_and],"INV_WORD_SEQ_[2 ) suppress apoptosis , and the downregulation of]",INV_VERB_DEP_PATH_[be]_[prep_of-nsubjpass|downregulation@auxpass]_[dep-nsubj|cll@auxpass-conj_and|involve],INV_VERB_DEP_PATH_[suppress]_[prep_of-nsubjpass|downregulation-conj_and|involve@]_[dep-nsubj|cll@]}	{0.145724,0.145724,0.145724,0.145724,0.145724,0.145724,0.145724,0.145724,0.145724,0.145724,0.145724}
